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Abstract 
Cell migration is present throughout the life of all organisms, starting during the first 
stages of development and is crucial later for physiological functions during adulthood, 
such as wound healing, immune response, among others. It primarily relies on the ability 
of the actin cytoskeleton to polymerise and depolymerise, resulting in the emergence of 
dynamic protrusions.  
 
Understanding the regulation of the actin cytoskeleton has been an exciting challenge for 
every scientists working in this field. Decades of research established a pathway involving 
the small Rho GTPase family, the Scar/WAVE complex and the Arp2/3 complex. Tight 
regulation of each other protein’s activity and localisation allows actin polymerisation and 
pseudopods formation. Polarisation of these protrusive arms is crucial for cell steering and 
efficient migration. However, mechanisms dictating where a protrusion forms are largely 
unknown. This decision requires the cells to constrain the activity of the actin machinery at 
specific locations while excluding it elsewhere. 
 
A protein-protein interaction screen aiming to find new partners of the Scar/WAVE 
complex identified FAM49 as a putative candidate in proximity to the complex. Sequence 
analysis revealed an extremely good conservation across evolution and also a shared 
domain, uniquely found in CYFIP, a member of the Scar/WAVE complex involved in 
Rac1-mediated complex activation. Using a combination of biochemistry and imaging 
approches, we show that FAM49B binds specifically to the active form of Rac1 and 
buffers the GTPase activity. We hypothesise that recruitment to the membrane is driven by 
a combination of myristoylation and palmitoylation events that regulate the spatio-
temporal activity of the protein. 
 
Cancer and normal cells genetically depleted in FAM49B are unable to form defined 
pseudopods resulting in the formation of a large lamellipodium that correlates with a 
higher Rac1 activity. Migration and invasion of these cells is increased, although invasion 
was restricted to cancer cells, as it was not observed in non-cancerous cells types migrating 
in 3D. We also demonstrate that FAM49B is crucial during cyst formation in 3D culture 
and depends on Rac1 activity. This observation links the role of Rac1 during cell 
polarisation and its spatial downregulation required for generating signals to appropriate 
effectors. 
 
	 	 	 	
	
iii 
Based on mathematical modelling, it is our hypothesis that FAM49B functions as a local 
inhibitor, which is crucial for narrowing the diffusion of the Scar/WAVE complex by 
direct binding to Rac1. Here, we propose that FAM49B acts as the first Scar/WAVE 
complex inhibitor by competing for the binding to Rac1 and negatively regulates 
protrusion formation. Understanding the full mechanism of FAM49B activation is among 
one of the most exciting questions to follow up in this project.  
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1 
1 Introduction 
1.1 Overview of cell migration in biology: From a 
developmental to a pathological point of view 
In this exciting period of high-throughput screening, development of new 
immunotherapeutic approaches and advances in our understanding of epigenetic 
modifications of the genome, investigations into basic processes such as cell migration 
tend to be underrated. However, this kind of fundamental knowledge is at the root of most, 
if not all, biological phenomena and is required for more translational studies. 
Although the first observation of cell movement was made in the middle of the 19th, 
Michael Abercrombie is considered as the pioneer in the modern history of cell migration 
(Abercrombie et al., 1970) but at this time, the complexity of the processes involved was of 
course unknown. Cells move throughout the body in order to achieve critical functions: 
From development to wound healing and immune response, cell migration is fundamental 
throughout the lifespan of an organism and underlying molecular mechanisms have just 
started to emerge. For example, during avian gastrulation, cells respond to FGF (Fibroblast 
growth factor) signalling inducing EMT (Epithelial to mesenchymal transition) and 
regulating downstream pathways such as somatic mesoderm migration (Yang et al., 2002). 
Examples of early requirements of cell migration and actin regulation during 
embryogenesis are numerous: Using Drosophila as a model, Martin et al (Martin et al., 
2009) and Mason et al (Mason et al., 2013) unravelled some important mechanisms 
leading to apical constriction, which is thought to be important for sheet invagination and 
early organ formation. In their studies, they show that constriction of the apical end of a 
cell follows a pulsed pattern dependent on Twist and Snail transcriptional factors, which 
are pacing the frequency of the acto-myosin network constriction. This was shown to be 
dependent on the polarisation and differential activation of RhoGEF across the cell. 
In physiology, cell migration is crucial during immune response. Indeed, immune cells are 
specialized in scanning their environment and migrating to specialized compartments upon 
recognition of foreign antigens. This complex mechanism involves different types of 
environment, different cell-cell interactions and this is reflected by different behaviours in 
term of cell motility. For example, naive T-cells migrate within the lymph node and follow 
a random walk, mostly guided by a reticular network and using a haptokinetic-mode of 
migration based on a ligand-receptor mechanism. Cells alternate between fast and slow 
migration, reflecting the heterogeneity of the environment (Gerard et al., 2014). Upon 
activation, T-cell migration is highly skewed by a chemotactic gradient produced by the 
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antigen-presenting cells (APC), resulting in the swarming and the clustering of T-cells, 
allowing differentiation and immune memory. At this point, activated T-cells are 
functional and are attracted to the site of injury by APC in order to trigger the immune 
boost and clear out the infection (Krummel et al., 2016). This specific example clearly 
demonstrates the complexity of cell migration under normal conditions. 
 
However, when the regulation of cell motility goes askew, the potency of its mechanisms 
can lead to serious and life-threatening effects. Among them, the most studied is cancer 
metastasis. Similar to embryonic cells during gastrulation, most cancer cells arise within an 
epithelium and re-activate some proliferation and EMT pathways, leading to tumour 
growth, increasing motility and seeding to a distant metastatic site. Better understanding in 
cancer biology and drug efficiency allows improved survival upon early diagnosis in most 
cases (Quaresma et al., 2015). However, if spreading from the primary tumour has already 
occurred, the survival of the patient drops significantly and clearly reflects a lack of 
understanding of underlying mechanisms. In line with those numbers, over 90% of cancer-
related deaths are linked to metastasis and this is directly related to the failure of treatment 
to recognise and stop cells from spreading. 
 
These dramatic statistics emphasise the need to gain a deeper understanding of how cancer 
cells use cytoskeletal remodelling to spread. Some molecules are already in use for 
different cancer treatment strategies. For instance, the most famous one, Paclitaxel 
(Taxol®), an anti-mitotic molecule that stabilises microtubule polymers and blocks them 
from disassembly (Schiff et al., 1979). This molecule has led to a significant improvement 
in combined cancer treatments, although clinicians are aware of considerable side effects 
due to the lack of specificity. Indeed, healthy cells must also divide to maintain the pool 
required for their physiological functions and these cells also get targeted following the 
treatment delivery in a cancer patient. 
 
Since cancer cells are particulary motile, especially driven by actin-based protrusions, actin 
cytoskeleton would make an ideal target for inhibition. However, actin and actin-related 
proteins have been difficult to target because of their abundance and essential functions in 
healthy cells, such as muscle fibre contraction. This has progressively changed over the 
years as new molecules targeting the actin cytoskeleton have come out and show greater 
specificity for actin-based motility. For example, Stehn et al (Stehn et al., 2013) developed 
a specific tropomyosin inhibitor called TR100. This inhibits the high levels of tropomyosin 
that are present in motile metastatic tumour cells but affinity is weak enough to not affect 
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much lower levels found in healthy cells. This area of inhibitors is in its infancy but opens 
an encouraging avenue for researchers to continue their work and obtain a clearer picture 
of the different effectors driving cancer progression. 
 
Cell migration is a very plastic event and although cells have their default type of 
migration (mesenchymal mode used by stromal cells, collective migration used by 
epithelial cells just to cite a few) they can switch from one type to the other in order to 
adapt to their environment (Friedl and Wolf, 2010) and this adaptation might also be 
involved in drug-resistance.. 
1.2 Biology and mechanisms of actin polymerisation and 
cell spreading 
1.2.1 Cytoskeleton, major architect of the cell 
Cells need a rigid internal skeleton to maintain their shape and move over a surface but 
also have the ability to dynamically modify the length and the stability of their internal 
cytoskeleton. The cytosketon of mammalian cells comprises 3 main fibrous structures 
(Figure 1-1) and all are organised as polymers forming networks able to respond to 
external and internal cues, such as pressure (Thamilselvan and Basson, 2005), damage 
(Gefen and Weihs, 2016) and oxidation (Wilson and Gonzalez-Billault, 2015). 
Microtubules are composed of 13 protofilaments of alpha-beta tubulin dimers, organised 
radially from the centrosome. During interphase, they act as dynamic trails facilitating the 
trafficking of molecular motors along the filaments. As cell division starts, they profoundly 
modify their organisation and form a radial spindle, aligned at the place of the future 
cleavage furrow. This assures the equal distribution of the genetic material to each 
daughter cell. Thus, microtubules are highly dynamic and polarised structures and are 
characterised by their ability to undergo successive cycles of polymerisation-
depolymerisation called dynamic instability. Detailed characterisation of microtubule 
dynamics and their regulation is beyond the scope of this thesis and has been extensively 
reviewed (Akhmanova and Steinmetz, 2015; Conde and Caceres, 2009). 
Intermediate filaments are probably the least well described and understood cystosketal 
structures within the cell. They also represent a whole family of diverse proteins, which 
makes their characterisation more difficult but they have been divided as cytoplasmic or 
nuclear. Similarly to microtubules and actin filaments, members of this family show cell 
and tissue specificity and are involved in a large variety of functions, all related to physical  
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Figure 1-1: The cytoskeleton: Components and organisation 
A – Tubulin dimers are the major units for the organisation of the microtubules. They associate as 
protofilaments that wind together to form a microtubule. Microtubules are polarised with a 
dynamically growing plus end, rich in GTP-Tubulin and a GDP-Tubulin enriched minus end that 
emerges from a microtubule organisation centre (MTOC) in a cell during interphase. The MTOC is 
usually located next to the nucleus but moves significantly during cell migration.  
B – Intermediate filaments can be found in the cytosol and inside the nuclear membrane. There are 
4 types of intermediate filaments, named according to the main protein (Keratin, Desmin/Vimentin, 
Neurofilaments, Laminin). Monomers associate to each other by their central rod domain and form 
a final rope-like structure involved in nuclear organisation, cell-cell and cell-ECM adhesion, to 
highlight a few. 
C – Actin filaments (F-actin) are polarised structures with a barbed end (= Plus end) and a pointed 
end (= Minus end). F-actin is enriched below the cell cortex and at the cell protrusions. They link 
intracellular forces to the environment using adhesive structures. To note, the nature of the 
nucleotide (ATP or ADP) is not mentioned in this simple schematic and will be fully addressed in 
section 1.2.3.  
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forces and tension. Because of their different nature, they adopt different organisations 
(homo/heteropolymers and homo/heterodimers) and can associate along side to each other. 
Unlike nuclear intermediate filaments forming the nuclear membrane, which are relatively 
stable (except during cell division), cytoplasmic intermediate filaments are very dynamic 
throughout the cell cycle. They represent a whole area of research and more details about 
their organisation and regulation can be found elsewhere (Herrmann et al., 2007; Herrmann 
et al., 2009). 
 
Like intermediate filaments, the presence of nuclear and cytosolic actin is now accepted in 
the field of actin dynamics. However, nuclear actin has been difficult to study and its 
functions within this compartment remain largely unknown (de Lanerolle and 
Serebryannyy, 2011; Sharili et al., 2016). My thesis has focussed on cytoplasmic actin; so 
nuclear actin will not be discussed further. 
Actin was initially visualised at the end of the 19th century by a British physiologist, 
William Halliburton but the discovery was co-attributed to Straub and Szent-Gyorgyi after 
the Second World War (Szent-Gyorgyi, 1945). Similarly to microtubules, actin exists as a 
monomeric form (known as globular actin or more simply as G-Actin) and as polymers 
(known as F-actin). Actin filaments are polarised structures and are defined by a barbed 
end (plus end) and a pointed end (minus end) (Figure 1-1). This distinction is purely 
qualitative and is based on the shape of the filament ends obtained from electro-
microscopy pictures. This is related to the presence of the myosin head, which binds to the 
actin filaments in a polarised way. However, in contrast with microtubules, there is no 
specific organisation centre where filaments originate. Indeed, actin nucleation only 
requires a sufficient concentration of G-actin. Once initiated and under the right conditions, 
actin displays a steady polymerisation and depolymerisation referred to as treadmillling 
(see section 1.2.3) (Heuser and Kirschner, 1980; Wegner, 1976). 
This was a brief overview of the main components of the cytoskeleton. Together, those 3 
structures maintain a defined cell shape, allowing the cell to resist and react to the 
environment. These are also at the base of specific structures driving cell motility and I 
will next focus on the different types of actin-based protrusions resulting from actin 
nucleation. 
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Figure 1-2: Morphological features of an mesenchymal cell in 2D 
A - Graphical representation of the actin cytoskeleton during cell migration. In 2D, the cell front is 
dominated by a motile lamellipodium composed by a tight network of branched F-actin, underneath 
the plasma membrane. Filopodia emerge from the lamellipodium with a distinct actin organisation, 
mainly dominated by thick actin bundle. Focal adhesions (green) are physical linkers between the 
internal cytoskeleton and the extra-cellular matrix. The cell rear is the place of high activity of the 
acto-myosin network. 
B – Schematic representation of a filopodium protruding from the front of the lamellipodium. This 
highlights the structural differences between actin filaments. Indeed, F-actin in filopodia are long, 
straight and parallel. This reflects the activity of different actin nucleators and actin-binding 
proteins. B’ Platinum replicate EM picture representing a filopodium protruding outside the 
lamellipodium of a B16F1 cell. Reprinted with permission from Rockefeller University Press: [J. Cell 
Biol.], (Svitkina et al., 2003), copyright (2003). 
C-C’ & D-D’ – EM pictures of detergent-extracted keratocyte lamellipodium. Within the 
lamellipodium, difference of the density of branched actin can be observed between the smooth 
actin network (C-C’) and the brushlike zone at the edge of the cell (D-D’). Reprinted with 
permission from Rockefeller University Press: [J. Cell Biol.], (Svitkina et al., 1997), copyright 
(1997). 
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1.2.2 Actin-based protrusions, drivers of the cell motility 
1.2.2.1 Lamellipodium, filopodium and cell rear 
Within a cell, actin filaments can adopt different organisations depending on the local 
environment. Most of the early cell migration studies have used cells migrating on planar 
2-dimensional (2D) surfaces. Although not physiologically relevant for all cell types, it is a 
relatively easy system to study basic mechanisms involved during cell migration. Under 
those conditions, many cells type adopt distinct features and become polarised with a 
defined front and rear (Figure 1-2). The front of the cell is dominated by a highly motile 
flat-sheet structure called a lamellipodium, characterised by a rich network of branched-
actin localised just underneath the plasma membrane. The lamellipodium contains all the 
elements required for Arp2/3-dependent actin polymerisation and its regulation (see 
section 1.2.3). It is also an important compartment where forces are generated that allows 
cells to pull themselves forward (Shahapure et al., 2010). Indeed, growing actin filaments 
point their barbed end toward the plasma membrane and create a flow able to transmit 
intracellular forces directly to the focal adhesions during cell protrusion (Hoffmann and 
Schafer, 2010). 
 
Coming out from the lamellipodium, filopodia are finger-like protrusions characterised by 
parallel actin filaments. Filaments are organised as tight bundles by specific crosslinkers, a 
major one being Fascin (Vignjevic et al., 2006) (Figure 1-2). Precise information about 
Fascin will be detailed in chapter 8 but briefly, it functions as an actin-bundling protein. 
Fascin contains 2 actin-binding sites that mediate parallel orientation of actin filaments 
within filopodia (Jansen et al., 2011). This specific organisation also reflects the activity of 
different actin nucleation proteins, among them the formin family (Peng et al., 2003; 
Romero et al., 2004). Formins are large multidomain proteins characterised by a FH2 
domain that binds to the barbed end enabling insertion of G-actin and prevent the 
association of capping proteins, which could inhibit actin polymerisation. The FH1 domain 
acts to deliver G-actin (in complex with profilin) to the growing end, stimulating filament 
elongation even further (Goode and Eck, 2007). 
Because of their high motility and their localisation pointing outside the cell, filopodia 
have been seen as signalling hubs, able to sense the surrounding environment and deliver 
information (Prols et al., 2016). Taking the example of the zebrafish embryo, molecules 
from the Wnt-pathway can form clusters (signalosomes) and mediate signalling from 
stable filopodia (Stanganello et al., 2015). Similarly, specific proteins involved in 
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EGF/FGF signalling are recruited at the filopodium but their clear functions remain elusive 
(Prols et al., 2016). 
 
The cell rear in contrast is highly contractile due to the localisation of strong actomyosin-II 
bundles (Yam et al., 2007). Frequently, a retraction tail can be observed and is connected 
to the front by thick stress fibres, allowing for good coordination and helping the cell to 
pull itself forward. It is mostly an area with high actin depolymerisation and focal 
adhesions disassembly (Parsons et al., 2010). 
1.2.2.2 Invadopodia and other degradative structures. 
Over the years, scientists have been developing new tools to study cell migration using 
more physiological systems than glass. When a cell is plated on an extracellular matrix 
(ECM), it forms specialised structures known as invadopodia (cancer cells) and podosomes 
(macrophages, osteoclasts, dendritic cells, amongst others) (Linder, 2007; Murphy and 
Courtneidge, 2011) (Figure 1-3). They are actin-rich patches protruding out from the 
ventral face (in 2D) of the cell directly toward the ECM. They possess the main 
components required for actin polymerisation and are composed by a mix of parallel and 
branched F-actin (Schoumacher et al., 2010). They are sites of active secretion of 
proteases, leading to the degradation and the remodelling of the underlying ECM (Clark et 
al., 2007; Gawden-Bone et al., 2010). Differences between invadopodia and podosomes 
have remained subtle for a long time but a proper nomenclature has been adopted to 
characterise these structures (Murphy and Courtneidge, 2011). They mostly differ by the 
duration of turnover, ranging from few minutes for podosomes to hours for invadopodia. 
Also, podosomes tend to be localised at the periphery of a normal cell whereas 
invadopodia are often contained below the nucleus of cancer cells. 
Finally, as well as their role in cell attachment (see section 1.2.2.3), focal adhesions have 
been shown to be a site of degradation mediated by an indirect interaction between FAK 
and the protease MT1-MMP (Wang and McNiven, 2012). This raised questions about how 
these various structures (podosome, focal adhesion and invadopodia) share common 
properties and work together to promote cancer dissemination. These structures allow 
ECM remodelling and cell migration and together promote cell invasion and metastasis, 
which has been classified as a hallmark of cancer (Hanahan and Weinberg, 2011). 
	 													Introduction	 	 	
	
9 
 
Figure 1-3: Invadopodia and ECM degradation 
A – Cell migrating on a thin layer of labelled ECM. Invadopodia are actin-rich structures composed 
by a mix of branched and parallel actin filaments (Red). Local delivery of proteases at the site of 
the invadopodia leads to degradation of the ECM. 
B – Representative picture of an invadopodia assay. SCC61 cells (head and neck squamous 
carcinoma cells) were plated on a fluorescent matrix and stained for F-actin. Degradation can be 
visualised by the appearance of black spots, colocalising with an actin-rich structure and reflects 
the presence of an invadopodia (white arrow). Reprinted with permission from Nature Publishing 
Group: [Nat. Rev. Mol. Cell Biol], (Murphy and Courtneidge, 2011), copyright (2011). 
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1.2.2.3 Coupling actin protrusions to adhesion 
In order to generate movement and transmit forces, protrusions interact with the 
surrounding matrix using focal adhesions. Focal adhesions represent an interface between 
the environment and the cells and contain multi-molecular complexes, known as the 
“adhesome” (Figure 1-4). Focal adhesions are considered as a signalling hub mediating 
the transmission of information regarding matrix composition, environmental cues, 
activation state of intracellular signalling, in a bi-directional way (the so-called inside-out 
and outside-in signalling). They are also characterised by their ability to assemble and 
disassemble within a few minutes. This high turnover reflects the importance for the cell to 
maintain a dynamic pool of focal adhesion and adjust to the environment. Defects in 
adhesion dynamics or failure to form functional adhesions can lead to different diseases, 
such as cancer, inflammation, cardiovascular diseases, dystrophies to cite only a few 
(Winograd-Katz et al., 2014). 
 
 
 
Figure 1-4: Schematic representation of an adhesion 
Integrins are the molecular and signalling linkers between the extracellular matrix (ECM) and the 
cell. Once activated, proteins are recruited and transmit signals to the cell. Among the stimulated 
pathways, Arp2/3-dependent actin polymerisation allows a mechanical link with the cell body. 
Dynamic activation and regulation of this process leads to a coordination between cell protrusion 
and adhesion known as the clutch model (see Figure 1.5). 
	  
	 													Introduction	 	 	
	
11 
Adhesions are protein-rich structures but they are mostly organised around a core made by 
key ECM receptors, the integrin family. Upon activation and integrin clustering, Talin gets 
recruited in an actin-dependent way (Banno et al., 2012), followed by signalling and 
scaffolding molecules such as Src-family kinase, focal adhesion kinase (FAK), Paxillin, 
and Vinculin (Arias-Salgado et al., 2003; Brown et al., 1996; Humphries et al., 2007). 
Together, these proteins form a platform able to recruit the Arp2/3 complex (DeMali et al., 
2002; Serrels et al., 2007). Those nascent adhesions are enriched underneath the 
lamellipodium area (Nobes and Hall, 1995) where they mature to focal adhesion (FA) and 
are mediators for force transmission. It is thought that transition to a maturation step is 
dependent and correlated to the matrix stiffness (Walcott et al., 2011). Moreover, 
actomyosin contractility (Choi et al., 2008) and Rac1 signalling (Nayal et al., 2006), and 
more generally RhoGTPases, are important factors for FA formation, maturation and 
dynamics. FA disassembly is mostly mediated by clathrin dependent and independent 
recycling of integrins, which are either degraded or sent back to the plasma membrane 
(Bridgewater et al.). Interestingly, integrins are still signalling even while being recycled 
by the endosomal compartment (Alanko et al., 2015). Together, those events lead to 
constant renewal of FAs and follow a clutch model synchronised with the cell protrusions 
(Figure 1-5) and this coordination is crucial during force transmission.  
 
 
 
Figure 1-5: The molecular clutch model 
The model is based on the coordination at 3 molecularly distinct levels signalling to each other. The 
integrin signalling layer involves the focal adhesion kinase (FAK) and Paxillin, which are in close 
relation with the integrins. Talin and Vinculin form an intermediate zone that connects the integrin 
layer and the actin cytoskeleton. The nature of interactions within this layer and its organisation 
suggest a role of force transduction. The more distal layer is rich in actin and actin-regulatory 
proteins that stimulate actin polymerisation and structure the actin network. Mechanistically, when 
integrins are not engaged as part of the clutch, actin polymerisation follows a rapid retrograde flow 
and does not promote any traction force. However, upon engagement, forces resulting from actin 
polymerisation are directly transmitted to the ECM and as a consequence, slow down the actin 
retrograde flow, while active polymerisation at the + end drives membrane protrusion. Reprinted 
with permission from Nature Publishing Group: [Nat. Cell Biol], (Case and Waterman, 2015), 
copyright (2015). 
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1.2.2.4 Relevance of cell protrusion in 3D and alternative structures 
A cancer cell making its way out from the primary tumour to reach the closest capillary has 
to remodel a complex surrounding matrix. In line with this observation and in order to 
mimic more closely physiological conditions, assays have been designed where cells are 
forced to migrate through an ECM plug. In this condition, the typical polarisation of a cell 
is altered with a less well-defined front/rear axis. Notably, the lamellipodium is absent and 
the presence of stable focal adhesions has been questioned (Doyle and Yamada, 2016; 
Fraley et al., 2010). In order to illustrate this principle, Lammermann et al knocked out all 
integrin heterodimers in murine leukocytes and showed that 3D migration is not affected 
(Lammermann et al., 2008). However, it is now generally accepted that cells form 
adhesions, which are smaller and more transient in most 3D models. Cells also extend 
transient protrusions called pseudopods but filopodia, actin spikes, and invadopodia-like 
structures have also been described during 3D migration (Jacquemet et al., 2015). 
Together, they represent an interface between cell-matrix and play an important role for 
mechanosensing and force transduction. The rear of the cell is still the place of contraction 
forces, helping the cell to pull its body forward. In parallel, active secretion of proteases 
help the cell body to make its way through the tight lattices. 
 
In spatially confined conditions such as 3D ECM, a new structure working independently 
of protease activity can be observed. Blebbing or amoeboid migration represents a high-
dynamic type of migration, independent from protease activity and is seen as a more 
primitive process. Membrane blebs are bulky membrane extensions characterised by their 
fast turnover. Unlike others, their formation is actin polymerisation-independent 
(Cunningham, 1995) and mostly based on different intrinsic and extrinsic properties, such 
as cortical tension and matrix stiffness (Tinevez et al., 2009). Their formation is driven by 
the increase of intracellular pressure, dependent on the tension of the acto-myosin network, 
combined with a disruption of cortical actin (Keller and Eggli, 1998; Paluch et al., 2005). 
This generates a hydrostatic flux, pushing the membrane apart from the underlying 
cytoskeleton until an equilibrium between intra and extracellular pressures is reached. At 
this point, bleb retraction requires both Actin and Myosin-II (Blaser et al., 2006), although 
the mechanisms mediating actin polymerisation in a bleb are unclear: Indeed, neither 
Arp2/3 complex nor formins have been found localising at the retractile blebs, whereas 
contractile proteins (myosin and regulators) were recruited during the last step and 
localised at tiny clusters below the blebbing membrane (Charras et al., 2006). 
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In order to translate membrane blebbing to a proper movement, cells need: 1) To undergo 
cycles of bleb expansion/retraction. 2) To polarise membrane blebbing to one side of the 
cell body. Mechanisms allowing bleb polarisation are barely known but contractile 
molecules were shown to localise at the rear of migrating blebbling cells (Pinner and 
Sahai, 2008), suggesting that forces could directly come from one end and lead to 
increasing pressure at the other end. Together, both mechanisms lead to translocation of 
forces to the environment, and reduced cell-matrix attachment (Blaser et al., 2005; 
Grebecki et al., 2001), allowing the cell body to pull itself forward.  
 
To conclude, although cell protrusions show differences between 2D and 3D, they also 
share some common features and both promote cell migration. Depending on the 
environment, cells can rely on one type of protrusion over the others and this cross talk can 
also be considered as a potential target for therapeutic approaches  
In order to go more deeply into the regulation of these protrusions and understand how the 
actin network is formed, we will now describe the molecular mechanisms of actin 
polymerisation. 
1.2.3 Actin & actin polymerisation  
Actin is a 42 kDa protein encoded by 6 different genes (in birds and mammals). Isoforms 
can be classified in 3 main categories: Alpha-actin is predominantly found in muscle cells 
(skeletal, smooth and cardiac) that are specialised to be primarily a contractile machine, 
while beta and gamma-actin are not restricted to any cell types.  
At the protein level, actin isoforms are extremely well conserved with greater than 93% 
between the isoforms. Furthermore, as one of the most conserved proteins throughout 
evolution, actin displays around 85% amino acid identity even between distant organisms, 
from mammals to yeasts and divergent single celled organisms. The crystal structure of the 
monomeric form reveals a globular shape composed of 2 domains (large and small), each 
of which is subdivided into 2 subdomains and organised around a nucleotide-binding cleft 
(Figure 1.6) (Kabsch et al., 1990; Otterbein et al., 2001). Each domain contains a five-
stranded β sheet, with a β meander region and a right-handed βαβ motif. A flexible region 
links the large and small domains, resulting in an open/closed conformation. (Kabsch et al., 
1990; Otterbein et al., 2001). 
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Figure 1-6: Structure of an actin monomer in the ADP-bound state 
Ribbon structure of uncomplexed ADP-bound G-actin corresponding to the PDB entry 1J6Z 
(Otterbein et al., 2001). Structure was generated using PyMOL (v.1.7.4.5) and subdomains are 
shown using different colours: Sub-domain 1 (turquoise), sub-domain 2 (yellow), sub-domain 3 
(purple) and sub-domain 4 (green). ADP is not represented in the cleft. Green balls represent 
calcium ions. 
Previous structures were missing some parts of the sub-domain 2 because of its tight binding to 
DNase-I that was used for stabilisation purpose. The presented structure was obtained by using a 
molecule (TMR) covalently bound to a cysteine from sub-domain 1. 
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ATP sits in this pocket formed by subdomains 2 and 4 and can further be hydrolysed. The 
nature of the nucleotide affects the conformation of the actin structure.  
Actin polymerisation is an ATP-Mg2+-dependent process, although other cations have been 
shown to function in vitro (Kang et al., 2012; Strzelecka-Golaszewska et al., 1978). 
Polymerisation follows different steps: 1) the nucleation requires the formation of an actin 
nucleus composed by a trimer of G-actin. Thermodynamically, this step is highly 
unfavourable due to the instability of the dimer (Kd=4.6M) and therefore represents the 
rate-limiting factor (Sept and McCammon, 2001). Recently, it was however suggested that 
this nucleus grows in an unstable way until forming a pentameric seed, which was 
proposed as a more stable structure to induce actin polymerisation (Oda et al., 2016). 
However, a lot of biochemical evidence suggests that a trimer would be enough to initiate 
actin polymerisation. 2) Once the initiation step is overcome, polymerisation occurs very 
quickly and the elongation rate is proportional to the concentration of ATP-G-actin, 
although not totally linear (Weber et al., 1987). Polymerisation of ATP/Mg2+ bound-G-
actin can occur at both ends but is thermodynamically more favourable at the barbed end 
(Kd=0.12µM versus Kd=0.6 µM) whereas depolymerisation preferentially occurs at the 
slow growing pointed end. At the steady state, rate of growth and shrinkage are equal and 
this is referred to as treadmilling. 
 
Moreover, the chemical property is not homogenous throughout the filament and a 
molecule of G-actin at one end of the filament is different from a molecule released at the 
other end. Indeed, just after its introduction into the growing filament, ATP/Mg2+ bound-
G-actin gets quickly hydrolysed to ADP+Pi/Mg2+ bound-G-actin (half-life ~2sec). This is 
followed by the release of the inorganic phosphate (Pi) with a half-life 6 min. This results 
in the existence of an ATP gradient along the filament itself (Carlier et al., 1984). 
However, in an in vitro set up, presence and hydrolysis of ATP is not essential for actin 
polymerisation per se (Cooke, 1975; Kinosian et al., 2004) and just stabilises the molecule 
of actin within the filament (Isambert et al., 1995). Similarly, De La Cruz et al demonstrate 
that nucleotide-free actin is able to polymerise in high-sucrose concentration forming 
stable filaments in these conditions. However, F-actin slowly disassembles in low sucrose 
concentration. Electron microscopy showed similar organisation of these filaments, 
although 3D-reconstruction revealed a difference in the density between the 2 strands 
forming the filaments, possibly reflecting a slight difference in the filament twist. 
Together, authors concluded that hydrolysis and Pi dissociation are required to create this 
differential energy at the two ends of the filament, resulting in distinct critical 
concentrations. (De La Cruz et al., 2000).  
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Moreover, actin dissociation can be accelerated by cofilin, an actin-binding protein that 
was shown to associate with ADP-bound G-actin (Didry et al., 1998). In cellulo, the 
complex cofilin-ADP-bound G-actin can move away from the F-actin-rich compartment 
where it can interacts with other proteins such as the LIMK1 and the cyclase associated 
protein, both acting in parallel for the release of ADP-bound actin (Moriyama and Yahara, 
2002). Finally, nucleotide exchange is mainly dependent on the concentration difference 
between cytoplasmic ATP and ADP-actins, and allows the pool of ATP-bound G-actin to 
regenerate (Figure 1.7).  
1.2.3.1 Arp2/3 complex 
As mentioned previously, initiation of actin polymerisation is very slow on its own and 
would not be efficient enough to allow an adequate cellular response. However, once this 
kinetic barrier is overcome, the efficiency of the elongation process is really high and must 
be regulated in order to avoid uncontrolled events. This requires a tight balance between 
the main activators and inhibitors of the actin machinery, both in space and time. 
Cells have developed a way to catalyse actin nucleation and concomitantly, allow a spatio-
temporal control of the polymerisation. Although different actin nucleators have been 
described, among them the formin family (Goode and Eck, 2007), I will mainly focus here 
on the Arp2/3 complex. 
 
The Arp2/3 complex was initially recovered from Acanthanoeba lysate in a screen aiming 
to find new profilin interactors (Machesky et al., 1994; Mullins et al., 1997). The complex 
is organised around 2 actin-related proteins (Arp), Arp2 and Arp3 and 5 other subunits 
(ArpC1-5). Protein purification followed by size exclusion chromatography directly 
confirmed that at least 5 subunits (Arp2, Arp3, p40-Arc and p35-Arc, p14-Arc, equivalent 
to human Arp2, Arp3, ArpC1, ArpC2, and ArpC5) display a 1:1:1:1:1 stoichiometry 
distribution. Despite a lower stoichiometry value explained by difference during the gel 
staining process, p18 and p19 (human homologue of ArpC3 and ArpC4 respectively) have 
also been considered as being distributed in equimolar proportions (Machesky et al., 1994; 
Welch et al., 1997) (Kelleher et al., 1995;) and this was confirmed later (Mullins et al., 
1997). 
Complex members are highly conserved across evolution and both Arp2 and Arp3 
sequences and structures show a good similarity to G-actin (~30-50%) (Kelleher et al., 
1995; Machesky et al., 1994; Mullins et al., 1997). 
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Figure 1-7: Actin polymerisation and treadmilling 
Actin filament is not a homogeneous molecule. ATP-bound actin gets incorporated at the barbed 
(+) end, promoting filament growth. Quickly, ATP is hydrolysed to ADP-bound actin followed by a 
slow released of inorganic phosphate (Pi). Accumulation of ADP-bound actin destabilises the 
pointed (-) end, in parallel with its association with Cofilin. ADP-actin-Cofilin complex shuttles away 
from the actin-rich zone and upon phosphorylation by various proteins, such as LIMK and CAP 
proteins, ADP-actin is released and passively re-loaded with ATP. However, this reaction can be 
stimulated by profilin. Image inspired by (Moriyama and Yahara, 2002). 
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An initial structural study characterised the complex as a horseshoe shape able to bind 
actin filaments sideways (Mullins et al., 1997). They also proposed a rough organisation of 
the subunits relative to each other based on different crosslinking experiments before the 
3D X-ray crystal structure was then released following the crystallisation of what is 
thought to be the inactive conformation of the complex (Robinson et al., 2001).  
All these studies brought new insights about actin polymerisation regulation and allowed 
the community to have a broader mechanistic view. Arp2 and Arp3 sit next to each other 
within the complex and because of their actin-like structure, they serve as an initial seed, 
mimicking an actin dimer, therefore significantly lowering the kinetic barrier required to 
initiate the nucleation step. In vitro experiments showed that Arp2/3-mediated nucleation 
starts by the addition of a molecule of ATP/Mg2+ G-actin to the pre-formed Arp2-Arp3 
dimer in order to complete the trimeric shape required for the initiation step. In parallel, 
ArpC2 and ArpC4 form a structural platform, which the remaining subunits can bind. 
Indeed, both major subunits create an interface with the actin filament and are crucial for 
nucleation, branching and stability of the complex itself but also for stability of the newly 
formed branch (Goley et al., 2010). 
Together, the subunits sit on the side of a pre-existing mother filament with a 70 degree 
angle and the current model suggests that this preferentially occurs near the barbed end 
(rich in ATP-loaded actin) (Amann and Pollard, 2001). Upon ATP hydrolysis during 
filament aging, the interaction between the filament and the complex becomes weaker 
leading to the dissociation of the complex and its recycling for a new cycle. 
1.2.3.2 Functions of Arp2/3 complex  
As previously mentioned, the Arp2/3 complex stimulates the formation of branched-actin 
networks by bringing a template for the formation of a trimeric actin seed. Functions of the 
Arp2/3 complex have been extensively studied in vitro. Since genetic knockout mouse 
models were reported as lethal (Schwob and Martin, 1992; Yae et al., 2006), 
characterisation of the complex’s function in vivo has been delayed. However, many 
groups have now directly studied Arp2/3 requirement in different in cellulo and in vivo 
systems. 
Overall, loss of Arp2/3 complex leads to the absence of lamellipodia correlating with a 
spiky phenotype. Cell spreading is also greatly affected (Suraneni et al., 2012; Wu et al., 
2012) but requirement during cell migration is still contradictory. While ArpC3 knockout 
cells have impaired chemotaxis toward EGF, knockdown of ArpC2 or chemical inhibition 
of the Arp2/3 complex doesn’t affect migration along PDGF gradient (Wu et al., 2012). 
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Experimental design and technical features might be enough to explain this surprising 
result (Wu et al., 2013). Interestingly, ArpC2 knockout cells have a strong defect in 
haptotaxis and in focal adhesion morphology and dynamics (Wu et al., 2012). Authors 
linked this observation to a defect in the ability to align focal adhesions properly, 
suggesting a new role of the lamelipodium for sensing molecules bound to the ECM and 
rearranging spatial organisation of the focal adhesions. The Arp2/3 complex is also 
involved in a wide range of intracellular mechanisms. For example, a homologue of ArpC1 
has been shown to be required for phagocytosis in E. histolytica (Babuta et al., 2015). In 
mammalian macrophages, Arp2/3 is recruited at phagosomes and required for engulfment 
(May et al., 2000). A potential mechanism in which the Arp2/3 complex brings opposite 
membranes close to each other, by excluding E-cadherin molecules, and therefore 
favouring membrane fusion has recently been proposed (Sumida and Yamada, 2015). 
Among other functions, we can mention the requirement of the Arp2/3 complex during 
endosome fission using forces generated by the actin network and microtubules (Derivery 
et al., 2009b; Duleh and Welch, 2010). 
Arp2/3 was also involved in monolayer integrity maintenance. Indeed, authors give some 
evidence of its requirement for proper localisation of the VE-cadherin at cell-cell junction 
allowing tissue remodelling (Abu Taha et al., 2014). Moreover, cortactin was shown to 
recruit WAVE2 and Arp2/3 at the zonula adherens, and together, maintains the cell-cell 
tension (Han et al., 2014; Verma et al., 2012). 
Finally, Arp2/3 can be hijacked by pathogens to locally polymerise branched actin 
filaments. This can promote internalisation from the microenvironment of bacterial 
pathogens such as Salmonella, large parasitic pathogens like Toxoplasma gondii and even 
viruses. Once inside the cell, Arp2/3 can assist in intracellular movement and spreading of 
pathogens such as Listeria. This is dependent on bacterial virulence proteins directly 
injected or secreted into the host cell that mimic NPF functions by recruiting and 
stimulating Arp2/3-mediated actin nucleation, creating actin comet tails. (Bugalhao et al., 
2015). 
1.2.3.3 Regulation of the Arp2/3 complex 
It is now well accepted that purified Arp2/3 complex is functionally inactive (Mullins et 
al., 1998; Welch et al., 1998). This observation reflects different thoughts: 1) Arp2/3 
activation is crucial for a cell and has to be controlled. 2) Complex activation is dependent 
on other factors. 
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1.2.3.3.1 Intrinsic organisation of the Arp2/3 complex 
For a long time, the existence of different subunit isoforms has been under-investigated 
from the mechanical and functional points of view. However, recent studies suggest a more 
complex intrinsic regulation directly linked to the ability of the complex to nucleate actin. 
Recently, Abella and colleagues (Abella et al., 2016) showed the existence of different 
Arp2/3 complexes composed by the combination of specific ArpC isoforms, resulting in 
functionally different complex. Indeed, in mammals, gene duplication has led to the 
evolution of 2 distinct ArpC1 (termed ArpC1A and ArpC1B) and ArpC5 (ArpC5 and 
ArpC5L) proteins. Surprisingly, in vitro and cell-based experiments showed that the 
association of ArpC1B/ArpC5L within the complex promotes much stronger actin 
polymerisation compared to a complex including the two other isoforms. In parallel, 
ArpC1B or ArpC5L-induced faster filament shrinkage because of the involvement of 
specific actin regulators. (Abella et al., 2016) 
In addition, some partial Arp2/3 complexes were retrieved from mass spectrometry 
experiments looking at the composition of focal adhesions (Chorev et al., 2014). The 
authors proposed a model involving a core complex composed by Arp2, Arp3, ArpC2 and 
ArpC3. This would be able to either form a fully functional Arp2/3 complex or be directed 
to the focal adhesions after binding to vinculin/alpha-actinin. Mechanisms regulating this 
switch are still unknown but the thought of having a site-specific functional Arp2/3 
complex can open new hypotheses and help to decipher new mechanisms controlling local 
polymerisation. 
1.2.3.3.2 Role of ATP during Arp2/3 regulation 
Like actin, Arp2 and Arp3 have a nucleotide-binding cleft where ATP is able to fit in 
(Dayel et al., 2001; Le Clainche et al., 2001). ATP binding is crucial for the complex 
activity and once coupled to nucleation promoting factor (NPF) binding (see section 
1.2.3.2.4), actin polymerisation is initiated. Both events allow conformational changes of 
the complex and are critical for the activity of the complex (Rodal et al., 2005). Recently, 
the conserved C-terminal tail of Arp3 was identified as an ATP-dependent molecular 
switch, regulating actin nucleation (Rodnick-Smith et al., 2016). Although ATP hydrolysis 
has been reported for Arp2 in specific experimental conditions, the same event has not 
been confirmed for Arp3 (Goley et al., 2004). However, it is still unclear whether ATP-
hydrolysis of Arp2 and potentially Arp3 is mandatory for stimulating actin assembly 
(Martin et al., 2005). Indeed, the current model points toward a link between ATP 
hydrolysis on Arp2 and complex dissociation in vitro and during endocytic event in S. 
cerevisae (Martin et al., 2006). 
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1.2.3.3.3 Role of phosphorylation during Arp2/3 regulation 
Post-translational modifications such as phosphorylations, are reversible events and can 
positively and negatively modulate protein activity within a few seconds. This is also true 
for the Arp2/3 complex and phosphorylation of Arp2 has been reported in rat 
adenocarcinoma cells. LeClaire et al (LeClaire et al., 2008) show that phosphorylations of 
the conserved Tyr202 and Thr237/238 are required for actin polymerisation and 
lamellipodia formation. This event is tightly regulated by the cell upon epidermal growth 
factor (EGF) stimulation and reached a peak after 3min before going back to its basal state. 
A model was proposed in which Arp2 was maintained in an inactive conformation by a 
network of salt-bridges, the latter being disrupted upon Arp2 phosphorylation and allowing 
the switch to an active conformation (Narayanan et al., 2011). However, phosphorylation 
events are not sufficient to induce actin polymerisation in the absence of NPFs, which 
remain key activators of the Arp2/3 complex (LeClaire et al., 2008). 
1.2.3.3.4 Nucleation Promoting Factors (NPFs) 
Most of the aforementioned events act in synergy with NPFs, and together, fine-tune the 
complex activity. They are classified in 2 categories based on the organisation of their C-
terminus end and the presence (Class I) /absence (Class II) of a VCA domain (Verpolin-
Central-Acidic domain) (Rotty et al., 2013). It represents a very conserved combination of 
amino acids with common features and is composed by 3 motifs with distinct functions: 1) 
V-motif also known as WH2-domain binds G-actin and brings an actin monomer in close 
vicinity to the Arp2-Arp3 dimer. 2) C-motif also known as Central domain and 3) A- or 
Acidic motif acts in parallel to mediate interactions with the Arp2/3 complex (Kelly et al., 
2006). Binding and activation of the complex were shown to be dependent on a conserved 
tryptophan residue in the A-motif (Ti et al., 2011). It has now been widely shown in vitro 
that VCA domain on its own is sufficient for the complex activation and can greatly 
accelerate filament formation (Higgs and Pollard, 1999; Machesky et al., 1999). 
 
Class I 
Members of the class I family include WASP, N-WASP, Scar/WAVE1-3, WASH, 
WHAMM, and JMY, and am commonly known as the WASP family. They are all 
characterised by a conserved VCA domain and a more diverse N terminal part leading to 
different regulating and binding partners. WASP and N-WASP are characterised by the 
presence of a Cdc42 Rac1 Interacting Binding domain, responsible for interaction with 
these GTPases (Rohatgi et al., 2000). Regulation of this family is thought to be similar, 
although still unclear for some members. For example, basic region of N-WASP interacts 
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with the A-motif while the autoinhibitory domain folds over the regulatory C-terminal 
domain, leading to the inhibition of the protein. Upon activation by Cdc42 and lipid 
binding, the protein opens up and releases its VCA tail, making it free to interact with the 
Arp2/3 complex (Rohatgi et al., 2000). In contrast, Scar/WAVE is part of a stable 
pentameric complex known as the WAVE Regulatory Complex (WRC) (see section 1.4), 
responsible for both localisation and regulation of the Arp2/3 complex. A similar 
mechanism is proposed to have evolved in parallel for the regulation of the WASH protein, 
which belongs to a homologous complex (WASH complex) and plays a role during 
Arp2/3-mediated endosomal trafficking (Jia et al., 2010). 
Biological functions of each member are reported in Table 1 and we will highlight the 
roles and the regulation of the Scar/WAVE proteins in more details in section 1.4.2.5. 
 
Class II 
Cortactin is the typical Class II NPF and similar to members from the Class I, it contains 
an acidic region mediating the binding to Arp2/3. The absence of a G-actin binding motif 
is overcome by an F-actin binding motif composed by a central tandem repeat motif. 
Cortactin-mediated Arp2/3 activation is much less efficient compared with Class I NPFs 
(Uruno et al., 2001; Weaver et al., 2001) and the mechanism is still not entirely clear. A 
FRET study suggests that cortactin is not able to promote the conformational change of the 
Arp2/3 structure required for its activation (Goley et al., 2004), which could explain the 
weaker effect observed. The actual view proposes a role of cortactin in the stabilisation of 
the Arp2/3 complex branching and strengthening the Arp2/3 association with F-actin 
(Weaver et al., 2001), by contacting Arp2, ArpC2, ArpC4 and ArpC5 (Weaver et al., 
2002). 
However, cortactin can act in parallel and synergise the activity of a Class I NPF. This was 
shown in vitro using smTIRF and by mathematical modelling based on the ability of 
cortactin to displace purified VCA within a N-WASP-stimulated Arp2/3 complex and 
speed up nucleation at the side of a forming branch (Helgeson and Nolen, 2013). 
 
Other NPFs. 
Deeper understanding of actin nucleation led to the discovery of new regulators. Among 
them, Dip1, a member of the WISH/DIP/SPIN90 family has been reported to stimulate 
Arp2/3-actin polymerisation during endocytosis using a distinct mechanism (Wagner et al., 
2013). Indeed, this family stands out because of the 3 major features: 1) Members do not 
bind to G-actin. 2) They do not require mother filaments to stimulate actin polymerisation. 
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3) Binding to Arp2/3 is different from the canonical model proposed for the WASP-family. 
Full understanding of how these proteins work awaits further research. 
 
 
 
 
Table 1-1:  Localisation of NPFs in mammalian cells 
Table summarising the localisation of the Class I NPFs and their importance for the formation and 
organisation of different cellular structures. 
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1.2.3.3.5 Branching inhibitors 
Actin polymerisation regulation is a double-edged process where the stimulating factors 
have to be counterbalanced. Here I will briefly discuss the emergence of negative 
regulators affecting actin branching. 
The first idea of actin branching inhibitor came based on the composition of the actin 
filament itself. Indeed, in a cell, actin filaments are not naked and can be covered by 
different molecules. Blanchoin et al (Blanchoin et al., 2001) showed that tropomyosin, a 
protein involved in acto-myosin contraction, has a negative effect on actin branching, 
probably due to a steric effect. Indeed, tropomyosin runs along each side of the filament, 
which impaired Arp2/3 binding to the existing filament playing a crucial role as a second 
signal to initiate actin polymerisation. This greatly delays the initiation of the branching 
and affects the number of branching events. 
 
PICK1 protein (Protein interacting with C kinase 1) was also shown to inhibit Arp2/3-
dependent endocytosis via a direct binding to both F-actin and Arp2/3 (Rocca et al., 2008). 
Although the mechanism by which the inhibition occurs has not been deeply investigated, 
residues involved were mapped and point mutants were not able to rescue the knockdown 
phenotype anymore. However, the function of PICK1 as a regulator of the Arp2/3 complex 
is still controversial (Madasu et al., 2015). 
 
GMF (Glial Maturation Factor) is a member of the ADF/cofilin superfamily and was 
described as a debranching protein, dynamically colocalising with cortical actin patches in 
S. cerevisae (Gandhi et al., 2010). Mass spectrometry and biochemical pulldown showed a 
direct interaction between GMF and Arp2/3, inhibiting actin nucleation. TIRF imaging 
shows that addition of GMF leads to the severing of the newly formed branches resulting 
in a more linear actin network. GMF function in vivo was confirmed using RNA 
interference (RNAi) in D. melanogaster as it affects actin rearrangement and drives 
collective migration of border cells during development (Poukkula et al., 2014). 
 
Since actin nucleation is not only restricted to the region adjacent to the plasma membrane, 
but also has an important role in intracellular vesicle trafficking, specific regulators have 
been described to spatially regulate Arp2/3 activity. Gadkin (Gamma-A1-Adaptin and 
Kinesin Interactor) is one of them and acts at the endomembrane level, specifically at the 
trans-Golgi compartment (Maritzen et al., 2010). Gadkin binds to the complex via a 
tryptophan residue located in its acidic motif and co-localises with endosomal ArpC2. 
Depletion of Gadkin redistributes Arp2/3 complex at the membrane and results in an 
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increase of cell spreading (Maritzen et al., 2012). Also, Gadkin is important for in vitro 2D 
and 3D migration of primary dentritic cells, although this effect is not reflected in vivo 
(Schachtner et al., 2015). 
 
Finally, Arpin (Actin-related protein inhibitor) is the most recent Arp2/3 regulator that 
came out from sequence alignments aiming to find new NPFs (Dang et al., 2013). Arpin 
binds to ArpC2 in an active Rac1-dependent manner and colocalises with the WRC. 
Together, this leads to negatively regulate protrusion dynamics and balance the activity of 
the WRC. Recent structural analyses suggest that the acidic motif of Arpin competes with 
and blocks the VCA-Arp2/3 interaction. Indeed, 2 Arpin-binding sites were mapped close 
to Arp2 subunit, and binding to Arp2/3 was shown to further induce a conformation 
modification of the complex (Fetics et al., 2016; Sokolova et al., 2017). Consistently with 
its inhibitory effect towards the Arp2/3 complex, Arpin is down-regulated in different 
breast cancer cell lines and mRNA level from patient samples has been anti-correlated with 
the tumour aggressiveness. Surprisingly, Nap1 and Arpin show co-exclusivity in the 
analysed samples (Lomakina et al., 2016). At the protein level, authors claimed that 
invasive carcinoma cells show a lower IHC signal for Arpin compared with adjacent 
fibroblast cells or to normal epithelial ducts, although further analysis and thorough 
quantification are still required to support their data. For example, independent cBioPortal 
analysis showed that Arpin is in fact upregulated in most cancer types.  
1.3 The RhoGTPases family 
1.3.1 Introduction to the RhoGTPases family 
The Ras superfamily contains evolutionary conserved proteins, subdivided into 5 
categories: The Ras, Rho, Ran, Rab, Arf families. Together, it accounts for over 150 
structurally related proteins with similar domains and functions. They are characterised by 
a common G-domain, which is responsible for the binding of GTP and most of them 
contain a carboxyl-terminal CaaX box, allowing lipid modification and membrane 
tethering. Extensive reviews of the different subfamilies are available (Rojas et al., 2012; 
Wennerberg et al., 2005) and I will discuss the Rho family in further detail as Rho proteins 
are implicated as master controllers of actin cytoskeleton. 
There are 20 members of the Rho family in mammals, divided into 5 classical (Rho, Rac, 
Cdc42, RhoF and RhoD) and 5 atypical (RhoBTB, Rnd, RhoU, RhoV and RhoH) 
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subfamilies, which signal to cytoskeleton, vesicular trafficking, and cell cycle progression 
(Etienne-Manneville and Hall, 2002) (Figure 1-8). 
Among these, Rac1, RhoA and Cdc42 have been the most characterised so far and their 
role during actin dynamics and migration are extensively studied. 
1.3.2 Structural features of the RhoGTPases 
Like other Ras-related family members, the structure of RhoGTPase encompasses a G-
domain, characterised by 5 G-motifs (G1-G5) and an insert region that determines the 
specificity of binding to effector proteins. G1, also known as the P-loop, connects the β-
Phosphate of the nucleotide with a Mg2+ ion, and is required for the nucleotide stability. 
Together, they form a globular structure made of 6-stranded β sheets and 5 α-helixes, 
complemented by an additional α-helix coming from the Rho-family specific insert region. 
This structure has high affinity for guanine nucleotide and is relatively stable, except 
across 2 regions named switch I and switch II (Milburn et al., 1990; Vetter and 
Wittinghofer, 2001). Because of their dynamic association with guanine nucleotide and 
their ability to hydrolyse GTP, RhoGTPases are seen as major signalling molecules. They 
have been widely pictured as molecular switches, oscillating between an active (GTP-
bound) and inactive (GDP-bound) state. This difference in the nature of the nucleotide is 
also reflected by a conformational change, mediated by the two flexible switches (Milburn 
et al., 1990). Indeed, oxygen from the γ phosphate of GTP creates 2 hydrogen bonds with 2 
residues on switch I and switch II. Upon GTP hydrolysis, this physical constraint is lost, 
resulting in a relaxation of the structure (called disorder-to-order transition) (Vetter and 
Wittinghofer, 2001). Together, nucleotide specificity and conformation changes mediate 
the binding to distinct downstream effectors. 
The carboxyl-terminal domain contains a motif of high sequence variability encompassing 
a common CaaX box (Cysteine, 2 aliphatic amino acids and any amino acid that will 
dictate the enzyme specificity) (Clarke, 1992). This motif is a signal for lipid modifications 
which allows proper localisation at the plasma membrane. A wide variety of lipids 
(geranylgeranylation, farnesylation, palmitoylation) have been identified as important for 
RhoGTPases functions and localisation. As an example, it has been reported that 
palmitoylation (Navarro-Lerida et al., 2012) and prenylation of Rac1 (Gorzalczany et al., 
2000) were crucial for its activity, specifically the ability to stimulate phosphorylation-
primed WRC (Lebensohn and Kirschner, 2009). 
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Figure 1-8: Evolution of the RhoGTPase family 
Graphical representation of the phylogenetic tree of the RhoGTPase family. Analysis was based on 
the similarity of amino acids between each member. Classical (blue circled) and atypical (orange 
circled) RhoGTPases are highlighted. Atypical RhoGTPases are preferentially GTP-bound and 
their function is independent of the activity of GAPs/GEFs. Their regulation is mostly based at the 
transcriptional level and their inactivation depends on proteasomal degradation, although protein-
protein interaction might also be involved.  
Most of RhoGTPases contain a CaaX sequence, regulating their localisation at the membrane 
following S-acylation. RhoBTB1/2 don’t contain a CaaX domain but instead two BTB domains. 
RhoV and RhoU are also devoid in CaaX sequence and have the antepenultimate cysteine 
palmitoylated (Kardash et al., 2010). 
Evolutionary distance is not proportional to the branch length. 
Adapted from (Roberts et al., 2008) and (Heasman and Ridley, 2008) 
	  
	 													Introduction	 	 	
	
28 
1.3.3 Regulation of RhoGTPases activity 
1.3.3.1 The guanine nucleotide exchange factors (GEFs) 
Stability of the GDP in the nucleotide binding pocket is high (nano to picomolar range), 
resulting in a very slow cycling between GTP and GDP-bound state. In order to speed up 
this process, RhoGTPases are activated at the plasma membrane by guanine nucleotide 
exchange factors (GEFs), which stimulate the exchange of GDP to GTP by several orders 
of magnitude (Bos et al., 2007). Indeed, GEF proteins will bind to the RhoGTPases in 
order to destabilise the switch regions and the P-loop, resulting in weakening of the 
phosphate binding first and then the base gets expelled. A ternary complex between GEF, 
GTPase and nucleotide can exist, but because of its transient state, it has been problematic 
to purify to date. Finally, the reloading of GTP is a passive event based on the excess of 
cytosolic GTP compared to GDP. Spatial localisation of the GEFs at the plasma membrane 
has been shown to be partially dependent of their pleckstrin homology domain (Ferguson 
et al., 1995). However, the low affinity and the lack of specifity of this binding (Snyder et 
al., 2001) require other protein domains for an efficient membrane targeting (Stam et al., 
1997). The mechanisms leading to the nucleotide exchange are highly dependent of the 
nature of the GTPase/GEF pairing, so it is difficult to give a specific example that could be 
generalised. In order to illustrate this part, I will focus on the published interaction between 
Rac1 and one of its GEFs, Tiam1 (Worthylake et al., 2000). Most of the GEFs are 
characterised by an invariable Dbl-homology domain followed by the Pleckstrin-homology 
domain in C-terminus (DH and PH domains) (Bos et al., 2007). These two domains are 
dependent on each other in order to mediate the protein’s functions. Worthylake and co-
workers used a truncated Tiam1 construct encompassing the DH-PH domains to crystallise 
and solve the dimer structure at 1.52Å. Despite some disordered portions in the Tiam1 
crystal, they reported that Tiam considerably modified the organisation of Switch I and II 
regions of Rac1. Following binding, Switch I moved up to ~3Å, resulting in the loss of 
interaction between Cys18 and the oxygen group from the α-phosphate of the nucleotide. 
Moreover, this shift led to a mis-orientation of Phe28 that usually stabilises the nucleotide 
inside the pocket. The major disruption in Switch II comes from the insertion of the Ala59 
inside the cation-binding site impeding the formation of a robust interaction with the Mg2+, 
which is fundamental for the high-affinity nucleotide binding. This structure also 
highlights the lack of direct interaction between Tiam and the active site of Rac1, which is 
now commonly accepted for most of the GEF/GTPases interactions (Worthylake et al., 
2000). 
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To note, the aforementioned description is related to the main GEF family (Dbl-family), 
containing a DH-PH domain. However, another family of GEFs lacking this usual structure 
and referred to as the DOCK-family have been described. Instead, they are characterised 
by two conserved sequences  (DOCK-homology region 1 and 2 – DHR1/2). DHR1 links 
the protein to PIP3 wherease DHR2 encompasses the GEF activity toward Rac1 and Cdc42 
(Cote and Vuori, 2002). 
 
 GTPase activating proteins (GAPs) 
Despite their names, intrinsic GTPase activity of the Rho family is actually very slow and 
can be enhanced by GTPase activating protein (GAPs). The diversity of mechanisms 
driving GAP activity reflects the high number of GTPase-GAP interactions but some 
common features can be highlighted to draw an overall picture. Briefly, the hydrolysis is 
based on an in-line nucleophilic attack coming from a molecule of water, stabilized by a 
conserved glutamine from the Rho protein. Meanwhile, a highly conserved arginine finger 
supplied by the GAP itself stabilises a transient interaction with the γ-phosphate and this 
conformation is crucial for GTP hydrolysis (Nassar et al., 1998). Together, this weakens 
the liaison between β and γ phosphates and results in the formation of a molecule of GDP 
+ Pi and a proton. This interaction drastically moves the reaction equilibrium and increases 
nucleotide cleavage by several orders of magnitude (Bos et al., 2007; Vetter and 
Wittinghofer, 2001). 
However, with regard to the diversity of GTPases involved and the multitude of GAPs and 
GEFs already identified, some mechanisms can be slightly different but have been 
reviewed extensively (Bos et al., 2007; Vetter and Wittinghofer, 2001). 
1.3.3.2 RhoGDIs 
Finally, RhoGDIs (Rho guanine nucleotide dissociation inhibitor) are not as well 
characterised regulators but are seen as essential inhibitors of RhoGTPase cycle. Indeed 
they bind to inactive GDP-loaded protein and inhibit their translocation to the membrane, 
allowing the maintenance of a cytosolic pool of dimer RhoGTPase-RhoGDI (Cherfils and 
Zeghouf, 2013). However, binding to the GTP-loaded form of the RhoGTPase has also 
been reported (Hancock and Hall, 1993). This pool of inactive RhoGTPases acts as a 
reservoir of easily activated proteins and allows a quick response of the cell. 
The main challenge for the RhoGDI is to keep RhoGTPases soluble. Indeed, prenylation of 
RhoGTPase is essential for their localisation and functions but incompatible with a 
cytosolic localisation of the protein due to its hydrophobicity. Once bound to a RhoGDI, 
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the isoprenyl moiety is shielded within a hydrophobic pocket of the protein, which then 
acts as a chaperone until a stimulus (protein-protein interaction, specific lipid composition, 
phosphorylation) releases this interaction and allows the interaction to the membrane. This 
switch is a highly regulated process and is seen as an essential step to maintain Rho 
activity at a basal level (Dovas and Couchman, 2005). 
1.3.3.3 Post-translational modifications (PTM) 
Post-translational modifications were also shown as potent regulators or RhoGTPases. 
While the carboxyl-terminal polybasic region helps for the GTPase targeting at the 
membrane, prenylation of the cysteine residue of the CaaX box is the most frequent PTM 
(Michaelson et al., 2001). Interestingly, only 16 out of 20 RhoGTPase contains this 
sequence, suggesting other membrane-targeting signals for Wrch-1 (RhoU), Chp/Wrch-2 
(RhoV), RhoBTB1 and RhoB2/DB2 (RhoBTB2) (Roberts et al., 2008) (Figure 1.8). Post-
translational modifications of the RhoGTPase family involve initial recognition and 
lipidation of the CaaX sequence by a farnesyltransferase or a geranylgeranyltransferase, 
followed by the cleavage of the 3 last residues (aaX) by an endoprotease. The last step 
involved a specific methylation process of the terminal cysteine. These successive 
modifications increase the hydrophobicity of the protein and assure its correct localisation 
at the membranes. Genetic disruption or chemical targeting of the CaaX domain leads to 
the cytosolic localisation and the inactivation the RhoGTPase and has been addressed as a 
potential therapeutic strategy (Winter-Vann and Casey, 2005). 
Once anchored at the membrane, additional signals, such as sumoylations, ubiquitinations, 
phosphorylations fine-tune the activity of the RhoGTPases (Olson, 2016). 
In addition, an extra level of regulation is assured by the post-translational modification of 
the GEFs and GAPs themselves (Hodge and Ridley, 2016). 
1.3.4 Coordination between RhoGTPases activation and cell 
protrusion 
Regulators finely coordinate RhoGTPases activity at specific locations and allow a fast 
cycle of activation/inhibition following stimulation. Over the last 15 years, the classical 
view of GTPase activity was restricted to a role of Rac1 and Cdc42 as regulators of 
membrane protrusions at the leading edge, whereas RhoA mostly regulates cell rear 
contractility. However, new imaging tools have been challenging this dogma and it is now 
accepted that this model is much more flexible according to the environment and the 
structures involved (Fritz and Pertz, 2016). 
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Indeed, the three main RhoGTPases were shown to be activated at the leading edge of 
migrating cells (Kraynov et al., 2000; Nalbant et al., 2004; Pertz et al., 2006) and much of 
Alan Hall’s work has focused on the crosstalk between Rac1, RhoA and Cdc42 (Nobes and 
Hall, 1995; Rottner et al., 1999), making the understanding of the mechanism even more 
complex. However the coordination of Rho, Rac and Cdc42 during membrane protrusion 
was unclear and this has greatly been addressed by the use of FRET markers during 
membrane extension/retraction (Machacek et al., 2009). These authors were able to show 
that a narrow pattern of RhoA activation at the leading edge occurs concomitantly to the 
protrusion formation and co-exclusively with Rac1 activation, which has been proposed to 
sustain protrusion stability with Cdc42. In line with this sequential activation, Cdc42 and 
Rac1 activation is delayed by around 40 seconds compared with RhoA activation. In 
different settings however (microfluidic device rather than cell in a dish), this Rac1/RhoA 
antagonism is less clear and might be context-dependent, such as experimental design, cell 
types (Martin et al., 2016). 
A tight coordination of RhoGTPases is then a crucial event for healthy cells to achieve 
their functions. On the other hand, deregulation of RhoGTPase signalling is a common 
features in cancers, and targets either the RhoGTPase directly (i.e. RacP29S frequently 
found in melanoma) or pathways involved throughout the GTPase cycle (Porter et al., 
2016). For example, Rac1 GEF P-Rex1 is overexpressed in different cancers and was 
linked to metastasis in prostate cancer (Marei and Malliri, 2017; Qin et al., 2009). 
1.3.5 Introduction to Rac family members 
Rac1 (Ras-related C3 botulinum toxin substrate 1) was discovered as a substrate for ADP 
ribosylation by Botulinum toxin C3 ADP-ribosyltransferase in HL-60 cDNA screen and 
showed similarity to Ras protein, especially in the guanine nucleotide-binding site 
(Didsbury et al., 1989). In mammals, Rac2 (Didsbury et al., 1989) and Rac3 (Haataja et al., 
1997) and RhoG (Vincent et al., 1992) complete the Rac family proteins (Figure 1-8) and 
play important roles in actin dynamics and lamellipodium regulation. Despite their high 
sequence conservation (human Rac1 is identical at ~95% with Rac2 and 3 and 72% with 
RhoG), expression pattern of the family members is quite different: Unlike Rac1 and RhoG 
that are ubiquitously expressed, Rac2 is hematopoietic-specific (Gu et al., 2002b) while 
Rac3 is enriched in the brain (Haataja et al., 1997). 
Interestingly, the human RAC1 gene encodes for two splice variants, Rac1a (hereafter 
referred as Rac1) and Rac1b (Jordan et al., 1999), which is extended by 19 amino acids 
following the switch II region. In overall, structures of Rac1 and Rac1b are highly similar, 
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with the exception of the switch regions, which are key parts to mediate alternative 
responses between an active versus inactive state of the protein. Indeed, both switches are 
suggested to be highly flexible (Fiegen et al., 2004). Intrinsic Rac1b GTPase activity was 
reduced but it can still respond to GAP activity (Fiegen et al., 2004; Matos et al., 2003). 
Unlike Rac1, Rac1b doesn’t induce lamellipodia formation (Nimnual et al., 2010; Singh et 
al., 2004) but it was shown to be over expressed in various solid cancers and has been 
linked to poor prognosis (Jordan et al., 1999; Schnelzer et al., 2000; Zhou et al., 2013). 
This surprising data can be explained by the cellular transformation potency of Rac1b 
(Singh et al., 2004) and also by the tumorigenic effect of this splice variant. Finally, in a 
colon-cancer model, Rac1b was specifically overexpressed over Rac1a and this triggered 
reactive oxygen species production, leading to hyperproliferation of intestinal stem cells 
and tumourigenesis (Myant et al., 2013). So together, studies characterised Rac1b as a 
constitutively active GTPase, although exhibiting some specificity concerning downstream 
effectors (Matos et al., 2003; Singh et al., 2004). 
1.3.6 Rac1, master regulator of cell protrusions 
Given its wide expression, we will mostly focus on Rac1 and its function in actin-based 
cytoskeleton remodelling. Initially, active Rac1 was described as the main regulator of 
actin reorganisation, membrane ruffling and macropinocytosis in fibroblasts (Ridley et al., 
1992). However, broader functions were later described and its roles in gene transcription 
(Matos and Jordan, 2006), proliferation (Hofbauer et al., 2014) and apoptosis (Zhang et al., 
2015) are now well accepted. 
Lamellipodia formation by Rac1 results from a balance between several signalling 
pathways, involving the Arp2/3 complex through Scar/WAVE complex and also the Rac1-
mediated actin turnover through the LIMK/Cofilin pathway (Yang et al., 1998). 
Involvement of Rac1 during lamellipodia extension has been widened to different systems, 
including T cells (Faroudi et al., 2010), epithelial cells (Keely et al., 1997) and neurons 
(Chen et al., 2007) and is thought to affect their motility. A surprising result comes from 
Rac1-null macrophages: Despite their spindly shape and their defect in membrane ruffling, 
they were still able to chemotax and migrate as efficiently as their wild type counterparts, 
suggesting a lamellipodial-independent mechanism driving cell migration. (Wells et al., 
2004). However, those observations contrast with more recent data obtained with Rac1 
knockout fibroblasts, which are defective in random migration and chemogradient sensing, 
although spreading and adhesion are largely unaffected (Steffen et al., 2013). 
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In vivo models confirmed previous in vitro results about Rac1 as a key player in actin 
dynamics and have also brought new insights into the role of this RhoGTPase. In neuronal 
cells, Rac1 loss or deletion has shown different roles in different systems. In transgenic 
mice, expression of constitutively active Rac1 in Purkinje cells increases dendritic trunks 
branching (Luo et al., 1996) while dominant negative and constitutively active Rac mutants 
indistinguishably cause embryonic lethality in Drosophila and affect axonal growth but not 
dendrite morphology (Luo et al., 1994). Also using Drosophila as a model, expression of a 
functionally dead version of Rac1 in egg chambers affected membrane protrusions and 
collective migration of border cells (Bianco et al., 2007; Duchek et al., 2001). Similarly, 
actin-protrusion formation as well as cell polarity were also affected upon inhibition of Rac 
activity in zebrafish, resulting in a defect in germ cell migration (Kardash et al., 2010). 
In a mouse model, constitutive whole-body depletion of Rac1 is lethal at mid-gastrulation 
(E9.5) (Sugihara et al., 1998). However, development of tissue-specific CRE-driven 
expression allows a precise study during development and in adult mice. For example, 
specific depletion of Rac1 during melanoblast migration (precursors of pigmented skin 
cells), profoundly affected adult colour coat with a striking white belly phenotype, white 
paws and tail (Li et al., 2011). This results from a migration defect of those cells during 
embryogenesis. Indeed Rac1-knockout cells displayed only short stubby protrusions that 
are Rac1-independent, compared with the normally long pseudopods extending from the 
cell body. Similar phenotypes were also obtained with the specific deletion of a RacGEF 
(P-Rex1) in the melanoblats (Lindsay et al., 2011) and the double null-mutant embryo 
(Lindsay et al., 2015), suggesting that active Rac1 is functionally important for driving 
melanoblast migration. 
1.3.7 Rac1, regulator of cell polarity 
Epithelial cells are characterised by apical and basolateral domains, which correspond to 
distinct cellular compartments with different protein content, mediating specific functions. 
Establishment of cell polarity is a crucial event for the fate of the future cell and requires 
interconnected signalling pathways involving the conserved Par protein family, 
Crumbs/Scribble/Coracle complexes, RhoGTPases and phospholipids (Rodriguez-Boulan 
and Macara, 2014). Maintenance of cell polarity is tightly connected to cell-cell adhesion 
(Desai et al., 2009), vesicle trafficking (Polgar and Fogelgren, 2017), cell division 
(Panbianco and Gotta, 2011) and is emerging as an important feature to regulate cell fate, 
normal cell-based functions and proper localisation of potentially harmful molecules. This 
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self-organisation is based on intracellular signals and RhoGTPases, especially Rac1 has 
been involved as a regulator of cell polarity (Mack and Georgiou, 2014). 
During the establishment of apico-basal polarity, Rac1 signalling allows proper lumen 
formation (O'Brien et al., 2001). Interestingly, Rac1 activity is not homogeneous along the 
apico-basal axis (High activity at basolateral – Low activity at apical). Creation of this 
gradient is based on differential activity of the RacGEF Tiam1, which gets baso-laterally 
activated by β2-syntrophin while the GEF activity is inhibited by the apical junctional 
complex and Par3 (Mack et al., 2012). Mis-activation of Rac1 using an apical-targeted 
Tiam1 in a 3D cyst system, results in the accumulation of cells within the cyst lumen and 
loss of tight junctions (Yagi et al., 2012b). So this differential expression has directly been 
linked to the ability of 3D cultured cysts to polarise a lumen (Mack et al., 2012; Yagi et al., 
2012b). This gradient has directly been visualised using FRET probes and was shown to be 
crucial for cyst structure, epithelial cell shape and monolayer integrity (Couto et al., 2017; 
Yagi et al., 2012b). However a Rac1 gradient does not seem to be present during early 
cystogenesis event (Yagi et al., 2012b), suggesting that it might be dispensable during 
early cyst formation but important for its maintenance and may send signals to specific 
downstream effectors. 
1.4 The Scar/WAVE complex and its regulators 
1.4.1 The Scar/WAVE complex 
WRC (WAVE regulatory complex) is a heteropentameric complex of ~400kDa and 
organised around 5 proteins Nap1, Cyfip1, Abi2, Hspc300 and Wave1 proteins (Eden et 
al., 2002; Gautreau et al., 2004). 
The crystal structure completely changed the understanding of the complex organisation, 
which at the time was mostly based on biochemical experiments (Chen et al., 2010) 
(Figure 1.9). The current model includes a dimeric platform created by Nap1 and Cyfip1 
forming a cradle, acting to recruit a trimer formed by Hspc300, Abi2 and WAVE1 where 
the VCA interacts at the surface of Cyfip1. In this state, in vitro assays show that WRC 
doesn’t have an activity toward the Arp2/3 complex, suggesting an autoinhibitory 
conformation (Derivery et al., 2009a; Ismail et al., 2009). However, addition of Rac loaded 
with a GTP analogue but not GDP, is able to activate the WRC (Eden et al., 2002; Ismail et 
al., 2009). It is worth mentioning that the crystals obtained by Chen et al are a modified 
version of the actual WRC and thus might prevent elucidating the fine details of some of 
the interaction of the subunits. Indeed, the C-terminal proline rich region and the SH3 
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domain of Abi2 were deleted, and the proline-rich region of WAVE1 was replaced with a 
18-mer linker (Chen et al., 2010). Intact structural characterisation still awaits other 
methods such as Cryo-EM, which might supplement this crystal structure with more 
details.  
Regulation of the WRC will be discussed in further detail but together these observations 
plus the fact that WAVE proteins do not contain a GTPase binding domain, support the 
idea of different mechanisms mediating WRC-dependent Arp2/3 activity. In order to get a 
global picture of this process, it is therefore important to reveal some features of each of 
the subunits of the complex. 
1.4.2 Characterisation of the WRC subunits 
1.4.2.1 CYFIP1/2 (Sra1 and PIR121 respectively) 
CYFIP1 (cytoplasmic FMR-interacting protein) was isolated from bovine brain extracts as 
a specific Rac1 interactor. CYFIP also goes by the names: Sra1 standing for Specifically 
Rac1-associated protein and PIR121 (p53-inducible RNA). Truncated mutants of the 
protein suggested interaction of RAC1 near the N-terminal region and showed that this 
interaction promoted colocalisation of both proteins at cell ruffles (Kobayashi et al., 1998). 
 
CYFIP1/2 are large proteins of ~145kDa with 88% identity and are highly conserved. Both 
isoforms have a Fragile X interacting protein domain at their C-terminus, mediating 
interactions with Fragile X-related proteins and have been involved in mental retardation 
anomalies (Pathania et al., 2014). Consistent with this neurological effect, CYFIP1 and 
CYFIP2 are expressed during brain development, although showing different patterns 
(Bonaccorso et al., 2015). Moreover, CYFIP1 has been involved in protein anabolism via 
its interaction with eIF4E (Napoli et al., 2008) and also as a regulator of the mTOR 
pathway in neuronal progenitors (Oguro-Ando et al., 2015). CYFIP1/2 are also 
characterised by a DUF1394 domain (Domain of unknown function), running across the 
first 300 amino acids. This domain is highly conserved and Pfam alignments suggest that is 
only shared with another protein family named FAM49 proteins (see section 1.5). 
In addition to their functions in the nervous system, CYFIP proteins are key players in 
actin dynamics due to their central role in the WRC. Indeed, CYFIP1 depletion leads to the 
disruption of the complex, probably suggesting a structural function for the complex 
integrity (Tang et al., 2013). Interestingly, depletion of CYFIP2 doesn’t affect the complex 
formation, possibly reflecting a distinct function of this isoform, at least in the cell types 
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tested thus far (Tang et al., 2013). Alternatively, it can also be claimed that CYFIP2 is only 
a minor component, while CYFIP1 is the most abundant form and is responsible for the 
WRC function. The WRC structure suggested a mechanism for the activation of the 
complex involving CYFIP1 playing a major role. It was proposed that active Rac1 could 
bind to CYFIP1 and causes a conformational change that displaced the VCA motif of 
WAVE1, which was previously hidden within the inactive complex (Chen et al., 2010). 
_________________________________________________________________________ 
									 	
Figure 1-9: Structure of the Scar/WAVE complex 
Ribbon structure of the Scar/WAVE complex represented as a front (top) and back (bottom) view. 
Figure was obtained from the published structure of the Scar/WAVE complex (PDB 3P8C) (Chen et 
al., 2010) using PyMol. Each subunit was assigned a specific colour: NAP1 (blue), CYFIP1 (green 
and lilac), Scar/WAVE (Pink), HSPC300 (yellow), ABI (orange). DUF1394 domain of CYFIP is 
highlighted in lilac. Red dotted square represents the region of CYFIP involved in Rac1 binding. 
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Point mutations along CYFIP1 sequence identified at least 5 critical residues required for 
Rac1 binding. Spatially, those residues form a tight pocket at the surface of an exposed 
part of the complex, where Rac1 could easily fit in (Chen et al., 2010) (Figure 1.9). 
 
In cells, CYFIP1 localises at the cell edge with other WRC members, consistent with a role 
in membrane protrusions (Steffen et al., 2004) and also drives force translocation during D. 
melanogaster egg chamber rotation (Cetera et al., 2014; Squarr et al., 2016). The 
interpretation of data on the role of WRC in cancer cell invasion is however less clear than 
its established role in migration. Silva et al (Silva et al., 2009) reported CYFIP1 as a 
putative negative regulator of invasion. Looking at human cancer tissues, the authors anti-
correlated CYFIP1 expression to tumour progression. This was confirmed with 
subcutaneous injection of cyfip1-knockdown transformed cells. However, the cooperation 
between CYFIP1, WAVE3 and Nap1 was recently shown to promote breast and prostate 
cancer invasion making unclear the exact involvement of CYFIP proteins during invasion 
(Teng et al., 2016a; Teng et al., 2016b). These differences may reflect other functions of 
CYFIP1/2 independently of its role in the WRC or can also be tissue-dependent. 
1.4.2.2 NAP1 
As its name suggests, NAP1 (Nck-associated protein 1) was identified as a binding partner 
of Nck (Kitamura et al., 1996) and in collaboration with CYFIP1, forms a structural base 
for the recruitment of the remaining WRC subunits. 
NAP1 also localises at the cell edge in mammal cells and is required to sustain 
lamellipodia formation (Steffen et al., 2004). NAP1 plays a role in motility and cell 
adhesion in D. discoideum partially mediated by the Scar/WAVE complex itself (Ibarra et 
al., 2006). An in vivo study in mice shows that constitutive deletion of NAP1, correlates 
with a loss of other WRC member and leads to midgestation lethality with failure in the 
organisation of the main embryonic tissues (Rakeman and Anderson, 2006). This is 
supposed to be directly linked to a defect in cell migration during embryonic development. 
However, NAP1 does not always seem to promote cell migration and the level of 
expression has to be tightly regulated. Indeed, ectopic expression of NAP1 stops cells from 
migrating and induces differentiation (Yokota et al., 2007). This might reflect a broader 
function of NAP1 in WRC-independent processes. Alternatively, too much NAP1 might 
disrupt the equilibrium of the complex as a whole and could be destabilised. We can also 
not exclude the fact that NAP1 on its own could aberrantly sequester a binding partner of 
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the WRC and thus act as a dominant negative. Those are just hypothetical mechanisms that 
could explain their result. 
1.4.2.3 ABI1/2/3 
ABI proteins (ABL interactor) were found as binding partners of the ABL tyrosine kinase 
in murine leukaemia cells (Shi et al., 1995) and play roles as scaffolding proteins. They are 
organised around an SH3 domain mediating the interaction with ABL and several proline-
rich domains interspersed with tyrosine residues, which can be phosphorylated and 
regulate protein activity. 
Given this direct interaction, ABI proteins play an important role in leukaemia (Chorzalska 
et al., 2014; Dai et al., 1998; Li et al., 2007; Yu et al., 2008). Indeed, leukaemia arises from 
the translocation between 2 regions from chromosome 9 and chromosome 22 (respectively 
encompassing the abl1 and bcr genes), resulting in a fusion gene called Bcr-Abl, or 
Philadelphia chromosome. This leads to the uncontrolled expression of the tyrosine kinase 
pathway, activating downstream proliferation-related signalling. Moreover, ABI1 has also 
been linked to other cancer types. For example, it has been shown to induce invadopodia 
formation during breast cancer progression (Sun et al., 2009). 
 
Although the role of ABI proteins is crucial in Bcr-Abl-driven leukaemia by diverse 
mechanisms, it exists in a strong collaboration with the WRC. Indeed, ABI proteins have a 
pivotal role and can either be found free, as a subunit of WRC or in complex with ABL. 
This is partially regulated by another adapter protein called CRK. CRK competes with 
ABI1 for the binding to ABL, and a high level of CRK displaces the equilibrium toward 
CRK-ABL complexes, leaving more ABI1 available to be integrated into the WRC. In 
light of this dual function, deregulation of either protein can affect actin polymerisation 
and cell motility. CRK expression is affected in various cancer types (Miller et al., 2003; 
Sriram and Birge, 2010; Wang et al., 2007) but these studies focused on the ABL-
dependent role of CRK and did not make a connection with the WRC. Involvement of ABI 
as a fully functional member of the WRC comes from mass spectrometry data and in vitro 
binding assay combined with in cellulo experiments (Innocenti et al., 2004). 
 
Finally, homozygote Abi1-null embryos stop developing after E11.5 and display abnormal 
neural tube and heart development (Dubielecka et al., 2011). Conditional Abi1-knockout 
MEFs affects ability of these cells to form dorsal ruffles and slightly decreases wound 
closure. This weak effect on cell migration is quite surprising as the WRC integrity is 
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compromised upon Abi1 loss. However, ABI2 and WAVE3 expression significantly 
increase and may offer partial compensation, although upregulation of both isoforms is not 
sufficient to reconstitute the complex (Dubielecka et al., 2011). 
1.4.2.4 HSPC300/BRICK1 
HSPC300 (Haematopoietic stem/progenitor cell protein 300) is the smallest member of the 
Scar/WAVE complex but plays important roles for the complex formation and its activity. 
Initial studies showed the role of plant homologue of HSPC300, BRICK1, as a regulator of 
epidermal cell shapes in maize (Frank and Smith, 2002) and in A. thaliana (Djakovic et al., 
2006). This phenotype is dependent on the activity of the Arp2/3 complex, SCAR1 and 
SCAR2 (Djakovic et al., 2006; Le et al., 2006). 
 
The central domain of HSPC300 forms an alpha helix, overlapping at the C-terminus with 
a coiled-coil region. The latter was shown as an important motif to promote the formation 
of a free homotrimer, initiating the formation of the WAVE complex (Derivery et al., 
2008). Supporting this observation, structure of the full complex shows that 3 helixes 
coming from HSPC300, WAVE and ABI form a stable core (Chen et al., 2010). This 
would suggest that the trimeric form of HSPC300 might recruit WAVE2 and ABI step by 
step, forming a structure stable enough to further recruit NAP1 and CYFIP1. However, 
there exists a dynamic equilibrium between the trimeric and the monomeric form (Linkner 
et al., 2011) but how this switch is regulated remains speculative although posttranslational 
modifications have been suggested as putative regulators (Derivery et al., 2008).  
 
HSPC300 functions in actin regulation driven by the WRC are conserved in D. 
discoideum, D. melanogaster and in mammal cells (Derivery et al., 2008; Kunda et al., 
2003; Pollitt and Insall, 2009). Unlike CYFIP1, which was surprisingly proposed as a 
tumour suppressor (Silva et al., 2009), loss of HSPC300 decreases cell proliferation and 
migration. Invasion and metastasis formation in a tail vein assay are also impaired. In 
parallel, hspc300-null embryos are undersized compared to their wild type counterpart and 
show early lethality, correlating with actin disorganisation, loss of cell compaction and 
increased apoptosis (Escobar et al., 2010).  
1.4.2.5 Scar/WAVE proteins 
Scar/WAVE proteins are the major NPFs stimulating Arp2/3 and mediating lamellipodia 
formation and extension. WAVE1 was discovered at the same time by 2 independent 
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groups aiming to find new WASP-like proteins (Machesky and Insall, 1998; Miki et al., 
1998). WAVE1 has been linked to membrane ruffling in a Rac1-dependent manner (Miki 
et al., 1998) whereas Machesky and colleague made a strong link between Scar/WAVE1 
and its ability to bind to G-actin and the Arp2/3 complex (Machesky and Insall, 1998). 
Together, they drew a good picture of the important actors regulating WAVE-dependent 
processes (see section 1.4.4). 
Scar/WAVE proteins are similarly organised with a conserved WAVE-homology domain 
mediating the binding to other WRC subunits, a basic domain (PI(4,5)P2 and other 
phospholipids binding) followed by a proline-rich domain and the VCA motif (Kim et al., 
2000). Unlike WASP proteins, they are not autoinhibited and follow a trans-regulation as 
part of the WRC. 
 
WAVE proteins are very well conserved (Kurisu and Takenawa, 2009). WAVE1 and 3 
show specificity to the brain and hematopoietic cells respectively whereas WAVE2 seems 
ubiquitously expressed. Interestingly, plants have an additional SCAR member (SCAR4) 
that reflects a divergent evolution of the Scar gene following successive gene duplications 
(Zhang et al., 2008a). Moreover, in this study, activity of the VCA motif was drastically 
different compared to the other Scar proteins used in the pyrene actin assay. This could 
suggest the need of different actin polymerisation efficiency in specific compartment. 
However in mammals, it is believed that all isoforms of Scar/WAVE are part of a 
functionally similar complex (Stovold et al., 2005) but functions of each isoform have not 
been deeply studied. For example, WAVE3 was linked to lamellipodia stability and 
persistence of cell migration (Spence et al., 2012). WAVE3 knockdown cells showed a 
reduced speed of migration but had no effect on invasion, which tends to reaffirm a 
potential role of tumour suppressor of the WRC.  
 
As previously mentioned, WAVE1 becomes restricted to the central nervous system during 
development. Disruption of the WAVE1 gene in mice is not embryonic lethal but severely 
compromises the lifespan (Dahl et al., 2003). Indeed, WAVE1 knockout (KO) mice die 
within 3 weeks after birth, correlating with loss of weight and cortex hypotrophy, which 
usually show high WAVE1 expression in normal individuals. However, primary neuronal 
cultures from wild-type or Wave1 KO embryos don’t show any striking differences in their 
ability to grow, polarise or form neurites, which emphasises the difficulties to equate 
findings made in vitro to in vivo (Kim et al., 2006). On the other hand, WAVE1 plays only 
a partial role during oligodendrocyte morphology and myelinisation of specific regions of 
the brain, affecting ion channel clustering (Kim et al., 2006). 
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Similarly to the Arp2/3 isoforms affecting actin nucleation in different ways, future studies 
should aim to link Scar/WAVE protein isoforms within the complex and their specificity in 
regulating actin polymerisation.  
1.4.3 Other function of Scar/WAVE complex 
Additional to its role in Arp2/3 activation that has already been emphasised, Scar/WAVE 
complex activity may also regulate actin cytoskeleton by a less direct way than via Arp2/3 
activation. Indeed, WRC can bind to a specific sequence present in a large family of 
membrane-associated/transmembrane proteins (WIRS standing for WRC interacting 
receptor sequence). Among the WIRS-containing proteins, protocadherins 10 and 19 are 
transmembrane proteins involved in cell-cell adhesion and have been previously confirmed 
to interact with the WRC (Nakao et al., 2008). Chen et al gave evidence that the interaction 
between WIRS-containing proteins and the WRC is mediated by Sra and Abi and 
structural analysis shows that it does not displace the VCA tail of WAVE1. In line with 
this observation, WIRS-containing peptides are not sufficient for WRC/Arp2/3 activation, 
although, addition of Rac1 shows a partial effect, suggesting that WIRS binding might 
prime the WRC for activation. Disruption of this interaction affected actin organisation and 
normal oogenesis in flies (Chen et al., 2014a) and other functions are still waiting for 
further characterisation. 
 
The mechanisms of activation of the complex have to be solved. On one hand Scar/WAVE 
proteins are not autoinhibited but on the other hand, the WRC complex itself is inactive, 
meaning that other signals are required to release the VCA C-terminal tail of the 
Scar/WAVE proteins, responsible of the stimulation of the Arp2/3. 
1.4.4 Regulation of the Scar/WAVE complex 
1.4.4.1 Rac1 
Prior to the understanding of the relation between the WRC and the mechanisms of actin 
polymerisation, a member of the complex was already linked to Rac1. Indeed, almost 20 
years ago, Kobayashi et al (Kobayashi et al., 1998) showed a direct interaction between the 
first 300 amino acids of Sra1/CYFIP and GST-Rac1 loaded with GTPγS but not with GDP. 
This shows a specificity of binding to the active Rac1, which was previously shown to 
induce membrane ruffles (Ridley et al., 1992). At this time though, the connection with the 
Scar/WAVE complex was not made. 
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In the most recent structure of the complex, active Rac1 interaction with the Scar/WAVE 
complex was estimated to be low affinity (~8 µM) (Chen et al., 2010). Moreover, cutting 
off the VCA from the complex improves the binding to 1 µM, suggesting that Rac1 and the 
VCA might compete with each other. Although we are still missing a structure of the 
active WRC, it is hypothesised that binding of Rac to CYFIP1 destabilises the interaction 
between the VCA and the surface of CYFIP1, exposing the VCA out from the complex 
and making it free to interact with the Arp2/3 complex (Chen et al., 2010; Davidson and 
Insall, 2011).  
However, a binding affinity of few micromolar is not considered as very high and other 
factors cooperating with Rac1 have been examined. For example, Arf GTPases collaborate 
with Rac1 to activate purified WRC in a lipid-coated beads assay (Koronakis et al., 2011). 
This finding might also have a bigger impact in the current view of the spatial activity of 
the WRC. Indeed, Arf signalling predominantly regulates Golgi morphology and 
trafficking (Gaynor et al., 1998), suggesting that WRC might also be important to mediate 
Arp2/3-dependent actin polymerisation away from the plasma membrane.  
Another link between Rac1 and the WRC was initially proposed to be IRSp53 (insulin 
receptor substrate protein of 53kDa). It was shown that IRSp53 binds concomitantly to 
Rac1 at its N-terminus and to WAVE via a C-terminal SH3 domain (Miki et al., 2000). 
This model was challenged by another study showing that the complex, which co-eluted 
with other components (including IRSp53) was totally inactive regarding Arp2/3 complex 
(Lebensohn and Kirschner, 2009).  
1.4.4.2 Phospholipids 
WRC acts just below the plasma membrane, which contains a full repertoire of lipids, 
mostly phosphatidylcholine. Among them, phosphatidylinositols have been extensively 
studied for their role as second messengers, able to interact with cytosolic proteins. They 
can be phosphorylated at different locations, resulting in a full combination of molecules 
that can activate different pathways, including the cytoskeleton. Their role as partner for 
the activation of the WRC has been studied in different in vitro systems, involving beads 
coated with different concentration/composition of lipids mixed with crude cell extract. In 
vitro, Rac1/WAVE pathways were shown to be important for PI(3,4,5)P3-dependent actin 
comet motility assay (Koronakis et al., 2011). Indeed, WAVE2 can bind to PIP3 via its N-
terminal domain, which is sufficient to localise the protein at the membrane. Conversely, a 
WAVE2 mutant defective in PIP3-binding is unable to induce lamellipodium formation 
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after Rac1 activation (Oikawa et al., 2004), emphasizing the direct role of PIP3 for the 
WRC activation.  
 
PIP3 can also directly bind to IRSp53, and plays an important role in the co-activation of 
the WRC with Rac1. However, PIP3-mediated activation of the WRC complex is 
independent of the formation of the complex (Suetsugu et al., 2006). Also, independently 
of their direct role as activator of the WRC, PIP3 is also required downstream from tyrosine 
kinase receptors, for the GEF-mediatied activation of Rac1, resulting in more active Rac1 
and the creation of a positive feedback loop (Innocenti et al., 2003; Welch et al., 2003). 
This can directly feed the activation of the WRC. However, the exact role of the PIP 
pathway in migration is still matter of debate. D. discoideum lacking all enzymes required 
for PIP3 generation still chemotax toward cAMP, although mean velocity was slightly 
affected (Hoeller and Kay, 2007). This mutant could polymerise actin as efficiently as the 
wildtype strain. So together, active Rac1 and PIP3 might play important functions for the 
complex activation in higher eukaryote but mechanisms involving PIP signalling remain 
unclear.  
Finally, physical properties of the plasma membrane lipid bilayer may also have a role for 
the organisation of the complex below the plasma membrane. Indeed, in the actual model 
based on Chen’s structure (Chen et al., 2010) it was proposed a distribution of basic 
charges all along the surface of CYFIP1 and NAP1, which can interact with the negatively 
charged PIP3 and orientate the complex in a way that makes the VCA accessible. However, 
it is still unclear whether the small amount of PIP3 compared to other phosphorylated 
forms, is enough for explaining the regulation of the complex activation in a structural 
point of view. Indeed, PIP3 represents roughly ~2% of the plasma membrane composition 
and this raises the question whether PIP3 patches in cellulo might be used by the cell to 
trigger PIP3-dependent WRC activation. 
1.4.4.3 Lamellipodin 
Lamellipodin was found from a screen aiming to find new regulators of the Ena/VASP 
family containing proline rich domains. It harbours a Ras-association motif and a PH-
domain that could mediate the binding to the plasma membrane. In addition, putative SH3 
domains and profilin binding sites were described. Microscopy analysis showed that 
lamellipodin expression correlates with lamellipodium dynamics. Knockdown cells have a 
defect in lamellipodium formation and F-actin content, although total actin was not 
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affected. This suggests a role of Lamellipodin in regulation of actin polymerisation at the 
lamellipodia (Krause et al., 2004). 
Mechanistically, three C-terminal regions interact with the SH3 domain of ABI1, in an 
active Rac1-dependent fashion, confirming that lamellipodin is a new partner of the 
Scar/WAVE complex. Further in vivo characterisation shows that Lamellipodin-KO mice 
are viable, although most of the homozygote mice either die within 6 weeks or are infertile. 
In either case, animals show a 20% reduction of their body weight (Law et al., 2013). 
Lamellipodin also affects melanoblast migration in mouse embryos resulting in a 
pigmentation defect of the adult animal. Lamellipodin functions as regulator of the 
Scar/WAVE complex activity, which is also conserved in Xenopus and Drosophila (Law et 
al., 2013). 
Finally, Lamellipodin expression correlates both with metastatic potential and breast 
cancer survival (Carmona et al., 2016). Distinct signalling pathways from ABL and SRC 
kinases lead to differential regulation of lamellipodin and together with Scar/WAVE and 
Ena/VASP, promotes invadopodia precursors formation and/or maturation/stabilization, 
leading to increase invasion in vitro (Carmona et al., 2016). 
1.4.4.4 Nance-Horan syndrome (NHS) 
NHS proteins (Nance-Horan syndrome) have been linked to cataract and dental defects, 
dysphormism, which are characteristic abnormalities of this syndrome (Toutain et al., 
1997). These defects are directly linked to mutations within the NHS gene that result in a 
frame shift and a truncated protein (Coccia et al., 2009; Tian et al., 2017). The wild-type 
gene produces different isoforms of the NHS proteins, although functions of each isoform 
have yet to be fully studied. NHS proteins localise to cell-cell junction, at focal adhesions, 
and translocate to the lamellipodium upon EGF stimulation. They contain a Wave-
Homology domain (similar to WAVE proteins) able to recruit the other members of the 
Scar/WAVE complex. In addition, depletion of NHS leads to increase spreading 
correlating with an accumulation of Scar/WAVE complex members at the leading edge 
(Brooks et al., 2010). Therefore, NHS proteins also regulate actin-based protrusions via the 
WRC. 
1.4.4.5 Post-translational modifications of the WRC 
Phosphorylation events of WRC members affecting actin polymerisation were described 
far before understanding the global mechanism. WAVE2 is the principal modified protein 
and phosphorylation is able to optimise the activity of the WRC. Interaction between ABI1 
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and WAVE2 promotes their localisation to the plasma membrane, followed by recruitment 
of the Abl kinase, which in turn phosphorylates Tyr150 of WAVE2 (Tyr151 of WAVE1). 
Moreover, Abl kinase is able to further stimulate the ability of WRC to activate Arp2/3 
(Leng et al., 2005). Based on Chen et al’s model (Chen et al., 2010), Tyr151 is proposed to 
hold the meander region in close contact to CYFIP1. Phosphorylation would destabilise 
this interaction, leading to the expulsion of the VCA from the core of the complex. Indeed, 
the phospho-mimetic WAVE2 mutant increased lamellipodia formation and Arp2/3-
dependent actin-polymerisation. Other residues of WAVE proteins can be phosphorylated 
by different kinases and work in common to affect actin dynamics by regulating Arp2/3 
interaction (Ardern et al., 2006; Krause and Gautreau, 2014; Miyamoto et al., 2008). 
Independently, these signals don’t dramatically affect the activity of the WRC. However, 
together, they co-amplify and fine-tune the activity of the complex (Lebensohn and 
Kirschner, 2009). 
 
However, to date, direct negative regulation of the Scar/WAVE complex has barely been 
addressed and the only way for a cell to turn the complex off, is to directly modify Rac1 
activity (via GEF, GAP, or GDI signalling) or to target the complex to the proteasome 
pathway. Here, we thus sought to find new regulators of the Scar/WAVE complex. 
1.5 FAM49 family: Characterisation & functions 
1.5.1 Discovery and organisation 
FAM49 (Family of unknown function 49) was retrieved from a pulldown experiment in 
Dictyostelium discoideum (D.d), aiming to characterise new Scar/WAVE complex 
interactors that could be considered as putative regulators (Fort et al, in revision) (Figure 
1-10). GFP-transfected wild-type cells or GFP-NAP1 rescued napA knockout cells were 
lysed and cross-linked, followed by GFP-pulldown and mass spectrometry analysis. 
Reversible crosslinking allowed stabilisation of weak and transiently associated proteins, 
increasing the sensitivity of the screen to identify novel interacting candidates. 
Unsurprisingly, the 4 members of the Scar/WAVE complex co-precipitated with GFP-
NapA and represented the most enriched hits (SRA1, ABI1, WAVE2 and HSPC300). 
Among the other significantly enriched candidates, VASP came down and was previously 
shown to interact with ABI1 (Chen et al., 2014c), giving us more confidence about the 
experimental design. Although not massively enriched, FAM49 was consistently pulled-
down in the 4 independent biological replicates. The absence of information about this 
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protein was seen as a challenge and Batista and co-workers decided to focus on FAM49. 
We joined in as collaborators to characterise the role of mammalian FAM49B, which is the 
main topic of my PhD thesis. 
 
FAM49 is a small protein of ~37 kDa with no previously described functions, domains or 
structure at the time of this screen. However, initial sequence alignments showed a very 
high conservation across evolution, especially in the metazoan phylum, highlighting an 
underestimated importance of FAM49. In vertebrates, 2 different genes encode for 2 
specific isoforms (FAM49A and FAM49B), sharing 80% identity and 90% similarity. 
Pfam searches (Finn et al., 2014) revealed that FAM49 proteins contain a unique domain 
named DUF1394 (domain of unknown function 1394). Interestingly, this domain is 
commonly shared with CYFIP proteins and overlaps with some portions of the Rac1-
binding site as described by Chen et al (Chen et al., 2010) (Figure 1-11). Multi sequence 
alignment pinpointed a 30 residues stretch with high conservation between FAM49 
homologues and also between DUF1394 domains of FAM49 and CYFIP proteins. 
Interestingly a Y-Y/F-RR motif stands out from the alignments. The second arginine is 
involved in Rac1-binding in CYFIP1 and required for WRC activation (Chen et al., 2010). 
Moreover, the structure of FAM49 has not been solved yet but a prediction tool based on 
multi-alignment and available protein structures database (i-TASSER) (Roy et al., 2010) 
considered CYFIP1 as the best template for FAM49 (Figure 1-11). Interestingly, a portion 
of FAM49B perfectly maps onto the pocket formed by Cyfip1 at the surface of the 
Scar/WAVE complex (PDB 3P8C) (Chen et al., 2010), where Rac1 fits. FAM49 putative 
structure suggests a fairly compact core made by successive alpha helixes. This contrasts 
with the N-terminal part of the protein that forms a short alpha helix followed by an 
unfolded region, which would stand out from the overall structure by its apparent 
flexibility. 
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Figure 1-10: Discovery of FAM49 in D. discoideum 
A – Schematic of the experimental design of the crosslinked GFP-Pulldown. Wild-type or napA 
knockout Ax3 cells were transfected with GFP or GFP-NAP1 respectively. Cells were lysed using a 
low concentration of detergent buffer complemented with 3% formaldehyde for the reversible 
crosslinking. GFP-tagged proteins were immunoprecipitated, resolved by SDS-PAGE and gels 
analysed by LC-MS/MS. 
B – Volcano plot from pooled replicates of the mass spectrometry experiment. Significant hits lay 
above the 5% false-discovery rate curve (black curve) and are represented with red dots. Gene 
name is reported for some candidates. Scar/WAVE complex members represent the top hits and 
are highlighted with a dotted circle. FAM49 is represented in blue. Colour scale is based on the 
Welch’s test difference. 
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Figure 1-11: Organisation and structure of FAM49 proteins 
A – Side by side comparison of the organisation of CYFIP1/2 and FAM49A/B. DUF1394 domain 
(Pfam PF07159) is shared between CYFIP and FAM49 proteins and is represented in lilac. Fragile 
X mental FMR1-interacting domain (FragX_IP, Pfam PF05994) is unique to CYFIP proteins and 
shown in green. Numbers represent position of the amino acid across the protein sequence based 
on Pfam. 
B - i-TASSER prediction structural model for human FAM49B. Two views are displayed, 
corresponding to a rotation of 90 degrees. The best template for this structure corresponds to the 
PDB entry 3P8CA (CYFIP1) with a TM-score (template modelling score) of 0.873. TM-score is a 
read out for the structural similarity between two proteins. It ranges from 0-1 with high value 
corresponding to better similarity. It is widely accepted that a TM-score above 0.5 corresponds to 
protein with a similar structure (Roy et al., 2010) 
The model is colour coded from blue (N terminus) to red (C terminus).  
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1.5.2 FAM49A 
FAM49A is localised on chromosome 2 and just one study has been published describing 
its function so far. FAM49ab (homologue of human FAM49A) was recently described as a 
negative regulator of PTEN (Phosphatase and Tensin homologue) signalling during 
zebrafish development (Li et al., 2016). PTEN is a major tumour suppressor by promoting 
differentiation and inhibiting proliferation in collaboration with PI3K. PTEN is frequently 
lost in lymphoid cancers but its roles during lymphopoiesis were unknown. Authors found 
that N-myc downstream-regulated gene 1b (Ndrg1b) could rescue PTEN loss during 
thymocyte development (Li et al., 2016). Database searches orientated toward Danio rerio 
FAM49ab as a conserved interactor of Ndrg genes, in zebrafish and C. elegans. In situ 
hybridisation revealed that FAM49ab is expressed at early developmental stage in the 
somites, eyes and neural crest before being expressed in the ventral aorta. Later, the 
transcript is found in the thymus and was confirmed by isolation of thymocytes and 
lymphoid precursors followed by qRT-PCR. Overexpression of FAM49ab affects 
differentiation of thymic precursors and blocks T-cells differentiation, mimicking the loss 
of PTEN. Interestingly, co-overexpression of FAM49ab and Ndrg genes or inhibition of 
PI3K signalling rescues this phenotype. Finally, over expression of FAM49ab synergises 
with the effect of Ndrg1b knockdown on T cell differentiation. 
Together, their model suggests that FAM49ab interrupts PTEN signalling by inhibiting 
Ndrg1b (Li et al., 2016) (Figure 1-12). However, involvement of FAM49A in cancer is 
still waiting for further investigation but analysis of FAM49A gene alteration in humans 
doesn’t seem to be hugely affected across different solid and blood cancers (cBioPortal). 
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Figure 1-12: Model of regulation of T cell differentiation by D. rerio FAM49A 
FAM49ab (D. rerio FAM49A) was shown to be a negative regulator of PTEN signalling in zebrafish. 
Based on genetic evidence, model depicts FAM49ab upstream of N-myc downstream-regulated 
gene 1B (NDRG1B), together regulating lymphoid differentiation. Figure inspired by (Li et al., 2016) 
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1.5.3 FAM49B in the literature 
FAM49B is localised on chromosome 8 and interestingly is amplified in a large subset of 
cancers (cBioPortal). For example, 50 % of the breast cancer samples available on the 
database display an amplification of the gene. Although this might be meaningful, one 
could also hypothesise that this amplification reflects the close proximity of FAM49B gene 
with the widely amplified oncogene Myc, as both genes are situated next to each other on 
chromosome 8, resulting in a passive amplification of the fam49b gene. To support this 
hypothesis, cBioPortal analysis reveals a strong and significant correlation of co-alteration 
between both genes. Nevertheless, one cannot rule out that amplification of FAM49B is 
associated with cancer progression and may have a functional role. 
FAM49B was also mentioned in various proteomic studies: For example, it has recently 
been proposed as a biomarker for oral cancer, as it has been found significantly enriched in 
the saliva of cancer patients. However, it cannot be used as a predictive marker associated 
with a risk of developing oral squamous cell carcinoma (Kawahara et al., 2016).  
Additionally, FAM49B was found, among other proteins, as downregulated in omental fat 
from women with endometriosis (Williams et al., 2015). Unfortunately, this study doesn’t 
bring more information about the mechanism or the biological relevance of their findings. 
FAM49B mRNA also was detected as enriched in multiple-sclerosis women before and 
after pregnancy, whereas levels go back to similar ratio throughout the pregnancy. 
However, this difference was not reflected at the protein level (Gilli et al., 2010) and 
suggests a minor contribution of FAM49B in this system. 
Finally, FAM49B has also been linked to immunosurveillance. Indeed, in normal cells, 
self-antigens are usually loaded onto a specific MHC-class I whereas FAM49B peptides 
are cleaved by the endoplasmic-reticulum specific endopeptidase ERAAP. However, 
ERAAP-deficient cells (cancers, auto-immune disorders to only cite some examples) 
cannot trim these self-antigens so a 9-amino acid peptide from FAM49B gets loaded onto 
the specific MHC-I and traffics to the cell surface where it mediates strong CD8+ T cell 
response and cytotoxicity (Nagarajan et al., 2012). This mechanism, mediated by a region 
of FAM49B, allows monitoring the functionality of an intracellular enzyme, leading to a 
targeted death if the cell is deficient in ERAAP signalling. However, function related to the 
full-length protein has not been reported yet. 
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1.5.4 Biological functions of FAM49 in D. discoideum 
Here I’m reporting the main unpublished findings of Jose Batista and co-workers regarding 
the study of D.d FAM49 in the Ax3 cell line (internal communication). 
Initial characterisation of D.d FAM49 were realised using GFP-tagged constructs and 
genetic knockout of the gene. Despite a cytosolic background, spinning-disc and TIRF 
(Total internal reflection fluorescence) microscopy clearly revealed a polarised localisation 
of GFP-FAM49 at the leading pseudopod of cells migrating in a chemotaxis under agarose 
assay. This enrichment is maintained during the extension of the pseudopod and the signal 
tends to disappear just before retraction, suggesting a very dynamic and controlled 
localisation of FAM49. Further imaging revealed that FAM49 is highly co-enriched with 
the active Rac reporter Pak-CRIB but only showed a weak co-localisation with Scar. These 
movies suggest that FAM49 accumulation is spatially similar to Rac1 but dynamically 
closer to Scar. It is worth noting that napA knockout cells still present a specific 
enrichment at the pseudopods, highlighting that the Scar/WAVE complex is dispensable 
for the localisation of FAM49. 
Finally, doxycycline-induction of active Rac1 drives the recruitment of GFP-FAM49 at the 
ruffling edge of the cell. Interestingly, the majority of the population shows homogenous 
localisation of active Rac1 reporter around the cell edge whereas FAM49 is more 
polarised. Unfortunately, in this experiment, correlation between localisation of FAM49 
and cell movement or protrusion formation has not been investigated.  
Disruption of the endogenous gene was performed by introduction of a blasticidin 
resistance cassette using homologous recombination technique, followed by clonal 
selection and PCR validation. Selected clones have a severe cell growth defect both in 
suspension or when plated on a bacterial lawn. Moreover FAM49 knockout cells become 
larger over time. Together these observations suggest a defect during cytokinesis and/or 
phagocytosis, which is the main strategy used by the amebae to uptake nutrients. 
Chemotactic development into fruiting bodies and cell adhesion were not affected upon 
genetic deletion of FAM49. Similarly, active Rac, Scar/WAVE, Arp2/3 and WASP 
localisation was similar between wild-type and knockout cells. Together, these results 
point toward a collaborative role between FAM49, Scar/WAVE complex and Rac for 
membrane dynamics and cell division, without affecting normal morphogenesis.  
Because FAM49 localises at protrusive ends, Batista and co-workers were interested by the 
behaviour of the knockout mutants and also the rescue clone in an under agarose 
chemotaxis assay. Interestingly, knockout cells showed a much rounder and smooth-edged 
phenotype, with a decrease in membrane protrusion rate leading in overall to a slower 
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motility. fam49b-knockout cells expressing GFP-FAM49 showed a full rescue of the 
phenotype whereas rescue using an untagged version of FAM49 made the wild-type 
phenotype even worse. Indeed, untagged rescued cells commonly exhibited split and 
narrow pseudopods. This may suggest an effect of the tagging strategy on the protein 
activity, and might provide some hints about a potential internal regulation of the protein. 
 
In conclusion, this work strongly suggests an important role of FAM49 in the protruding 
behavior of D. discoideum, with possible cross talk with Rac signalling. The fact that 
FAM49 homologues are highly conserved convinced us to investigate deeper into the 
functions of FAM49 in mammals, especially as FAM49B antibodies were available at the 
beginning of the project. 
1.6 Aim of the thesis 
Cell protrusion is at the base of all cell motility events and is required throughout the 
normal lifetime of an organism but can also be altered during cancer. Indeed, a very tight 
balance and coordination of signals has to be processed within a range of seconds to 
achieve an appropriate response.  
 
Understanding the mechanisms regulating pseudopod formation, splitting and dynamics 
has been an exciting challenge over the last decade and a precise vision of the main 
pathways has already been pictured. However, until recently negative signals involved in 
this process have unwisely been under estimated. Strong and elegant data from D. 
discoideum revealed FAM49 as an important partner in the loop between Rac1-
Scar/WAVE complex and protrusion dynamics. Despite its extraordinary sequence 
conservation, FAM49B has barely been studied and so far, no function has been assigned 
to the full-length protein. By using different genetic approaches, biochemical strategies, 
imaging and 3D culture, I will attempt to address this question by deciphering the 
molecular mechanism(s) driving FAM49B functions.  
 
Aims in summary: 
 
Aim 1: Evolutionnary study of FAM49  
Aim 2: Mechanistic and functional analysis of FAM49B  
Aim 3: Relevance of FAM49B in 3D models and in vivo 
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In addition, Fascin is associated with cancer dissemination and invasion. As a side project, 
I will discuss the data obtained after Fascin overexpression in a slow pancreatic cancer 
mouse model and the potential involvement of Fascin during pre-malignant lesion 
formation. 
 
Aim 4: Importance of Fascin 1 during early pancreatic cancereous lesion formation  
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2 Materials and methods 
2.1 Material and reagents 
2.1.1 Cell lines and bacterial strains 
Table 2-1: Cell lines and bacterial strains 
Name Description & Application Source 
Mammalian cell lines 
CHL1 Human melanoma cell line ATCC 
B16F1 Mouse melanoma cell line Prof. K. Anderson 
COS-7 Monkey kidney cell line ATCC 
HEK293T Human embryonic cell line Prof. L. M. Machesky 
MDCK Dog kidney cell line Dr. D. M. Bryant 
Chemically competent cells 
E. Coli DH5alpha Cloning and subcloning Homemade 
E. Coli BL21 CodonPlus 
(DE3)-RIL 
Expression of GST-tagged 
proteins 
Agilent #230245 
E. Coli BL21 (DE3) pLysS Expression of His-tagged 
proteins and inclusion 
body 
Promega #L1195 
2.1.2 Reagents and solutions 
Table 2-2: Reagents and solutions 
Name Description, Composition  & Application Source 
Cell culture 
DMEM  Gibco #21969-035 
MEM, high glucose, high 
sodium bicarbonate 
 Gibco #A1451801 
L-Glutamine  Gibco #25030-032 
FBS  Gibco #10270-106 
FBS TetON Approved tetracycline-free 
FBS 
ClonTech #631106 
PBS 3.3mM KCl, 137mM 
NaCl, 8mM Na2HPO4 and 
1.5mm KH2PO4, pH7.3 
Beatson central services 
2.5% Trypsin, no phenol 
red 
Serine protease Gibco #15090046 
PE buffer 0.037% (w/v) EDTA in 
PBS 
Beatson central services 
CASYton buffer Cell counter diluent OLS OMNI Life Science 
#5651808 
DMSO  Fisher Chemical 
#D/4121/PB08 
Doxycyclin  Sigma #D9891 
Hexadimethrine bromide  Sigma #H9268 
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Puromycin  Gibco #A11138-03 
Matrix 
Fibronectin from bovine 
plasma 
 Sigma #F1141 
Rat tail Collagen-I  Corning #10224442 
Laminin from Engelbreth-
Holm-Swarm murine 
sarcoma basemement 
membrane 
 Sigma #L2020 
Matrigel basement 
membrane matrix 
 BD Bioscience #354234 
Gelatin from pig skin, 
Oregon-green 488nm 
 Molecular Probes #G13186 
Protein lysate, SDS-PAGE and Western blotting 
RIPA buffer 150mM NaCl, 10mM Tris-
HCl pH7.5, 1mM EDTA, 
1% Triton X-100, 0.1% 
SDS 
Homemade 
NuPAGE Protein Sample 
buffer 4X 
 Invitrogen #NP0007 
NuPAGE Reducing 
Reagent 10X 
 Invitrogen #NP0004 
4-12% NuPAGE Bis-Tris 
gels 
 Invitrogen #NP0321 
MOPS Running Buffer 
20X 
 Novex #NP0001 
MES Running Buffer 20X  Novex #NP0002 
PageRuler pre-stained 
protein ladder 
 Thermo Scientific #26616 
Nitrocellulose blotting 
membrane 
Protran 0.45µm GE Healthcare #10600002 
Transfer buffer 20% Methanol, 10% 10X 
SDS-blotting buffer 
diluted in water 
Homemade 
10X SDS-blotting buffer 1% SDS, 250mM TRIS 
and 1.92M Glycin 
Beatson central services 
TBS-T 150mM NaCl, 10mM Tris-
HCl pH7.4, 2.7mM KCl, 
0.1% Tween20 
Beatson central services 
Molecular biology and subcloning 
2X PrimeStar Master Mix  Takara #R045 
High molecular biology 
grade agarose 
0.8-2% final concentration Melford #MB1200 
50X TAE buffer 2M Tris, 50mM EDTA, 
1M Glacial acetic acid, 
pH~8.3 
Beatson central services 
Midori green  Nippon Genetics #MG04 
6X DNA loading buffer 12% glycerol, 60mM 
Na2EDTA, 0.6% SDS, 
0.003% bromphenol blue, 
0.003% xylene cyanol, 
H2O 
Homemade 
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O’GeneRuler 1kb  ThermoScientific #SM1163 
100pb DNA ladder  NEB #N3231L 
L-Broth  Beatson central services 
SOC medium 2% w/v trypton, 0.5% w/v 
yeast extract, 10mM NaCl, 
2.5mM KCl, 10mM 
MgCl2, 20mM glucose 
Homemade 
LB-agar plate 15g agar/L of L-Broth Beatson central services 
Ampicillin Working concentration 
50µg/mL 
Sigma #A9518 
Kanamycin Working concentration 
50µg/mL 
Sigma #K4000 
Chloramphenicol Working concentration 
50µg/mL 
Sigma #C0378 
Protein purification 
IPTG  Sigma #I6758 
Lysis buffer 200mM NaCl, 30mM Tris-
HCl pH7.5, 3mM β-ME, 
Protease inhibitors 
(Roche) 
Homemade 
GST buffer 200mM NaCl, 30mM Tris-
HCl pH7.5, 3mM β-ME 
Homemade 
GSTrap HP column  GE Healthcare #17-5282-01 
GSH buffer 20mM GSH in GST 
buffer, pH7.5 
Homemade 
Thrombin Serine protease Sigma #T4648 
His buffer A 300mM NaCl, 25mM Tris-
HCl pH7.5, 2mM β-ME 
Homemade 
His buffer B 300mM Imidazol in His 
buffer B, pH 7.5 
Homemade 
HisTrap HP column  GE Healthcare # 17-5248-01 
Gel filtration buffer 150mM NaCl, 25nM Tris-
HCl pH7.5, 2mM β-ME 
Homemade 
HiLoad 16/600 Superdrex 
75pg 
 GE Healtcare #28989333 
HiLoad 16/600 Superdrex 
200pg 
 GE Healtcare #28989335 
Amicon Ultra-4 
centrifugal Filter unit 
 Amicon #UFC801024 
Amicon Ultra-15 
centrifugal Filter unit 
 Amicon #UFC901008 
MicroAmp Fast Optical 
96-well plate 
 Applied Biosystems 
#4346906 
Surface Plasmon Resonnance 
CM5 chip  GE Healtcare #BR100012 
NTA chip  GE Healtcare #BR100034 
Biacore T200   
Biacore Buffer 150mM NaCl, 25nM Tris-
HCl pH7.5, 2mM β-ME, 
10% P-20 
 
Surfactant P-20  GE Healtcare #BR100054 
Cell biology technics 
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GST Pulldown 
Buffer A GST pulldown - 50mM 
NaCl, 50mM Tris-HCl 
pH7.5, 5mM MgCl2, 3mM 
DTT 
Homemade 
Glutathione sepharose 4B 
beads 
 GE Healthcare #17075601 
Lysis buffer 100mM NaCl, 25mM Tris-
HCl pH7.5, 5mM MgCl2, 
1x Protease and 
Phosphatase inhibitor, 
0.5% NP-40 
Homemade 
Washing buffer 100mM NaCl, 25mM Tris-
HCl pH7.5, 5mM MgCl2 
Homemade 
GFP-Trap 
Lysis buffer 25mM Tris HCl, pH7.5, 
100mM NaCl, 5mM 
MgCl2, 0.5% NP-40, 
Protease and phosphtase 
inhibitors 
Homemade 
GFP_Trap_A beads  ChromoTek #gta_200 
Immunofluorescence & Immunohistochemistry  
16% paraformaldehyde  Electro Microscopy Sciences 
#15710 
Permeabilisation buffer 20mM Glycine, 0.05% 
Triton-X100 
Homemade 
ProLong Gold antifade 
mounting media 
 Molecular Probes #P36934 
Glutaraldehyde   
Citrate buffer pH6.0 Antigen retrieval solution Dako #S2031 
Peroxydase blocking 
solution 
 Dako #S2023 
Dako Antibody diluent 
solution 
 Dako #S3022 
Anti Mouse/Rabbit 
peroxidase labeled 
polymer 
 Dako #K401011 or 
#K400611 
CLICK reaction 
Fatty-acid free BSA  Sigma #A7030 
Palmitic acid-azide  Gift from Jennifer Greaves 
(Strathclyde university) 
Myristic acid-azide  Gift from Jennifer Greaves 
(Strathclyde university) 
Tris[(1-benzyl-1H-1,2,3-
triazol-4- yl)methyl]amine 
 Sigma #678937 
L-Ascorbic acid  Alfa Aesar #A15613 
Copper II Sulphate  Sigma #451657 
GFP-Trap 
Lysis buffer 100mM NaCl, 10mM Tris-
HCl pH7.5, 5mM MgCl2, 
0.5% NP-40, Protease 
Inhibitor Cocktail, 
Homemade 
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Phosphatase Inhibitor 
Cocktail 
Washing buffer 100mM NaCl, 10mM Tris-
HCl pH7.5, 5mM MgCl2 
Homemade 
GFP-Trap_A beads  ChromoTeK #gta_10 
3D MDCK cysts 
PFS 0.7% (w/v) fish skin 
gelatin in 0.025% 
Saponin-PBS 
Homemade 
Sodium azide  Sigma #S2002 
2.1.3 Cell culture plastic ware and consumables 
Table 2-3: Cell culture plactic ware and consumables 
Dishes, plates and tissue culture material 
Name Description & Application Source 
∅10cm plastic plate  Corning #430147 
6-well plastic plate  Falcon #353046 
24-well plastic plate  Falcon #353047 
96-well plastic plate  Falcon #353072 
∅35mm glass-bottom dish  MatTek #35G-1.5 20-C 
∅35mm glass-bottom dish For circular invasion assay Ibidi #81158 
Silicon stopper For circular invasion assay Ibidi #80209 
6-well glass-bottom plate  MatTek #06G-1.5 20-F 
24-well plate with 
transwell 
 Corning #3422 
E-Plate 16 xCELLigence assay Acea #05469830001 
∅13mm glass coverslips  VWR #631-0151 
8-well glass bottom 
chamber 
For MDCK cysts MatTek #Lab-TekII 155409 
Precellys CK14 lysing 
tubes 
Tube for tissue lysate Precellys #03961-1-003 
Tissue culture centrifuge Rotor A-4-44 Eppendorf C5804R 
2mL Cryovial  Greiner bio-one #126263 
2.1.4 Inhibitors 
Table 2-4: Inhibitors 
Inhibitors 
Name Description & Application Source 
Proteases inhibitor cocktail For cell lysate - WB ThermoFisher #1861279 
Phosphatases inhibitor 
cocktail 
For cell lysate - WB ThermoFisher #78427 
cOmplete™, EDTA-free 
Protease Inhibitor Cocktail 
For protein lysate – 
Protein purification 
Roche #11873580001 
PMSF For tissue lysate - WB Sigma #93482 
Aprotinin For tissue lysate - WB Sigma #A6279 
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NaF For tissue lysate - WB Sigma #S7920 
Na3VO4 For tissue lysate - WB Sigma #450243 
EHT 1864 Rac family GTPase 
inhibitor 
Tocris #3872 
NSC 23766 Selective inhibitor of 
Rac1-GEF interaction 
Tocris #2161 
2.1.5 Kits 
Table 2-5: Kits 
Kits 
Name Source 
Lipofectamine 2000 Invitrogen #11668019 
Lullaby OzBiosciences #FLL73000 
Calcium phosphate 
transfection kit 
Invitrogen #K2780-01 
Prescission Red advanced 
assay 
Cytoskeleton Inc. #ADV02 
Zymoclean DNA gel 
recovery kit 
ZymoResearch D4008 
Zero Blunt TOPO PCR 
Cloning Kit 
Invitrogen #K2800 
Rapid DNA ligation kit Thermo Scientific 
#10775841 
Q5-site directed 
mutagenesis kit 
NEB BioLabs #E0554 
µMACS GFP isolation kit MACS Miltenyl Biotec 
#130-091 
Thermal shift assay Applied Biosystem 
#4461146 
2.1.6 Antibodies and dyes 
Table 2-6: Antibodies and dyes 
Antibodies and dyes 
Antibody Source 
Working 
concentration & 
Dilution  
Rabbit anti FAM49B Sigma #HPA009076 WB 1:500 
Rabbit anti FAM49B ProteinTech #20127-1-AP WB 1:1000 
Mouse anti GFP (4B10) Cell Signaling #2955 WB 1:1000 
Rabbit anti GFP  Abcam #ab290 WB 1:2000 
Chicken anti GFP Abcam #ab13970 IF 1:500 
Mouse anti GST Abcam #ab18183 WB 1:1000 
Rabbit anti GST Cell Signaling #2622 WB 1:1000 
Rabbit anti Phospho-
Paxillin (Y118) 
Cell Signaling #2541 IF 1:200 
Mouse anti Vinculin Sigma #V9131 IF 1:400 
Rabbit anti WAVE2 (H-
110) 
SantaCruz #sc-33548 IF 1:50 
Rabbit anti Ki67 Abcam #ab15580 IF 1:200 
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Rat anti Tubulin (YL1/2) Abcam #ab6160 IF 1:200 
Mouse anti Podocalyxin  Gift from Dr. David Bryant IF 1:100 
Mouse anti Cortactin 
(4F11) 
Millipore #05-180 IF 1:200 
Rabbit anti p34-
Arc/ARPC2 
Millipore #07-227 IF 1:200 
Rabbit anti N-WASP 
(30D10) 
Cell signaling #4848 IF 1:100 
Mouse anti Fascin (55K-2) Dako #M3567 IF 1:200 
WB 1:1000 
IHC 1:500 
Mouse anti BrdU BD Bioscience #347580 IHC 1:200 
Rabbit anti Ki67 Thermo #RM9106 IHC 1:200 
Rabbit anti Cleaved 
Caspase 3 (Asp175) 
Cell Signaling #9661 IHC 1:300 
Rat anti NIMP (NIMP-
R14) 
Abcam #ab2557 IHC 1:200 
Rat anti F4/80 (CI:A3-1) Abcam #ab6640 IHC 10 µg/mL 
Rabbit anti Rac1/2/3 Cell Signaling #2465 WB 1:500 
Rabbit anti GAPDH Cell Signaling #2118 WB 1:1000 
Mouse anti Tubulin 
(DM1A) 
In house WB 1:3000 
Donkey anti Rabbit-HPR GE Healtcare #LNA934V WB 1:2000 
Goat anti Rabbit 800nm Thermo Scientific #SA5-
35571 
WB 1:10000 
Goat anti Mouse 800nm Thermo Scientific #SA5-
35521 
WB 1:10000 
Donkey anti Rabbit 680nm Invitrogen #A21206 WB 1:10000 
Donkey anti Mouse 680nm Invitrogen #A10038 WB 1:10000 
Donkey anti Rabbit 594nm Invitrogen #A21207 IF 1:200 
Donkey anti Mouse 594nm Invitrogen #A31203 IF 1:200 
Goat anti Rat Invitrogen #A11077 IF 1:200 
Goat anti Rabbit 488nm Invitrogen #A11008 IF 1:200 
Goat anti Mouse 488nm Invitrogen #A11001 IF 1:200 
Donkey anti Chicken 
488nm 
Invitrogen #A11039 IF 1:200 
Phalloidin 488nm Molecular Probe #A12379 IF 1:200 
Phalloidin 594nm Molecular Probe #A12382 IF 1:200 
Phalloidin 647nm Molecular Probe #A22287 IF 1:200 
Hoechst 33342 Thermo Scientific #62249 IF 1:50000 
Calcein AM Life Technologies #C1430 4µM 
800CW Alkyne Infrared 
dye 
LICOR Biosciences Ltd 
#929-60002 
5µM 
2.1.7 DNA constructs 
Table 2-7: DNA constructs 
cDNA and DNA constructs 
Name Backbone Source 
Human FAM49B pOTB7 GE Healthcare - Clone ID: 
3501828 
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Mouse FAM49B pCMV-SPORT6 GE Healthcare – Clone ID 
4012217 
GST-2x8His-FAM49B pBDDP-SPR4 Homemade (backbone: 
Gift from Dr.Chris Gray) 
GFP-30-236 FAM49B pEGFP-N1 Homemade 
R160D GFP-30-236 
FAM49B 
pEGFP-N1 Homemade 
R161D GFP-30-236 
FAM49B 
pEGFP-N1 Homemade 
R160/161D GFP-30-236 
FAM49B 
pEGFP-N1 Homemade 
eCFP-PBD-Pak pECFP-N1 Prof. L. M. Machesky 
GST pGEX4T2 Gift from Dr. Jan Ohotski 
GST-wt Rac1 pGEX2T Prof. L. M. Machesky 
GST-Q61L Rac1 pGEX2T Prof. L. M. Machesky 
GST-Q61L Cdc42 pGEX2T Prof. L. M. Machesky 
GST-Q63L RhoA  pGEX2T Prof. L. M. Machesky 
GFP-rGBD pCS2+ Addgene #26732 
mTq-sREACh Raichu Rac 
probe 
pKan-Rac-Raichu Gift from Dr. Kirsty 
Martin 
mTurquoise2-C1  Gift from Dr. Kirsty 
Martin 
FAM49B-GST pProExHT6 Homemade (Backbone: 
Gift from Dr. Shehab 
Ismail) 
G2A FAM49B-GFP pEGFP-C1 Homemade 
C10A FAM49B-GFP pEGFP-C1 Homemade 
C223A FAM49B-GFP pEGFP-C1 Homemade 
C231A FAM49B-GFP pEGFP-C1 Homemade 
C253A FAM49B-GFP pEGFP-C1 Homemade 
C284A FAM49B-GFP pEGFP-C1 Homemade 
pLIX401-mVenus-
FAM49B 
pLIX401-mVenus_New 
MCS 
Homemade (backbone: 
Gift from Dr. David 
Bryant) 
pLIX401-mVenus-R160D-
FAM49B 
pLIX401-mVenus_New 
MCS 
Homemade (backbone: 
Gift from Dr. David 
Bryant) 
pLIX401-mVenus-R161D-
FAM49B 
pLIX401-mVenus_New 
MCS 
Homemade (backbone: 
Gift from Dr. David 
Bryant) 
pLIX401-mVenus-
R160/161D-FAM49B 
pLIX401-mVenus_New 
MCS 
Homemade (backbone: 
Gift from Dr. David 
Bryant) 
6His-wt Rac1 pRSET Homemade 
6His-Q61L Rac1 pRSET Homemade 
GST-Pak-CRIB pGEX2T In-house 
GST-30-236 FAM49B pGEX4T2 Homemade 
R161D GST-30-236 
FAM49B 
pGEX4T2 Homemade 
GFP-Fascin pEGFP-N1 Gift from Dr. Josephine 
Adams 
GFP-Paxillin pEGFP-N1 In-house 
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FAM49B-FLAG pcDNA3.1 Homemade 
2.1.8 siRNA, shRNA and sgRNA sequences 
Table 2-8: siRNA, shRNA and sgRNA sequences 
Silencing RNA and guide RNA 
Target gene Type Sequence (5’-3’) Source 
Human 
FAM49B – 
Exon 3 
CrispR CACCGGGTGCAGTCGTGCCACTA
GT 
LifeTech 
Human 
FAM49B – 
Exon 4 
CrispR CACCGCGAGTATGGCGTACTAGT
CA 
LifeTech 
Mouse 
FAM49B Seq1 
siRNA CAGGCTCTCGCTAAACAGTTT Qiagen 
#SI04452035 
Mouse 
FAM49B Seq4 
siRNA TCAGGTGAATGTAGTGTTAAA Qiagen 
#SI00782341 
Human 
FAM49B Seq6 
siRNA AGGGTAATGGTGGGTGTCATA Qiagen 
#SI04278890 
Human 
FAM49B Seq7 
siRNA ATAGAAGAACATTGAGTCGTA Qiagen 
#SI04359369 
AllStar 
Negative 
siRNA 
siRNA  Qiagen 
#SI03650318 
Dog FAM49B 
#577 
shRNA GATGAGACTACCTCCAAGCAA Sigma 
#TRCN0000172577 
Dog FAM49B 
#901 
shRNA ACTGCCTATTCTGCTATTTAA Sigma 
#TRCN0000430901 
2.1.9 Softwares and websites 
Table 2-9: Softwares and Websites 
Softwares & Websites 
Name Provider Version 
ImageStudioLite LICOR Biosciences Ltd v 5.2.5 
NEBaseChanger NewEngland Biolabs v 1.2.6 
ApE M. Wayne Davis v 2.0.47 
7500Fast Real-Time PCR 
system 
Applied Biosystems v 2.06 
Fiji National Health Institute, 
USA 
v 1.48t 
Prism GraphPad v 5.0c 
Digital Image Hub Leica Biosystems v 4.0.6 
CrispR Design Zhang lab 2015 
MaxPlant Max Planck Institute V 1.5.5.1 
DAVID NIAID, NIH v.6.7 
i-TASSER Zhang lab v. 5.1 
Skylign Jody Clements, Travis 
Wheeler & Robert Finn 
v.3.0 
PyMol Schrödinger v. 1.7.4.5 
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2.2 Methods 
2.2.1 Cell culture 
2.2.1.1 Cell lines and growth conditions 
CHL1, B16F1, HEK293T and COS7 cells were maintained in 10% FBS and 2mM L-
Glutamine supplemented Dulbecco’s Modified Eagle’s Medium. MDCK cells were kindly 
provided by Dr. David Bryant (University of Glasgow and Beatson Associate). Cells were 
cultured in MEM, high glucose, high sodium bicarbonate, 5% FBS and 2mM L-Glutamine. 
Cells transfected with a TetON plasmid were grown in their respective medium 
complemented with approved Tetracycline-free FBS. All cell lines used in this study were 
maintained in ∅10cm plastic dishes at 37 °C and perfused with 5% CO2. 
2.2.1.2 Subculture and counting 
The following protocol applies for all cell types used during this work. Subconfluent cells 
were washed once with 1X phosphate buffer saline. Cells were detached using an 
appropriate volume of trypsin diluted at 0.25% in PE buffer and incubated at 37 °C. Cell 
detachment was checked regularly under a phase transmitted light microscope. Once fully 
detached, cells were resuspended in fully complemented medium, therefore inhibiting 
trypsin activity. Cell suspension was carefully resuspended and 400uL were taken up and 
diluted in 20mL of CASYton buffer. Cell counting was proceeded using CASY cell 
counter (Roche). Cell concentration was automatically calculated after averaging 3 
counting cycles and adjusted by the aggregation coefficient. In order to start off a fresh 
culture, cells were typically passaged at 1 in 5 (CHL1 and MDCK) and 1 in 10 (HEK293T 
and B16F1). Passages were recorded and fresh cells were taken out from the liquid 
nitrogen once reaching passage 20. 
2.2.1.3 Cryopreservation and cell recovery 
The following procedure applies for all cell types used during this work and has been 
optimised for a confluent 10 cm dish. Cells were collected as described above. Cell 
suspensions were centrifuged for 5min at 1000 rpm and pellets were resuspended in 3mL 
of freezing medium (50% fully complemented DMEM, 40% FBS, 10% DMSO). 1mL of 
cells was then aliquoted into 2mL cryovial tubes and immediately frozen at -80°C before 
being transferred to the liquid nitrogen tank. 
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To recover cells from the liquid nitrogen, cryovials were quickly transferred into a 37°C 
waterbath. Cells were gently resuspended in pre-warmed fully complemented medium and 
centrifuged as previously described in order to remove any trace of DMSO. Cell pellets 
were resuspended in fresh medium and plated onto 10cm dishes. Fresh media was added to 
the adherent cultures the day after thawing and cells were allowed to recover for at least 
one week before using them for any experiment. 
2.2.1.4 Transient transfection - Plasmids 
All cells lines were transfected in suspension, except when mentioned otherwise. Basically, 
cells were collected and counted as previously described. 1x106 cells were seeded into 6-
well plate. For CHL1, cells were plated at 70% confluence the day before processing. 
Meanwhile, Lipofectamine 2000 transfection mix was prepared accordingly to the 
manufacturers instructions. Briefly, 2.5-5µg of plasmid was diluted in 100µL final of SFM 
and 7µL of Lipofectamine 2000 was diluted in 93µL of SFM. Plasmid mix was then added 
to the Lipofectamine mix and incubated 5min at RT before adding onto cells. Cells were 
typically used 24-48h after transfection. Transfection of cells plated onto 15cm dishes 
requires scaling up to 20 µg of plasmid and 35µL of Lipofectamine 2000. 
2.2.1.5 Transient transfection - siRNA 
3x105 cells were used for each reaction according to the manufacturers protocol. Oligos 
were used at a final concentration ranging from 10-100nM. Briefly, 1.5-15 µL of 20µM 
stock oligos was diluted in 100µL final of SFM, whereas 7-14µL of Lullaby was diluted in 
100uL SFM in another eppendorf. Tubes were mixed together and kept 5min at RT before 
adding onto the cells. The same procedure was repeated 48h after the first treatment and 
cells were typically used 24-48h following the second shot. 
2.2.1.6 Lentiviral infection and stable cell line selection 
Knockout cell lines were produced using the CrispR-Cas9 editing genome technique as 
published by Ran et al (Ran et al., 2013). Basically, HEK293T cells were seeded at 1.5 x 
106 cells/10cm dish and transfected the day after using the calcium phosphate transfection 
kit. 10µg of lentiCrispR (empty vector or containing the CrispR targeting sequence), 7.5µg 
of pSPAX2 and 4µg of pVSVG were diluted in a final volume of 440µL of tissue culture 
water, mixed with 500µL 2X HBS and 60µL of 2M CaCl2 and left 30min at 37°C. 
Transfection mix was added overnight onto HEK293T cells. Medium was then removed 
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and replaced by 6mL of 20% FBS complemented DMEM, allowing virus production. 
Meanwhile, recipient cells were plated at 1 x 106 cells/10cm dish, in order to be at 40-50% 
confluence. 
The day after, medium-containing viruses was filtered through a ∅0.45µm pore membrane 
and mixed with 2.5µL of hexadimethrine bromide at 10mg/mL before infecting recipient 
cells. The same procedure was repeated the following day and puromycin selection was 
carried out after two shots of infection. Puromycin sensitivity was tested beforehand by 
treating untransfected recipient cells with a range of drug dose (usually up to 5µg/mL) and 
the appropriate concentration (leading to 100% cell death within 48h) was chosen for 
stable cell line establishment. Generally, most cell lines were sensitive to 1µg/mL but 
puromycin concentration had to be increased up to 5µg/mL for the MDCK cells.  
2.2.2 SDS-PAGE, coomassie staining and western blotting 
2.2.2.1 Protein lysate preparation from cell lines 
Culture medium was aspirated and cells were washed three times in ice cold PBS. Plates 
were then transferred onto ice and ice-cold RIPA buffer containing proteases and 
phosphatase inhibitors were added onto the cells, leading to direct cell lysis. Cells were 
scraped out from the dish, collected into a clean chilled eppendorf tube and kept on ice for 
about 5min. Tubes were centrifuged at 13000rpm for 10min at 4 °C and soluble proteins 
were transferred into a clean eppendorf for either direct analysis or frozen down. 
2.2.2.2 Protein lysate preparation from tissues 
Tissues were collected from humanely sacrificed mice, snap freezed on dry ice and kept in 
a pre-chilled eppendorf. Samples were thawed on wet ice and tissues were transferred into 
Precellys CK14 lysing tubes. 300µL of Ripa buffer containing 0.5% deoxycholate and 
protease inhibitors (1.25mM PMSF, 1µg/mL of Aprotinin, 0.5mM NaF, 1.25mM Na3VO4) 
was added and lysis was performed after 1 cycle of shaking using a pre-cold Precellys 
homogenizer (3 blasts of 30 sec with 90 sec gap between each blast). Tubes were kept on 
ice 1h to allow sedimentation of debris and supernatants were centrifuged at 13000rpm for 
15min at 4 °C. If the lysates were not clear, another spin was performed. 
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2.2.2.3 Protein quantification  
Protein concentration is routinely tested using Prescission Red advanced protein assay. 
Briefly 5µL of cell lysate was mixed with 995µL of reagent and incubate for 30sec. Protein 
concentration is proportional to the absorbance at OD600nm and typically 15-40µg of 
proteins was resolved on a SDS-PAGE gel. 
2.2.2.4 Protein separation using SDS-PAGE 
Appropriate protein concentration was mixed with NuPAGE LDS sample buffer and 
NuPAGE reducing agent to a final concentration of 1X. Samples were boiled 5min at 100 
°C and quickly centrifuged prior to loading. Samples were resolved using pre cast Novex 
4-12% Bis-Tris acrylamide gels and NuPAGE MOPS SDS running buffer, along side to 
6µL of PageRuler pre-stained protein ladder. When looking at Rac1, NuPAGE MES SDS 
buffer was used in order to increase the resolution of low molecular weight proteins. Gels 
were usually run at 180V until the front of the sample buffer reaches the bottom of the gel. 
2.2.2.5 Coomassie staining 
Gels were gently transferred into a clean plastic tray and stained overnight with 
InstantBlue. Stained gels were scanned using laser 700nm from the Li-Cor Odyssey CLx 
scanner. 
2.2.2.6 Western blotting 
Wet electrotransfer allows proteins to be exposed at the surface of a solid matrix. To do so, 
SDS-PAGE size-separated proteins were transferred onto a 0.45µm nitrocellulose blotting 
membrane for 60min at 110mA using a BioRad tank, filled with transfer buffer and an ice 
block. Membranes were blocked for at least 30min at room temperature using either 5% 
(w/v) non-fat dry milk/TBS-T or 5%BSA/TBS-T then incubated overnight at 4°C with 
primary antibody (see Table 2.6). In order to remove background caused by the excess of 
antibody, the membrane was washed 3 times for 5min in TBS-T at room temperature. 
Alexa-Fluor conjugated secondary antibody was diluted 1:10000 in 5% (w/v) non-fat dry 
milk/TBS-T and membrane was incubated 1h at room temperature. Excess antibody was 
washed out twice in TBS-T and finally once in water. All incubation steps were realised 
with gentle agitation. 
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2.2.2.7 Western blot scanning and quantification 
Membranes were scanned using the automatic setting intensity mode of the Li-Cor 
Odyssey CLx scanner. Images were processed as grey scale picture and signal intensity 
was calculated using the Li-Cor ImageStudioLite v.5.2.5 software. 
2.2.3 Molecular biology and subcloning 
2.2.3.1 PCR reaction  
Each reaction was set up with with 10ng of DNA template, 100ng of forward and reverse 
primers, 25µL of 2X PrimeStar Max Premix to a final volume of 50µL. PCR reaction was 
performed accordingly to Takara’s Taq polymerase requirements using a T100 Thermal 
Cycler (BioRad). Basically, program was set up as follows: 
	 	 1) 5min @ 98°C 
  2) 10sec @ 98°C 
  3) 15sec @ Tm (specific for each primer set) 
  4) 1min/kb @ 72°C 
  5) Repeat steps 2-4 for 30 cycles 
  6) 15min @ 72°C 
  7) ∞ @ 4°C 
 
2.2.3.2 Agarose gel electrophoresis and gel purification 
DNA gels were made up using high-grade agarose (from 0.8 up to 2% depending of DNA 
fragment size) diluted in TAE buffer. Agarose was boiled until completely dissolved and 
1% of Midori green added before casting the gel. DNA was diluted in 6X loading buffer 
and loaded into each well along with 8µL of O’GeneRuler 1kb or 8µL of 100pb DNA 
ladder for smaller fragments. Gels were typically run at 100V for 35min in TAE buffer. 
DNA fragments were quickly excised under UV lamp and DNA was purified using 
Zymoclean DNA gel recovery kit accordingly to manufacturer’s protocol. Basically, 
agarose fragments were weighed and heated at 50°C with 3 volumes of ADB buffer until 
completety dissolved. The mix was then loaded onto the spin column and centrifuged for 
30 sec at 10000rcf. Filters were washed twice with 200µL of washing buffer and DNA was 
eluted using 15µL of pre-heated nuclease-free water. 
2.2.3.3 Zero Blunt Topo cloning 
Eluted DNA was subcloned into a shuttle Topo vector accordingly to manufacturer’s 
protocol. Briefly, 4µL of PCR product was mixed with 1µL of salt solution and 1µL of 
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PCR-II-Blunt-Topo and kept for 5min at room temperature. 3µL of the Topo reaction was 
transformed into chemically competent E. Coli DH5alpha cells as described below. 
2.2.3.4 Transformation of chemically competent cells 
Most of cells used in this study were E. Coli DH5alpha, E. Coli BL21 CodonPlus (DE3)-
RIL or E. Coli BL21 (DE3) pLysS. Plasmids were gently mixed with competent cells and 
kept for 30min on ice. 45sec heat-shock at 42°C allows a transient permeabilisation of the 
plasma membrane and incorporation of the DNA into the cells. Cells were then allowed to 
recover on ice during 2min and a further hour at 37°C with 500µL of SOC medium before 
spreading a fifth of culture on pre-warmed LB-agar plates containing the correct antibiotic 
(50µg/mL). Plates were transferred overnight into a 37°C incubator. 
2.2.3.5 Restriction digestion 
All restriction enzymes and buffer used were purchased from New England Biolabs. 
Reaction were basically set up using 0.5-2µg of DNA, 2µL of appropriate NEB buffer and 
5-10 units of each enzyme and left overnight in a 37°C waterbath. Incubation time was cut 
down to 0.5-1h for FastDigest enzymes. Reactions were gel purified as previously 
described before any further applications. 
2.2.3.6 Ligation 
DNA concentrations were quantified using NanoDrop2000C (Thermo Scientific). Ratio 
vector:insert of 1:5 were mixed together in 2µL of rapid ligation buffer and 1µL of T4 
DNA ligase to a final volume of 20µL. Reactions were left at room temperature for 5 min 
and 5µL were transformed into E. Coli DH5alpha competent cells.  
2.2.3.7 Mutagenesis 
Primers were designed using the NEBaseChanger website (v1.2.6) and point mutations 
were created within the cDNA of interest using the Q5-site directed mutagenesis kit. 
Basically, PCR reactions were set up using 10ng of parental backbone, 0.5µM of each 
primer and 1X of Q5 Hot start high-fidelity master mix and following manufacturer’s 
instructions: 
1) 30sec @ 98°C 
  2) 10sec @ 98°C 
  3) 15sec @ Tm (specific for each primer set) 
  4) 30sec/kb @ 72°C 
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  5) Repeat steps 2-4 for 25 cycles 
  6) 2min @ 72°C 
  7) ∞ @ 4°C 
	
1µL of the PCR reactions was then used for circularization and template removal based on 
the digestion of the parental methylated DNA for 5min at room temperature using the KLD 
mix. 5µL of the  reactions were then transformed into chemically competent E Coli 
DH5alpha cells as previously described. 
2.2.3.8 Miniprep, screening of transformants, sequencing and maxiprep. 
Individual colonies were delicately touched with a sterile tip and used to inoculate 5mL of 
LB containing appropriate antibiotic(s). Cultures were grown overnight at 37°C with 
energetic shaking (200 rpm). Plasmids were purified using the QIAprep Spin Miniprep kit 
and 5µL were used for a quick screen by restriction digest. Clones containing the insert 
were sent for sequencing performed by the Beatson research services. Correct DNA 
sequences were confirmed by sequence alignment to the plasmid map (ApE Mavericks 
v2.0.47) and DNA was transformed into new E. Coli DH5alpha competent cells. 250mL 
culture was used for the Maxiprep purification performed by the Beatson research service. 
Plasmids were eluted in nuclease-free water. 
2.2.4 Protein purification and Biacore analysis 
2.2.5 Culture and induction conditions 
Basic protein preparations were set up in 2.5L flasks containing 1L of LB. Depending on 
the application, between 5-20 flasks were prepared. Pre-culture were grown overnight in 
LB containing appropriate antibiotics. For each culture, 10mL was used to inoculate 1L of 
pre-warmed LB containing antibiotics and kept at 37°C, 200rpm until culture reached 
OD600nm 0.4. At this stage, 0.2mM IPTG was added to the culture and temperature was 
decreased to 20°C for 17h. 
2.2.5.1 Cell lysis  
Overnight cultures were centrifuged for 15min at 4000rpm and pellets were re-suspended 
in filtered lysis buffer containing protease inhibitor. Lysates were passed twice through a 
20000psi-pressurised microfluidizer and collected in a clean beakers. Soluble and insoluble 
proteins were separated out by centrifugation at 20000rpm for 50min at 4°C and 
supernatant was filtered through ∅5µm pore membranes. 
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2.2.5.2 Purification of GST-tagged proteins 
AKTA machine was cleaned with water and equilibrated with fresh GST buffer. GSTrap 
HP column was washed with 5 column volumes of water and equilibrated with at least 10 
column volumes of buffer and until UV curve becomes stable. Lysate was loaded from the 
P960 pump onto the column and flow-through was collected in a clean bottle. At this step, 
UV curve typically picks up at 3500 units. The column was then extensively cleaned with 
GST buffer until UV went back to the baseline.  
At this step, the protein was either directly eluted in its tagged form by stripping the 
column with 10mL of elution buffer, or the tag was directly cleaved on the column. To do 
so, a loop was created between the column and a Falcon tube and 8mL of GST buffer 
supplemented with 100 units of thrombin was circulated overnight at 0.5mL/mL, 12°C. 
Efficient cleavage was monitored on the screen and resulted in a wave-like pattern of the 
UV curve, reaching ~150-300 units. 3-4 column volumes of GST buffer were used to 
collect the untagged protein. 
2.2.5.3 Purification of histidine-tagged proteins 
For purification of histidine-tagged protein, a similar protocol was used for the cleaning, 
equilibration and loading steps but buffer A and HisTrap HP column were used to 
specifically retain histidine-tagged protein. Proteins were directly eluted using a gradient of 
imidazole at 1mL/min. Basically, buffer A was pumped through lane A and buffer B 
through lane B. A gradient from 0-100% of buffer B was created with 1% step increase 
over 120mL and 1.5mL fractions were collected. 
2.2.5.4 Size exclusion chromatography 
Proteins were all gel purified in order to increase purity but also to facilitate storage in the 
standard GF buffer. The appropriate columns (HiLoad 16/600 Superdrex 75pg or HiLoad 
16/600 Superdrex 200pg) were equilibrated using GF buffer flowing at 1mL/min for at 
least 1hour. Proteins were injected into a 10mL loop and GF buffer was pumped at 
1mL/min into the loop, pushing the protein down the column. 1.2mL fractions were 
collected and few microliters of each fraction matching to a UV peak was loaded on a 4-
12% Bis-Tris acylamide gel for Coomassie staining.  
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2.2.5.5 Protein Concentration and protein storage 
Proteins were concentrated was performed using Amicon Ultra-4 or Ultra-15 centrifuge 
filter units with a 10kDa cut-off. Basically, samples were loaded and the tubes were 
centrifuged at 3000rcf, 4°C for at least 15min. Successive spins allowed concentratation of 
the protein to an appropriate volume. 200µL aliquots of proteins were snap frozen in liquid 
nitrogen and transferred at -80°C for long-term storage. 
2.2.5.6 Thermal shift assay 
Protein folding was tested by thermal shift assay. Basically, 5µM of protein was mixed 
with 1X dye diluted in buffer. Both GF buffer and kit melt buffer were tested and enough 
mix was prepared to have four technical replicates. 20µL of mix was pipetted into a 
MicroAmp Fast Optical 96-well plate and reaction run on the 7500Fast Real-Time PCR 
system using the 7500 software v2.06. The melt screen went from 25 to 95 °C with 1% 
increments. 
2.2.5.7 SPR – Biacore 
SPR analysis was performed using Biacore T200 (GE Heathlcare). Using GF buffer 
complemented with 5mM MgCl2 and 0.5% of surfactant P20 as running buffer, GST-
tagged proteins were immobilised at 22°C onto CM5 sensor chip and reached ~320 RU. 
Same procedure was used for His-tagged protein onto NTA sensor chip and reached 650 
RU. All immobilisation step were done at a flow rate of 10µL/min. Serial dilution of each 
analyte was injected across a reference flow cell and the flow cell containing the ligand at a 
flow rate of 30µL/min. Data were solvent corrected, reference subtracted, quality 
controlled and evaluated using the Biacore T200 evaluation software. Affinity was 
determined by curve fitting a 1:1 binding model.   
2.2.6 Cell biology technics 
2.2.6.1 GST pull down 
100mL preculture of E. Coli BL21 CodonPlus (DE3)-RIL were grown overnight. Cells 
were diluted 1:100 and induced at OD600nm 0.4 for 4h with 0.2mM IPTG. Lysates were 
obtained by resuspending cell pellets in ice-cold buffer A and 8x10sec blasts of sonication, 
followed by a 30min spin at 20000rpm (Beckman JA17). GST tagged proteins were 
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immobilized on glutathione-sepharose beads 30min at 4°C with gentle agitation whereas 
unbound proteins were washed out 3 times in ice-cold buffer A.  
CHL1 cells were transfected transfected as previously described and collected in ice-cold 
lysis buffer. 2mg of lysates were mixed with pre-equilibrated beads and binding was 
allowed for 2h at 4°C with gentle agitation. Beads were then washed 3 times in washing 
buffer and proteins eluted with sample buffer, prior to loading and blotting as described. 
2.2.6.2 Coating 
Coatings were done at a final concentration of 20µL/mL of protein diluted in PBS. Plates 
were kept overnight at 4°C. The next day, coatings were washed out 3 times in PBS and 
kept in PBS. 
2.2.6.3 Immunofluorescence 
Immunofluorescence was performed using ∅13mm glass coverslips. Cells were seeded at 
low concentration (3-5x104cells/coverslip) and allowed to adhere overnight (uncoated) or 
4h (coated coverslips). Media was aspirated from coverslips and cells were fixed in 4% 
paraformaldehyde for 10min, permeabilised for another 10min and blocked for 30min in 
5% BSA-PBS. For fascin staining, cells were fixed 10min with -20°C methanol, washed 
with PBS and directly blocked in 5% BSA-PBS. Primary and secondary antibodies, 
phalloidin and nuclear dye were diluted in blocking buffer and incubated for 1h in a dark 
and humidified chamber. Coverslips were washed twice in PBS and once in water before 
being mounted on glass slides using ProLong Gold antifade reagent. Coverslips were 
allowed to settle down on a glass slide overnight at room temperature, protected from light. 
Images were taken using an inverted Olympus FV1000 confocal microscope using a Plan 
Apochromat N 63x/1.40 oil SC or a Uplan FL N 40x/1.30 oil objective. 
2.2.6.4 Peptide array 
Overlapping 25-mer peptides of FAM49B were spotted on a cellulose membrane by Fmoc 
(9-fluorenylmethoxycarbonyl) chemistry (Frank, 2002) using an AutoSpot-Robot ASS222 
(Intavis Bioanalytical Instruments). Membranes were then mounted on a glass slide. Slides 
were first wet in TBS-T and blocked in 5% BSA-TBS-T for 1h at room temperature. Slides 
were rinsed with TBS-T and incubated overnight at 4°C with 0.9µM of recombinant 
untagged protein diluted in 0.5% BSA-TBS-T, with gentle agitation. After 3 washes in 
TBS-T, primary Rac1/2/3 antibody was added overnight at 4°C with gentle agitation. 
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Slides were washed 3 times with TBS-T and incubated with the horseradish peroxidase 
conjugated anti-Rabbit antibody. ECL pico system was used according to the 
manufacturer’s protocol and pictures taken using MyECL Imager chemoluminescent 
mode. 
2.2.6.5 Two-hybrid  
Two-hybrid screen was outsourced but below is a short description of the method used by 
Hybrigenics SA. 
The coding sequence for the constitutively active full-length Rac1 (NM_006908.4 ; 
mutations G12V, C189S) was PCR-amplified and cloned into pB27 as a C-terminal fusion 
to LexA (LexA-Rac1). All libraries that were used to screen are domain libraries cloned 
into the prey vector pP6. pB27 and pP6 derive from the original pBTM116 (Vojtek and 
Hollenberg, 1995) and pGADGH (Bartel et al., 1993) plasmids, respectively. The bait was 
screened against the different libraries using a mating approach with YHGX13 (Y187 
ade2-101::loxP-kanMX-loxP, mat alpha) and L40deltaGal4 (mata) yeast strains as 
previously described (Fromont-Racine et al., 1997). Positive colonies were selected on a 
medium lacking tryptophan, leucine and histidine, and supplemented with 3-aminotriazole 
whenever necessary to reduce the total number of clones. The prey fragments of the 
positive clones were amplified by PCR and sequenced at their 5’ and 3’ junctions. The 
resulting sequences were used to identify the corresponding interacting proteins in the 
GenBank database (NCBI) using a fully automated procedure. A confidence score (PBS, 
for Predicted Biological Score) was attributed to each interaction as previously described 
(Formstecher et al., 2005). 
2.2.6.6 Inverted invasion assay 
This method is a modified version of the previously published assay from Hennigan et al 
(Hennigan et al., 1994). Matrigel was diluted 1:1 in ice cold PBS and 100µL was allowed 
to polymerise for 30min at 37°C in each transwell. Meanwhile, cells were collected in fully 
complemented DMEM and 4x104 cells were plated onto the underside of the filter in order 
to cover the entire filter. Transwells were then carefully covered with the base of the 24-
well plate such that it contacted the droplets of cell suspension and was left for 2h in the 
incubator, allowing cell attachment to the bottom side of the filter. Transwells were finally 
washed into 3 x 1mL of serum free medium. Chemotactic gradients were created by filling 
the upper chambers with fully complemented medium, and the bottom chambers were kept 
in SFM. Cells were then allowed to migrate for 3 ½ days and stained for 1h at 37 °C with 
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4µM of calcein AM. Serial optical sections of 15µm interval were obtained with an 
Olympus FV1000 confocal microscope, UplanSApo 20x/0.74 objective. Images were 
analysed using Fiji software (ImageJ v1.48t) 
2.2.6.7 Fluorescent gelatin degradation assay – Invadopodia assay 
Sterile ∅13 mm coverslips were coated with 1mg/mL Oregon green 488nm gelatin and 
kept for 30min in the dark at room temperature. Coating was fixed for 40min using 0.5% 
of gluteraldehyde in PBS, then washed 3 times in PBS and sterilized with 70% ethanol for 
15min, before extensive washes. 3x104 cells were then seeded, fixed after 4h and 
immunofluorescence was performed as previously described. Images were taken using an 
inverted Olympus FV1000 confocal microscope, equipped with a Plan Apochromat N 
63x/1.40 oil SC objective. 
2.2.6.8 Random migration assay and spider plots 
1x105 cells were plated onto glass bottom 6 well plates and kept 4h (coated) or overnight 
(uncoated) at 37°C. Timelapse movies (1frame/10min – 17h) from randomly migrating 
cells were acquired using a Nikon TE2000 microscope, PlanFluor 10x/0.30 objective and 
equipped with a heated CO2 chamber. Cells were individually tracked using the MTrackJ 
plugin from Fiji. The chemotaxis tool from Fiji was used to plot individual x-y points from 
each track and to generate spider plot. 
2.2.6.9 3D Spheroid invasion assay 
1.5% agarose was diluted in PBS and microwaved until completely dissolved. 100µL were 
then pipetted into 96-well plate and kept at room temperature until totally set. Cells were 
collected as previously described and diluted at 2x104cells/mL. 100µL of cell suspension 
were added on the top of the agarose plug and cells were grown for 6 days until tightly 
packed. 
At this stage, the spheroid was gently transferred into a new 96-well plate and sandwiched 
between 2 layers of polymerised matrigel. Normal complemented medium was then added 
on the top and pictures taken every 24h using an inverted Olympus CKX41 micrcoscope 
equipped with a CAch N 10X/0.25PhP objective Invasion through the matrigel was 
calculated as below: 
  !"#$%&'" !"#$% = !"!!"#$% !"#$ !! !!"#$ !"#$ !!!"!!"#$%  !"#$  !! !100  
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2.2.6.10 Circular invasion assay 
∅35mm glass bottom dishes were specifically used for this assay. A square-shaped silicon 
stopper was added at the center of the dish, creating a space devoid of cell. 1x106 cells 
were collected and seeded as a confluent layer. Once attached, medium was aspirated from 
the dish, the insert was removed and 250µL of Matrigel diluted 1:1 in ice-cold PBS (final 
concentration of 4.5mg/mL) was overlaid onto the cells. The dish was transferred back to 
the incubator for 1h allowing matrigel polymerisation prior to adding fully complemented 
DMEM on the top of the matrigel layer. Timelapse movies (1frame/15min – 24h) were 
recorded using a Nikon TE2000 microscope, PlanFluor 10x/0.30 objective and equipped 
with a heated CO2 chamber. Invasion was quantified by measuring the invasion of cell 
within the cell free area created by the silicon insert. Basically, invasion was calculated as 
follows: 
   !"#$%&'" !"#$% = !"## !"#$ !" !!"## !"#$ !!!"##  !"#$  !! !100  
2.2.6.11 XCelligence spreading assay 
E-Plates 16 were coated as previously described with collagen I and equilibrated with fully 
complemented medium for 30min at 37°C. 5x103 cells were seeded on each well in 
quadruplicate and the plate was immediately set up into the Acea RTCA DP xCELLigence 
device. Cell index was measured every 5min for 8h and readings were averaged for each 
condition. 
    !"## !"#$%! =  !"#!!!"!"  
Rcet corresponds to the cell-electrode impedance at time point t and Rb to the background 
impedance. The nominal impedance value of 15 is constant for this device. 
2.2.6.12 Immunohistochemistry staining 
Tissues were dissected out from humanly sacrificed mice and fixed overnight in a large 
volume of 10% formalin. Tissues were embedded into a paraffin block and 2.5µm sections 
were cut and placed on a glass slide. Sections were dried in a 60°C oven for at least an 
hour. Most of the stainings were performed using the DAKO autostainer by the histology 
research service. Otherwise, tissues were manually rehydrated by successive baths in 
xylene (5min), 100% ethanol (2x1min), 70% ethanol (1min) and finally in tap water. 
Antigene retrieval was performed using the pressure cooker system by pre-warming a 
basket containing citrate buffer pH6.0 placed in 600mL of water. Slides were microwaved 
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for 13min using the full power setting and cooled down on ice for 15min. Slides were 
quickly washed with TBS-T and incubated 5min with the peroxidase blocking solution. 
Tissues were washed 3 times in TBS-T and overlaid with the primary antibody diluted at 
the appropriate concentration in the diluent solution for 2h at room temperature in a 
humidified chamber. After 3 washes in TBS-T, peroxidase labeled polymer was applied for 
30min at room temperature. Sections were washed and 1 drop of the substrate-chromogen 
DAB was diluted in 1mL of buffer and applied on the tissue until a light brown precipitate 
was detected. At this stage, slides were washed in TBS-T, dehydrated by passing through 
an ethanol gradient, counterstained with hematoxylin, and mounted between a rectangular 
coverslip. Slides were archived using the Leica SNF400F scanner and analysed using the 
Leica Biosystems software version 4.0.6. 
2.2.6.13 Cell labeling with fatty acid and alkyne probes  
HEK 293T cells were seeded onto 27-well poly-D-lysine coated plates and transfected 
using Lipofectamine 2000 reagent. 24h post transfection, cells were serum-starved in 
DMEM containing 1% fatty-acid free BSA for 30min at 37°C and then incubated with 
DMEM/1% fatty-acid free BSA containing 100µM azido-palmitate or azido-myristate 
(synthesised by Prof. Nicholas C. O. Tomkinson and Dr. Kevin R. Munro) for 3hours at 
37°C 
2.2.6.14 CLICK chemistry, GFP-IP step and detection of S-acylated 
proteins 
Cells were washed twice in ice-cold PBS and lysed with 100µL of 50mM Tris pH8.0 
supplemented with 0.5% SDS and protease inhibitors. 80µL of CLICK reaction mix (5µM 
alkyne dye, 2mM CuSO4, 0.2mM Tris[(1-benzyl-1H-1,2,3-triazol-4- yl)methyl]amine, 
4mM ascorbic acid) were added to the cell lysate and incubated 1h at room temperature 
with end-over-end rotation. GFP-tagged proteins were isolated using the µMACS GFP 
isolation kit following manufacturer’s protocol and resolved by SDS-PAGE as previously 
described. Protein acylation was quantified by expressing the intensity of the CLICK 
signal relative to the protein signal. 
2.2.6.15 GFP-Trap pulldown and mass spectrometry analysis 
Transiently transfected COS7 cells expressing GFP, GFP-FAM49B, FAM49B-GFP or 
GFP-30-236 were washed twice with PBS on ice and scraped out with 400 µL of lysis 
buffer. Lysates were kept on ice 30min and thoroughly mixed every 10min. Soluble 
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proteins were collected after a 10min centrifugation step at 15000rpm and protein 
concentrations were measured as previously described. 1.5mg of protein were mixed with 
25µL of pre-equilibrated GFP-Trap_A beads and incubated 2h at 4°C with gentle agitation. 
Beads were then washed 3 times with 500 µL of washing buffer. 
Purified proteins from biological triplicates were digested with Lys-C (Alpha Laboratories) 
and trypsin (Promega) on beads as previously described (Hubner et al, 2010). Tryptic 
peptides were separated by nanoscale C18 reverse-phase liquid chromatography using an 
EASY-nLC 1200 (Thermo Fisher Scientific) coupled online to an Orbitrap Q-Exactive HF 
mass spectrometer (Thermo Fisher Scientific) via nanoelectrospray ion source (Thermo 
Fisher scientific). Peptides were separated on a 20 cm fused silica emitter (New Objective) 
packed in house with reverse phase Reprosil Pur Basic 1.9 µm (Dr. Maisch GmbH). For 
the full scan a resolution of 60,000 at 250 Th was used. The top ten most intense ions in 
the full MS were isolated for fragmentation with a target of 50,000 ions at a resolution of 
15,000 at 250 Th. MS data were acquired using the XCalibur software (Thermo Fisher 
Scientific). 
The MS Raw files were processed with MaxQuant software version 1.5.5.1 (Cox and 
Mann, 2008) and searched with Andromeda search engine (Cox et al., 2011), querying 
both UniProt (UniProt, 2010) Chlorocebus sabaeus (13/03/2017; 19,228 entries) and 
Homo sapiens (09/07/2016; 92,939 entries) plus an in-house database containing common 
proteomic contaminants and the sequence of all GFP-FAM49 constructs used in the 
experiment. Combined databases were searched requiring specificity for trypsin cleavage 
and allowing maximum two missed cleavages. Methionine oxidation and N-terminal 
acetylation were specified as variable modifications, and Cysteine carbamidomethylation 
as fixed modification. The peptide, protein and site false discovery rate (FDR) was set to 1 
%. The common reverse and contaminant hits (as defined in MaxQuant output) were 
removed. Only protein groups identified with at least one uniquely assigned peptide were 
used for the analysis. For label-free quantification, proteins were quantified according to 
the label-free quantification algorithm available in MaxQuant (Cox et al., 2014). 
Significantly enriched proteins were selected using a t-test analysis with a 5% FDR 
(Welch’s test). 
Hits from the mass spectrometry data were submitted for gene ontology analysis to the 
DAVID database 
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2.2.6.16 FLIM imaging 
Level of active Rac1 was measured by FLIM, based on the emission lifetime of the 
mTurquoise2 fluorophore. The probe used in this study is a modified version of the initial 
Raichu Rac1 probe (Martin et al, PloS One in revision). Basically the initial acceptor was 
switched with the sREACh dark acceptor (super resonance energy-accepting 
chromoprotein), designed to improve the signal-to-noise ratio (Murakoshi et al., 2008). 
Probe and control mTurquoise alone were transfected transiently into cells using 
Lipofectamine 2000 as previously described. 4x105 cells were plated on laminin coated 
glass-bottom dishes and imaged 4h later. Widefield pictures were acquired using a Nikon 
FLIM/TIRF system Z6014 equipped with a Plan Apochromat 63x/1.45 oil objective and a 
465nm LED. Dishes were fit in a 37°C heated chamber perfused with 5% CO2. 
Fluorescein was used for the microscope calibration in order to optimise the microscope 
parameters. Once calibrated, MCP was kept at the same voltage for all readings. For each 
repeat, lifetime from at least 15 cells was measured. FRET efficiency was calculated by 
standardising the probe lifetime (!!"#$%) to the average lifetime of the donor alone (!!"#) 
as follows: !"#$ !""#$#!%$& % = !!"# − !!"#$%!!"# !100 
2.2.6.17 3D MDCK cyst - Culture 
MDCK cells were split 1:10 the day before, in puromycin-free medium in order to ensure 
cells are in proliferation mode. High growth factor Matrigel was thawed in an ice-water 
slurry for 30min while a 8-well glass bottom chamber was cooled down on ice inside a 
sterile dish. Chambers were coated by spreading 5µL of undiluted Matrigel over the well 
and transferred to 37°C incubator for at least 10min. MDCK cells were collected as 
described before and diluted to 4x104 cells/mL in puromycin-free medium. Suspension was 
thoroughly mixed by pipetting in order to break down any aggregates that would affect 
normal cyst formation. Matrigel was then diluted to 4% in normal medium and mixed with 
the similar volume of cell diluted at 1.5x104 cells/mL, bringing the final Matrigel 
concentration down to 2%. 300µL of the cells-Matrigel mix was added to each well and the 
chamber was placed for 5 days at the back of the incubator. In order to reduce the 
evaporation, a humidified environment was created by placing the Mat-Tek chamber in a 
∅10cm dish filled with a small amount of sterile water.  
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2.2.6.18 3D MDCK cyst – Immunofluorescence and imaging 
Medium was aspirated and wells were quickly washed twice with PBS. Cysts were fixed 
using 4% PFA for 10min, washed, and permeabilised for 10min at room temperature using 
0.5% Triton X100 diluted in PBS. PFS was used as blocking solution for 30min at room 
temperature with gentle shaking. Primary antibodies were diluted in PFS and incubated 
overnight at 4°C with gentle shaking. The day after, cysts were washed 3 times in PFS at 
room temperature. Secondary antibodies, nuclear dye and phalloidin were diluted at 1:200 
in PFS and incubated for an hour at room temperature before further washes. Chambers 
were then kept sealed in 0.02% NaN3-PBS at 4°C until analysis. Cysts were imaged using 
the Nikon A1R Z6005 confocal microscope using either a Plan Apochromat 20x/0.75 DIC 
N2 or a Plan Fluor 10x/0.30 DIC L/N1 objective. In order to sharpen up images, factor line 
averaging was set up at 4. Z-stacks images were acquired with a 4µm increment step from 
the bottom to the top of the cyst. 3D-reconstruction using the Fiji plugin was used for a 
better visualisation. 
2.2.6.19 Ex vivo skin explant preparation and imaging  
This protocol is adapted from a previously published method (Mort et al., 2010). Skin from 
a E15.5 mouse embryo was delicately peeled off and flattened between a nucleopore 
membrane and a gas permeable 24-well Greiner Lumox plate. In this set up, the epidermis 
is facing the Lumox membrane, the dermis is in contact with the nucleopore membrane 
and covered by a fine layer of 100% Matrigel. Plate was incubated 15min at 37°C and 
500µL of 10% FBS Phenol-free DMEM was added to each well. Timelapse movies 
(1frame/5min over 4h) were acquired using a Nikon A1R Z6005 confocal microscope at 
37°C/5%CO2, with a Plan Fluor 10x/0.30 DIC L/N1 objective. Tracking and quantification 
of cell speed were obtained using the MTrackJ plugin from Fiji. 
2.2.6.20 Adhesion and FAAS server 
During the 2nd shots of siRNA, B16F1 cells were co-transfected with 5µg of GFP-Paxillin. 
24h post transfection, cells were re-plated on laminin-coated glass-bottom dishes and 
imaged 4h later. Short timelapse movies (1frame/30sec over 30min) were acquired using a 
Zeiss 880 LSM with AiryScan Z6028 at 37°C/5%CO2, with a Plan-Apochromat 63x/1.4 
oil DIC M27 objective. Movies were processed using the Zeiss software ZEN, version 2.1 
SP1 and submitted to the Focal Adhesion Analysis Server (http://faas.bme.unc.edu/). 
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Threshold of 3.5 units was set up and any GFP-Paxillin positive structures above 15 pixels2 
lasting for at least 5 successive frames were quantified as being a focal adhesion. 
2.2.7 Fly work 
2.2.8 Maintenance and mating conditions 
D. Melanogaster strains bearing a transposable element targeting CG32066 (D.m.. 
FAM49B gene) were obtained from the Vienna Drosophila Resource Center (KK107318 
and GD44825). Mattings were set up using virgins with a tubulin-Gal4 driver and males 
from either a w1118 background (control flies) or the RNAi lines (knockdown flies). 
Crosses were kept at 25°C with a 12-12h dark-light cycle and flies were flipped into a 
fresh tube every 2 days. 
2.2.9 Hemocyte extraction  
L3 stage larvae were collected and quickly washed in PBS and placed in a drop of PBS in 
order to isolate circulating hemocytes. Basically, the larval posterior part was pulled apart 
from the rest of the body using 2 forceps. A round forceps was placed at the level of the 
anterior part and pushed inward into the body so that the inner part is facing outside. 
Hemolymph was pipetted and adjusted to 200µL with PBS. Cells were then plated in a 
glass-bottom 24-well plate and processed for immunofluorescence microscopy as 
described previously. 
2.2.10 Mouse work 
2.2.10.1 Mouse maintenance, breeding and genotyping 
Mice were maintained by the animal house service staff according to the UK home office 
regulations. Breedings were set up between 1 male and 2 females with the appropriate 
genotype in order to respect the 3R’s. Ear punch was used for genotyping puropose and 
sent to TransnetYX®. 
2.2.10.2 Fascin mouse 
Fascin mouse was created by Douglas Strathdee’s group and details can be found in 
appendix.  
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2.2.10.3 FAM49 mouse 
Flox FAM49B mouse was obtained by IVF of frozen sperm (Tm1c variant) obtained from 
the Canadian Mouse Mutant Repository. C57BL/6 mice were used for the rederivation and 
maintained as described above. 
2.2.10.4 Quantification of PanIN 
Quantification were realised on haematoxylin/eosin staining. Area of PanIN, PDAC and 
cyst were independently measured and a ratio of lesion area over the total area of the 
pancreas was calculated. Classification of PanIN was based on 
http://pathology.jhu.edu/pancreas/professionals/DuctLesions.php 
2.2.11 Statistical analysis 
Datasets were analysed using Graph Pad Prism5 v5.0c. Normality of the distribution was 
tested using the Agostino and Pearson function. If the dataset failed to pass the test, an 
arcsine transformation was applied and the normality tested again. Non-parametric tests 
were only used when dataset failed to pass both tests. Description of the test performed for 
each experiment can be found in the corresponding figure legends. If not stated otherwise, 
all experiments were performed at least 3 times corresponding to independent biological 
replicates. Error bars represent S.E.M (ns: p >0.05, *: p ≤0.05, **: p ≤0.01, ***: p ≤0.001). 
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3 Evolution and characterisation of FAM49B 
sequence 
3.1 Introduction 
Starting a project with no background has been the most challenging part of this study. 
Indeed, FAM49B has been defined as a protein of unknown function, with a unique 
uncharacterised DUF1394 domain encompassing the whole protein, except the first 18 N-
terminal amino acids and the last 4 amino acids. However FAM49 was shown to have 
important functions in actin-driven protrusions formation in D. discoideum (Jose’s thesis) 
but its function in mammals has not been addressed yet.  
We then decided to focus on the only information available that we could trust: the protein 
sequence. Jose’s preliminary work was based on sequence alignment across evolutionarily 
distant organisms. The overall picture showed a good conservation in the eukaryotic 
phylum meaning a putative conserved function. However a more thorough and unbiased 
analysis has not been done. 
The aim of this chapter is to look precisely at FAM49 sequences and distinguish residues 
or domains with high conservation or with similarities to already published motifs. Indeed, 
we hypothesised that 1) given its putative role in actin dynamics, FAM49 must have co-
evolved with main actin regulators. 2) important functional motifs must have been 
positively selected over time. 
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3.2 Results 
3.2.1 FAM49B is conserved and seems to have co-evolved with 
Arp2/3 and WASP proteins 
In order to get a picture of the diversity of FAM49 sequences that have emerged from 
evolution, selected candidates from Uniprot were aligned using the Clustal multi-alignment 
tool (Appendix 1). Alignment of FAM49 sequences from evolutionary distant organisms 
showed an extremely good conservation of the protein and confirmed Jose’s previous 
alignments. For example, H. sapiens and D.discodeum FAM49 have just below 50% 
identity. The fact that the level of conservation had not been noticed before convinced us 
of the importance to follow up this project and extend the study to FAM49B in mammals. 
Together, Jose’s data and the sequence homology suggest that FAM49 is highly conserved 
and may have a role in actin dynamics. We therefore compared the evolution of FAM49B 
with the Arp2/3 complex and the WASP family proteins, keeping in mind that if FAM49 
plays an important role for actin dynamics, it would have been co-selected with the main 
components driving this process. A study published a few years ago about the evolution of 
WASP family proteins (Veltman and Insall, 2010) was used as a template. Authors 
concluded their paper with a phylogenetic tree reflecting the co-evolution of Arp2/3 
complex subunits and WASP proteins. Basically, the organisms mentioned in this paper 
were used for a BLASTP search for the presence of FAM49 sequence (Appendix 2). We 
noticed the absence of FAM49 in chromalveolates and plants whereas both Arp2/3 and 
WASP proteins were conserved in the second half of the plant phylum. The only plant with 
a putative FAM49 is A. amincola and it might be interesting to look at this candidate for 
further study and characterisation. Conversely, we noticed a parallel evolution between 
FAM49, Arp2/3 and WASP proteins in the other phyla. Together, we can then say that 
presence of FAM49 seems to be specific of the excavates and the unikonts phyla. It also 
appears that FAM49 has co-evolved with key actin dynamics players suggesting that they 
might belong to and regulate the same pathway. 
3.2.2 Notable features of FAM49B sequence 
Looking at the good overall sequence conservation, we went on and looked precisely at the 
sequence of FAM49B. We started our analysis by the common DUF1394 domain that runs 
across most of the protein sequence. We took the advantage of the hidden Markov models 
(HMM) logos online tool (Wheeler et al., 2014). HMM logos are a useful tool to 
summarise and represent complex alignments in an unbiased way. The output is a 
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graphical alignment, displaying a stack of letters according to their distribution and 
conservation at a specific position across the entire dataset. The height of the stack reflects 
the relative entropy at one position, whereas the height of one letter represents the letter 
frequency. This visual representation allowed us to look over various DUF1394 domains 
coming from a seed or a full Pfam dataset. The seed dataset contains an alignment of 38 
sequences from which the family is built using Pfam reference proteomes. The full dataset 
represents over 900 sequences from the entire Pfam database and can be found in appendix 
3. However, DUF1394 domains from CYFIP versus FAM49 proteins cannot be 
distinguished. From the HMM logo, regions with a minimum of 5 consecutive residues 
with the highest letters were considered as highly conserved motifs. Eight portions were 
retrieved as fully conserved in the seed dataset (Figure 3-1). 
Among those, 4 motifs are present in all the DUF1394 sequences (occupancy=1), whereas 
the low occupancy value from the others suggests they show up only in a small subset of 
sequences (occupancy=0.03) and therefore, are unlikely to be conserved. However, only 
one of these motifs is retrieved from the HMM logos generated using the full Pfam dataset 
(Q-N-D-F-S-Y-Y-R/K-R). Although not present across every single sequence, it has the 
highest occupancy value of the dataset, peaking at 0.91 (Figure 3.1 - inset). Together 
analysis of the HMM logo suggests a positive selection of a highly conserved 9-amino acid 
sequence that is found in most of the DUF1394 domains present in the Pfam database. This 
sequence stretches from residue 153-161 in H. sapiens FAM49A/B and unsurprisingly, 
multi-alignment confirmed its wide conservation across divergent organisms (Appendix 
1). The 2 last arginine residues stand out from the alignment with 100% identity in FAM49 
proteins and 100% similarity between FAM49B and CYFIP proteins and kept our 
attention. Indeed Arg161 is fully conserved whereas Arg160 is replaced by a lysine in 
CYFIP, although both are positively charged, so with similar chemical properties. 
Moreover, using our CLUSTAL alignments and some of Jose’s previous work, we also 
noticed that the second glycine is highly conserved (Figure 3.2 - A). Presence of a glycine 
as the second residue of the protein is commonly seen as signal for protein myristoylation 
(Chamberlain and Shipston, 2015). Myristoylation is an irreversible process where a 
myristate group (C14:0 lipid) is added by a N-myristoyl-transferase (NMT) and mediates a 
weak interaction to the plasma membrane. However, stable interaction with the plasma 
membrane requires an additional signal.  
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Figure 3-1: HMM logo of the DUF1394 domain 
HMM logo was generated by feeding a 38-sequence seed dataset of the DUF1394 domain to 
Skylign. Letter stack represents the conservation of the residue at this position across the dataset. 
Occupancy score is also mentioned below each letter and is a readout of the presence of a letter 
across the dataset, ranging from 0 (no present) to 1 (present). Highly conserved motifs have been 
highlighted in blue (low occupancy) and red (high occupancy). Among all the red motifs, motif 2 
was the only portion with high conservation/high occupancy. Motif 2 alignment of the full dataset 
(915 sequences) is represented on the side. 
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This can either be a hydrophobic patch near the putative myristoylation site or the addition 
of another lipid that stabilises the myristoylated protein at the membrane. In the latter case, 
palmitoylation (addition of a C16:0 lipid) is a common second signal. We then sought for 
potential lipidation events across FAM49B sequence using CLICK chemistry. This 
technique allows to metabolically label proteins using azide-analogues (azide-myristate or 
azide-palmitate). Typically, the lipid is added onto each modified protein with the free 
azide able to react with a labelled metabolite. Immunoprecipitation of the protein of 
interest followed by western blot allowed us to investigate the post-translational 
modifications occurring across FAM49B sequence. FAM49B-GFP was used over the N-
terminal tagged protein because of the close proximity between the Gly2 and the GFP tag. 
Indeed, depending on the folding of the fusion protein and because of the steric hindrance, 
NMT might not be able to access to and modify the Glycine. 
Following GFP-pull down, we were not able to distinguish any signal coming from control 
GFP-transfected cells incubated with either azide-C14:0 or azide-C16:0. However, a strong 
signal was detected for the fusion protein, indicating that FAM49B gets both myristoylated 
and palmitoylated (Figure 3-2 - B). The next step was to determine what residues were 
modified. This question was addressed by performing point mutation along the protein 
sequence. As mentioned earlier, myristoylation only occurs on N-terminal glycine residue 
therefore, a point mutation mediating the transition Gly->Ala (G2A mutant) was 
introduced. Interestingly, expression of this construct in cell resulted to a shifted migration 
on a SDS-PAGE gel (Figure 3-2 - C). It is quite commonly accepted that post-translational 
modifications affect protein migration, especially because of differential charges present 
on the modified versus unmodified protein. This differential running pattern was also 
observed using an alternative in vitro approach (Figure 3-2 - D). Bacterially expressed 
FAM49B-GSTΔMet1 was purified so that the glycine is the 1st N-terminal residue. This is a 
trick to pass over the methionine cleavage happening in cellulo to allow PTMs. C-terminal 
tagging strategy was also preferred for a similar reason as mentioned above for the GFP 
construct. Incubation of the purified protein with NMT and in the presence or not of 
Myristoyl-CoA shows a similar differential running pattern. In this case, the protein mixed 
with the myristoyl-CoA migrated slightly faster compared to the un-myristoylated protein. 
In order to fully confirm that this shift was a consequence of the myristoylation, these 
samples were sent for further analysis but mass spectrometry was unable to detect any 
myristoylation event, even on the positive control (Lck protein incubated with Myristoyl-
CoA and NMT). We suspected a technical issue with the column used for the analysis that 
might retain hydrophobic proteins. This analysis might require a different mass 
spectrometry strategy in order to ascertain the modification of the protein (i.e. SILAC). 
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Based on these observations, I directly asked whether FAM49B was modified and 
performed the CLICK reaction with both WT and mutants FAM49B (Figure 3-2 - E). 
Incorporation of C14:0 analogue was quantified in our different constructs. CLICK signal 
level from the G2A mutant was close to the background level, meaning that myristoylation 
of the protein is specific to the Gly2 and mutation of this residue abrogates the protein 
myristoylation. Once again, a shift of the G2A mutant compared with the other constructs 
was observed. Studying palmitoylation was not as straightforward and this is mainly due to 
the diverse range of putative residues present. Palmitoylation is a dynamic and reversible 
event, preferentially occurring on cysteine but glycine palmitoylation has also been 
described (Kleuss and Krause, 2003). FAM49B contains 5 cysteine residues at position 10, 
223, 231, 253, 284 (Figure 3-2 - A). Despite its lack of conservation Cys10 was initially a 
good candidate as we thought it would have been close enough from the Gly2 to strengthen 
the interaction of the protein at the membrane. It is also one of the predicted palmitoylated 
residues in FAM49B when using a palmitoylation prediction tool 
(www.swisspalm.epfl.ch). However, C10A mutant was still showing a strong CLICK 
signal in the preliminary experiment already performed (Figure 3.2 - F). Interestingly, 
palmitoylation of the G2A mutant was abrogated, suggesting that myristoylation is crucial 
for further modification and confirms the 2-step model for protein acylation. In order to 
map the palmitoylation site, individual point mutants of each cysteine were created. 
Among them, Cys231 is extremely well conserved whereas Cys223, Cys253 and Cys284 
show a fairly good conservation, although not as good as the previous one (Figure 3.2 and 
3.2 - A). Results from the CLICK assays didn’t show any significant reduction of the 
CLICK signal (Figure 3.3), bringing to the hypothesis that more than one cysteine must be 
modified. A FAM49B-GFPCys->Ala mutant was designed but despite many different 
conditions and cell lines tested, none of them were able to express this construct. This was 
really unfortunate for our purpose but also not totally surprising as cysteines are important 
residues for protein folding by participating to the formation of disulphide bridges. So 
mutations to any other amino acid might affect protein stability and lead to the degradation 
of the construct. 
Together, our data show that FAM49B is myristoylated and palmitoylated. We mapped the 
myristoylation site on the conserved glycine 2. At this point however, we cannot conclude 
concerning the residue(s) involved in palmitoylation and we are currently working on this 
specific question. We hypothesised that several cysteines are involved and double/triple 
mutant will next be investigated.  
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Figure 3-2: Post-translational modifications of FAM49B 
A – Selected fragments from the protein alignments of FAM49 homologues from different 
organisms. UniProt accession number is mentioned for each protein. The full alignment is 
presented in appendix 1. In order to facilitate the nomenclature, red numbering above the 
alignment is based on the human FAM49B sequence. Conserved glycine 2 is highlighted in red 
and corresponds to a putative myristoylation site. Cysteine residues are pointed with a black 
arrowhead. 
B – Western blot membrane from a CLICK experiment. HEK293T cells were transfected with GFP 
or FAM49B-GFP and incubated either with C14:0-Azide (myristate analogue) or C16:0-Azide 
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(palmitate analogue) for 3h. GFP-tagged proteins were pulled down and CLICK reaction performed 
before resolving the samples on a SDS-PAGE gel. Membranes were blotted against GFP (red) or 
the CLICK (green). Picture of the merge channel is also presented with the corresponding 
molecular weights on the side. 
C – Western blot analysis from the different FAM49B-HA mutants. Lysate from control CHL1 cells 
(NT) or transfected with wild type FAM49B-HA (wt), single G2A or C10A FAM49B-HA mutant or 
double G2A/C10A FAM49B-HA, were resolved by SDS-PAGE and blotted against HA-tag. 
Molecular weights are displayed on the side. 
D – In vitro myristoylation assay. Purified FAM49-GSTΔMet1 was incubated overnight at RT with 
NMT in the presence (+) or absence (-) of MyrCoA. Samples were loaded on SDS-PAGE and 
Coomassie stained. Top black dotted line highlights the migration shift of the GST-tagged protein 
compared to a contaminant band (bottom black dotted line). Molecular weights are displayed on 
the side. 
E - CLICK experiment looking at myristoylation of the different FAM49B-GFP constructs 
transfected into HEK293T cells and incubated with C14:0-Azide for 3h. Individual channel and 
merge picture are presented with the corresponding molecular weights on the side. Protein 
acylation was quantified from 3 independent experiments by comparing the CLICK signal relative to 
the protein signal, and normalised to the wild-type control. One-Way ANOVA with Tukey test was 
applied. (n.s. p> 0.05, *** p<0.001). 
F - CLICK experiment looking at palmitoylation of the different FAM49B-GFP constructs transfected 
into HEK293T cells and incubated with C16:0-Azide for 3h. Individual channel and merge pictures 
are presented with the corresponding molecular weights on the side. Protein acylation was 
quantified from only one experiment by comparing the CLICK signal relative to the protein signal, 
and normalised to the wild-type control. 
_________________________________________________________________________ 
Both palmitoylation and myristoylation suggest a partial localisation of FAM49B at the 
plasma membrane during the protein lifetime. It has however been impossible to localise 
the endogenous protein as none of the commercially available antibodies have shown 
specific staining. Indeed, cytosolic staining was obtained in both control and fam49b 
knockout cells under different antibody concentrations and fixation conditions. This 
problem is specifically addressed at the moment as we are currently in the process of 
purifying our own antibody. Meanwhile a tagging strategy was preferred, always keeping 
in mind that small tags might be more relevant for a localisation study, in order to not 
disrupt PTMs. FLAG tag was an initial good candidate for its fairly small tag (8 amino 
acids) and easy detectability by immunofluorescence. However, among the different cell 
lines tested (B16F1, B16F10, CHL1, MDCK), only COS-7 cells would tolerate more than 
twice the endogenous level (Figure 3.4 - A and B). FAM49B-FLAG-transfected COS-7 
cells were plated on laminin and stained against the FLAG-tag. Population had two distinct 
localisation of the tagged-protein. Signal was either exclusively cytosolic or accumulation 
of membranous FLAG staining at cell protrusions was also noticed. In the latter case, 
staining seems to follow a gradient fading on each side of the protrusion and across the 
cell. Quantification of pixel intensity of the Phalloidin and FLAG-tag staining across 
different transfected cells clearly reflects this gradient, peaking at the tip of the protrusion 
(Figure 3.4 - A and C). Also, FAM49B colocalises with both F-actin and WAVE2 
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(Figure 3.4 - A and D). The correlation between the FLAG positive areas and the 
protrusion is however worth noticing. Characterisation of the FAM49BG2A-FLAG mutant, 
defective in myristoylation and palmitoylation, has not been investigated but loss/reduction 
of the membrane staining and colocalisation with WAVE2 would be expected and would 
reflect its lack of membrane targeting sequence.  
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Figure 3-3: Palmitoylation events on FAM49B 
A - Western blot membrane from a CLICK experiment. HEK293T cells were transfected with GFP 
or wild type FAM49B-GFP (WT) or C>A point mutant FAM49B-GFP and incubated with C16:0-
Azide (palmitate analogue) for 3h. GFP-tagged proteins were pulled down and CLICK reaction 
performed before resolving the samples on a SDS-PAGE gel. Membranes were blotted against 
GFP (red) or the CLICK (green). Picture of the merge channel is also presented with the 
corresponding molecular weights on the side.  
B - Protein acylation was quantified from 4 independent experiments by comparing the CLICK 
signal relative to the protein signal, and normalised to the wild-type control. One-Way ANOVA with 
Tukey test was applied. (n.s. p> 0.05) 
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Figure 3-4: Localisation of FAM49B-FLAG 
A – Immunofluorescence of COS7 cells transfected with empty vector (pcDNA3.1) or FAM49B-
FLAG. Cells were plated on laminin for 4h, fixed and stained for FLAG-tag (green) and F-actin 
(magenta). Scale bar = 10 µm. 
B – Western blot from COS7 cells, transfected with empty vector (pcDNA3.1) or FAM49B-FLAG. 
Lysates were resolved on a SDS-PAGE gel and membranes were blotted against FLAG-tag, 
FAM49B and α-Tubulin. Molecular weights are displayed on the side. 
C – Fluorescence intensity quantification of FLAG-tag (green) and F-actin (magenta) staining, 
across 17 transfected cells (red arrow from panel B). Intensity is normalised for each channel with 
the average intensity along the red arrow. Protrusive end =1 and opposite end = 0. Error bar 
represent S.E.M. 
D - Immunofluorescence of COS7 cells transfected with FAM49B-FLAG. Cells were plated on 
laminin for 4h, fixed and stained for FLAG-tag (green) and WAVE2 (H-110) (magenta). Scale bar = 
10 µm  
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3.3 Discussion 
In this chapter, we showed that FAM49B appears as a conserved protein that has co-
evolved in parallel to the Scar/WAVE complex and the Arp2/3 complex in most of the 
eukaryote kingdom. H. sapiens FAM49B is myristoylated and palmitoylated allowing its 
localisation at the plasma membrane where actin polymerisation is initiated. Also, Jose 
Batista’s work shows that the DUF1394 domain is only shared between the Scar/WAVE 
complex member CYFIP and FAM49 proteins. Looking at these alignments and some 
additional sequence analysis, we noticed a specific motif (Q-N-D-F-S-Y-Y-R/K-R) with a 
striking conservation across evolution. 
Interestingly, the homologue of Arg161 in CYFIP (Arg190) is localised at the surface of an 
exposed loop of the Scar/WAVE complex and was involved in Rac1 binding (Chen et al., 
2010). Mutation of this arginine to an acidic residue abrogates the interaction between the 
WRC and active Rac1 in a pulldown assay. This conserved motif does not show any kind 
of similarity with the well-characterised CRIB (Cdc42/Rac interactive binding) domain. 
CRIB domain consists of ~16 conserved amino acids corresponding to the following 
sequence: I-S-X-P-(X)2-4-F-X-H-X-X-H-V-G (Burbelo et al., 1995) and is part of 
Rac/Cdc42 effectors. For example, PAK peptides containing this motif show affinity to 
Rac1Q61L starting from 50 nM up to a micromolar range, depending on the length of the 
peptide (Thompson et al., 1998). Therefore, CRIB domain binds with high affinity to the 
GTP-bound conformation of GTPase over the inactive GDP-loaded version. However, 
such a domain is absent from the DUF1394 domains. Alternatively, a conserved sequence 
containing 2 consecutive basic amino acids and mediating CYFIP1-mediated Rac1 binding 
is conserved in FAM49B. This can reflect a functional similarity between the 2 proteins. 
 
It is now well accepted that the Scar/WAVE complex is acting at the plasma membrane 
upon recruitment/activation by Rac1 and together, mediate actin polymerisation. Indeed, 
although prenylation of the Scar/WAVE complex has not been described, Rac1 was shown 
to be geranyl-geranyl modified at Cys189 allowing its localisation at the membrane 
(Kinsella et al., 1991). Additional palmitoylation of Rac1 on Cys178 drives a full 
activation of the GTPase and its stabilisation at the membrane (Navarro-Lerida et al., 
2012). This allows spatio-temporal regulation of the GTPase. Indeed, palmitoylation is a 
reversible event, allowing cycles of palmitoylation/depalmitoylation, thereby mediating 
different signalling cascades (Chamberlain and Shipston, 2015). Using 
immunofluorescence, we were able to confirm the localisation of FAM49B at the 
membrane, but only in a subset of the population due to the low transfection efficiency 
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(<5% of the total). In some cases, FLAG-staining was cytosolic and this different 
localisation might reflect different activation state during the protein lifespan (when the 
protein is not needed/inactive). 
 
How FAM49B gets targeted to the membrane has been an exiting question throughout this 
PhD. Multiple proteomic studies looking at global post-translational modifications, have 
already found FAM49B as being myristoylatied/palmitoylated in their screen (Thinon et 
al., 2014; Wilson et al., 2011). Martin et al (Martin et al., 2011) designed a pulse-chase 
experiment combined with SILAC analysis to look at the dynamic palmitoylation signature 
of the proteome. Interestingly, this study characterises FAM49B as an outlier of their 
dataset and concludes that it might reflect an extremely high palmitoylation turnover of the 
protein. Here we suggest that upon activation of the protein, myristoylation of FAM49B 
irreversibly anchors the protein at the membrane and that cycles of palmitoylation further 
stabilise FAM49B and regulate its activity. Our data suggest that the protein is multi-
palmitoylated as CLICK signal was not significantly decreased after mutating individual 
cysteine. Presuming that multiple cysteines would be modified, and given the large number 
of possible combinations that this would imply, this part is still being investigated. Also, 
we cannot rule out that FAM49B belongs to the subset of glycine-palmitoylated protein 
family. Together, these modifications may allow the protein to be spatially close from the 
Scar/WAVE complex and Rac1. 
An althernative model would be that FAM49B gets modified while being synthesised and 
would be able to hide the myristoyl group within an internal hydrophobic pocket of the 
protein. This model is called myristoyl switch and enables a pool of inactive cytosolic 
protein that is ready to respond to a stimulus. The myristoyl group is most frequently 
released following interaction with another protein that leads to changing the conformation 
of the myristoylated protein. In order to test this hypothesis, Peter Thomason expressed full 
length or truncated version of the N-terminal region of FAM49B (residue 1-15 or 1-27) 
with a C-terminus GFP tag into wildtype D. discoideum cells. As previously observed, full 
length protein did not show any specific localisation whereas 1-15-GFP strongly localised 
to endomembranes in Ax3 cells. Interestingly, the longer truncation, 1-27-GFP showed a 
decrease of intensity at endomembranes, suggesting that this construct might already be 
able to hinder membrane localisation. It is interesting to note that a hydrophobic patch, 
mostly formed by leucine residues, lies between Gly2 and Cys10. This would be enough to 
stabilise the membrane interaction, along with a potential palmitoylation of the Cys10, 
supporting the 2-signal model for membrane targeting (Wright et al., 2010). Based on this 
model, the endomembrane localisation is consistent with a weak affinity of myristoylated-
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only protein. Weak signals tend to target protein to abundant cellular membranes. A 
second signal - such as palmitoylation – will trap the protein by increasing its 
hydrophobicity. In the case of palmitoylation, this trapping occurs at the membrane where 
the palmitoylating enzymes reside. Since zDHHCs (S-acyltransferases) are mainly, but not 
exclusively, enriched to the endoplamic reticulum and Golgi membranes (Gorleku et al., 
2011; Lemonidis et al., 2015), protein trapping in these compartments allows its 
modification and newly modified proteins can then continue their journey and traffic to the 
plasma membrane. The point mutant 1-27-GFPG2A is exclusively cytosolic, suggesting that 
the Glycine 2 is sufficient to drive the membrane localisation of the construct. These data 
are still preliminary but it would be interesting to get similar constructs for mammalian 
expression. The mutated constructs will also be analysed by CLICK chemistry and 
compared with the full-length version. Finally, we will look at shorter truncations in order 
to restrict the minimum membrane-binding site before performing alanine scanning of the 
sequence. 
Moreover, during the in silico analysis of D.discoideum FAM49, the sequence was 
submitted to an online structure homology prediction tool (Phyre2 - 
http://www.sbg.bio.ic.ac.uk). Similarly to i-TASSER, this software uses the available 
protein structures with an identified PDB to apply it to the query sequence and found the 
closest template that matches to the putative protein structure based on primary sequence 
and biochemical properties. We were intrigued to see that the second hit with the highest 
structural homology was the viral protein H7 of vaccina virus (PDB c4w5xA) that contains 
a phosphoinositide-binding fold. This also showed up in human FAM49B Phyre2 model 
but with a lower confident score. Together, we think than the N-terminus part of the 
protein mediates membrane tethering and we are currently investigating this. 
 
Based on the protein sequence and similarity to CYFIP, we then hypothesised that the 
DUF1394 domain might be a new Rac1-binding domain and play a role in Rac1 signalling.
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4 Investigating the cross-talk between FAM49B 
and the small RhoGTPase Rac1 
4.1 Introduction 
The previous observations motivated us to understand the functions of FAM49B and 
whether the conservation between the DUF1394 domains of FAM49B and CYFIP, 
especially in the Rac1 binding region of CYFIP is significant. The link with Rac1 was also 
emphasised by the initial mass spectrometry experiment. Indeed, GFP-NAP1 used as bait 
also pulled down Rac1 (falling just above the 5% FDR Welch’s test) (Figure 1-8). This 
could come from either a direct interaction between the Scar/WAVE complex and Rac1, or 
a binding of Rac1 with any of the significantly enriched candidates.  
Rac1 oscillates between an inactive GDP-bound and an active GTP-bound state. This 
dynamic activity is reflected by its ability to bind to different proteins, mostly effectors or 
GAPs/GEFs. Rac1 activation is downstream of the growth factor signalling pathway and 
occurs within 5-15 min depending of the cell type and the method used for the stimulation 
(Fujii et al., 2013; Kurokawa et al., 2004; Royal et al., 2000). Activation is mostly based 
on GEF proteins that allow rapid dissociation of GDP from the nucleotide pocket. Subtle 
re-arrangement of Rac conformation in key motifs (switch I and II) favours Rac1 binding 
to downstream effectors that contain some specific motifs, including the CRIB domain and 
rasGAP-related domain, which are unrelated to any conserved motif of the DUF1394 
domain. Turning off Rac1 signalling is a much slower process and so far GAP proteins are 
thought to be the only major actors involved. 
In this chapter, I used a combination of molecular biology, biochemistry and imaging to 
decipher the biological relevance of the putative Rac1 binding site of FAM49B in vitro and 
in cellulo. 
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4.2 Results 
4.2.1 FAM49B binds active Rac1 mediated by a central domain 
containing the two conserved arginine residues 
As part of Hybrigenics services for a two-hybrid screen, I gained access to their archived 
database entries in which FAM49B appeared as an interactor. Surprisingly, FAM49B had 
previously only been found in screens where full length Rac1G12V, C189S was used as bait 
(Figure 4-1 - A). Point mutation on the cysteine 189 abrogates Rac1 prenylation and so is 
more appropriate for a yeast 2-hybrid nuclear screen. This interaction was consistent in 
over 10 various cDNA libraries (human, mouse and rat), although not very strong 
according to the statistical analysis (Figure 4-1 - B). 
This interaction was tested by pulldown assay using full length FAM49B but the binding 
was extremely weak, close from the background level and inconsistent (not shown). 
However, based on two-hybrid data, a minimum fragment sufficient for Rac1 binding was 
mapped between residues 20-204 or 39-223 of FAM49B (Figure 4-1 – B & C). Both 
fragments contain the conserved sequence of the DUF1394 domain. N and C terminal 
GFP-tagged constructs were designed and used in a GST-Rac1 pulldown assay but failed 
to bind to Rac1 (not shown). Looking more carefully at the predicted secondary structure 
of FAM49B, we noticed that the previous constructs started/finished in the middle of 
putative structurally folded regions of the protein (Figure 4-1 – C). We re-designed our 
GFP-tagged construct so that the first and last amino acids (Glu30 and Glu236) are 
respectively at the beginning and the end of a predicted alpha-helix (Figure 4-1 – C & D). 
We repeated our GST-pull down assay with this optimised Rac1 binding domain (termed 
RBD from now on). Bacterially expressed GST, GST-RacWT and GST-RacQ61L were 
purified and immobilised on sepharose beads. Lysates from CHL1 cells expressing GFP 
only, eCFP-CRIB-PBD (CRIB Pak Binding Domain), or GFP-RBD were incubated with a 
similar amount of GST-tagged proteins, pulled-down and resolved by SDS-PAGE. As 
expected, GFP does not bind to either GST-tagged proteins whereas the CRIB domain 
shows a weak interaction to RacWT and strongly interacts with RacQ61L. The FAM49B 
RBD shows a weak but consistent interaction specific to active Rac1 (Figure 4-2 – A & 
B). 
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Figure 4-1: Two-hybrid strategy and screen analysis 
A – Prey (pB27) and bait (pB6) vectors used for the two-hybrid screen (Hybrigenics Services). 
Vectors were incorporated using a mating strategy and cells selected in medium depleted in 
Tryptophane (Trp), Leucine (Leu) and Histidine (His). 
B – Summary table of the two-hybrid screen presenting the library with a positive interaction 
between Rac1 G12V, C189S and FAM49B. Interacting domains were restricted by PCR and confidence 
score was assigned for each hit. High confidence hits are highlighted in red (see Materials and 
Methods). 
C-D – Minimal interacting sequence found by two-hybrid was aligned with the putative secondary 
structure of human FAM49B (C) or on the graphical representation (D). Interacting fragment was 
adjust to start/finish at the beginning/end of a secondary structure. Rac-binding domain (RBD) used 
throughout this assay is highlighted in C with a grey background  
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Figure 4-2: FAM49B interacts with active Rac1 
A – B – GST pull down assay of immobilised GST, GST-RacWT and GST-RacQ61L mixed with lysate 
from CHL1 cells expressing GFP, eCFP-CRIB-PBD, GFP-RBDWT, GFP-RBDR160D, GFP-RBDR161D. 
Membranes were blotted against GFP (cross-reacts with eCFP) and GST. Molecular weights are 
displayed on the side. 
Three independent experiments were quantified based on densitometry reading and standardised 
to the input loading (B). Error bars represent S.E.M. 
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Figure 4-3: FAM49B binds to mutant Rac1 Q61L but not to GppNHp-loaded Rac1 WT 
GST pull down assay of immobilised GST, GST-RacWT, GST-RacWT loaded with GppNHp and 
GST-RacQ61L mixed with lysate from CHL1 cells expressing GFP, eCFP-CRIB-PBD, GFP-RBDWT. 
Membranes were blotted against GFP (cross-reacts with eCFP) and GST. Molecular weights are 
displayed on the side. 
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Figure 4-4: FAM49B binds specifically to active Rac1 over other active RhoGTPases 
GST pull down assay of immobilised GST, GST-RacWT and GST-RacQ61L, GST-Cdc42Q61L, GST-
RhoAWT and GST-RhoAQ63L mixed with lysate from CHL1 cells expressing GFP, eCFP-CRIB-PBD, 
GFP-Rhothekin, and GFP-RBD WT. Membranes were blotted against GFP (cross-reacts with eCFP) 
and GST. Molecular weights are displayed on the side. 
Three independent experiments were quantified based on densitometry reading and standardised 
to the input loading. Error bars represent S.E.M. 
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Next, we asked whether FAM49B binds to Rac1 in a similar way as CYFIP1. Given that 
the RBD encompasses the Rac binding domain of CYFIP (Jose’s thesis), we point-mutated 
Arg161, which was previously implicated in Rac1-mediated binding of CYFIP (Chen et 
al., 2010). The adjacent Arg160 is fully conserved in FAM49 proteins but switched to a 
lysine in CYFIP proteins, thus was also a good candidate for mutagenesis. These 
constructs are referred to as RBDR160D, RBDR161D or the double mutant RBDR160/161D and 
were used for the same pull-down experiment.  
 
Mutation of either or both arginines fully abrogates the binding of the RBD to RacQ61L 
suggesting that these residues mediate Rac1 interaction (Figure 4-2).  
The pulldown experiments were repeated using the non-hydrolysable GTP analogue 
GppNHp, in which the oxygen between β and γ phosphates is replaced by an amine, 
making this compound non-hydrolysable. GST-Rac1WT was loaded with GDP or GppNHp 
and binding to GFP-RBDWT was tested. Surprisingly, no binding was measured in this 
condition, although the CRIB-PBD bound with a similar efficiency between the GppNHp-
loaded RacWT and the Rac1Q61L mutant condition (Figure 4-3). 
 
To test the specificity of binding to active Rac1 among other GTPases, a pulldown using 
constitutively active mutants of the 3 main RhoGTPases was performed. GST-Rac1Q61L, 
GST-Cdc42Q61L, GST-RhoAQ63L were purified and loaded on beads. GST and GST-RacWT 
were also included as negative controls. In parallel, GFP, GFP-RBDWT, eCFP-CRIB-PBD 
and GFP-Rhotekin-RBD were expressed into CHL1 cells. As mentioned previously, CRIB 
domains are Cdc42/Rac1-specific binding domains, so in order to assess Rho activity, 
Rhotekin-RBD was used as reporter. GFP alone didn’t bind to any GST-tagged proteins. 
Pak-CRIB construct and Rhotekin-RBD showed a specific binding to their respective 
active RhoGTPase mutants over the wild-type forms (Figure 4-4). As expected from the 
previous pull down, GFP-RBDWT binds only the Q61L mutant and not the Rac1WT 
construct. Moreover, this binding is specific to Rac1, as quantification doesn’t show any 
specific interaction with the other RhoGTPases in their active state (Figure 4-4).  
4.2.2 Biochemical characterisation of the binding between 
FAM49B and Rac1 
In order to test whether this interaction was direct and to restrict a minimal interacting 
domain, we used a peptide array assay in collaboration with George Baillie’s Lab 
(Glasgow University). 
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Figure 4-5: Active Rac1 binds to FAM49B fragments in a peptide assay 
A – Chemilumiscence assay reveals Rac1 binding to different FAM49B peptides. 0.8 µM of purified 
untagged Rac1WT or Rac1Q61L was incubated on peptide slides and interaction was revealed using 
a Rac1/2/3 polyclonal antibody. Horseradish-Peroxydase-coupled antibody was used as a 
secondary antibody and incubated with ECL reagents. Green box highlights peptides containing 
the 2 conserved arginine residues involved in Rac1 binding. 
B – Slide layout from the human FAM49B protein. Colour code represents the signal intensity. 
Green box highlights peptides containing the 2 conserved arginine residues involved in Rac1 
binding.  
C – Alignment of 25-mer peptide representing the sequence overlapping. Peptide number is 
mentioned accordingly to the slide layout. C-terminus part of FAM49B shows a strong binding to 
Rac1 and is indicated with a black arrow running over the corresponding peptides. Peptides 
containing the conserved arginine residues (red) are highlighted with a green box. 
	  
																																										Investigating	the	cross-talk	between	FAM49B	and	Rac1	 	 	
	
106 
This method allows the creation of overlapping 25-mer peptides running across the entire 
protein length. 61 peptides corresponding to FAM49B sequence were synthetised onto a 
cellulose membrane and incubated with purified, untagged RacWT or RacQ61L. Interaction 
was revealed using a Rac1 antibody and the chemiluminescence assay (Figure 4-5 - A). 
Antibody background was null on the membrane. However, RacQ61L, but not RacWT, 
showed a strong binding to specific parts of the protein. Indeed, a medium interaction 
ranging from peptide 28-32 (136-180 FAM49B) and a strong binding from peptide 52-61 
(266-324 FAM49B) were consistently found (Figure 4-5 – A & B). Unfortunately, GFP-
fusion proteins of those peptides failed to bind to Rac1Q61L in a GST-pulldown assay. 
Although this assay is purely qualitative, it is however interesting to see that the first 
peptide showing a convincing binding (peptide 28) is the 1st fragment containing Arg160 
and conversely, the binding is lost simultaneously to this same arginine (peptide 33). 
 
Given the lack of quantitative data from the previous experiment and in order to confirm 
that this interaction between active Rac1 and the RBD was direct and not mediated by 
other components, surface plasmon resonance (SPR) assays were performed using a 
Biacore T200. This is a highly sensitive method that allows measurement of protein-
protein interactions, kinetics and affinity. It is based on a detector sensor chip, linked to an 
attached binding partner (ligand). The method uses the phenomenon of SPR to detect the 
molecular interactions as they happened. SPR causes a reduction in the intensity of light 
reflected at a specific angle from the glass side of the sensor surface. As molecules 
(analytes) bind to the ligand, the refraction index at the surface changes, altering the angle 
of the minimum reflecting intensity. The change in SPR angle is proportional to the 
amount of molecules bound, so together it gives information about affinity and kinetics of 
the ligand/analyte pair. 
 
Before running the SPR assay, these proteins were tested for folding using a thermal shift 
assay (Appendix 4). Indeed, unfolded or denatured proteins do not show any activity and 
are therefore useless. This assay is based on the ability of proteins to shield hydrophobic 
residues within the protein core, leaving hydrophilic residues at their surface. However, 
denatured proteins expose both hydrophobic/hydrophilic amino acids at their surface. In 
this assay, the protein is mixed with a dye that fluoresces when bound to hydrophobic 
residues. Temperature is then gradually increased to induce protein unfolding, resulting in 
an increase of fluorescence. This explains the absence of the full length FAM49B in the 
following SPR assay. Indeed, the protein didn’t show any melting upon temperature 
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increase meaning that protein induction or purification steps led to a non-functional 
protein. 
 
His-tagged Rac1WT or His-tagged Rac1Q61L (ligands) were immobilised on a nickel chip 
while purified untagged RBD (analyte) was flowed over a surface linked to either ligand or 
over a reference surface, in order to measure the unspecific binding. This value represents 
the background of the system and was subtracted from the final sensogram. Purified CRIB-
PBD domain gave a Kd of 112 µM and 5 µM for Rac1WT and Rac1Q61L respectively 
(Figure 4-6 – A & B). This construct allowed us to be confident about the differential 
activity state of Rac1. Confirming our previous data, no binding was detected for Rac1WT 
whereas a Kd of 22 µM was determined between RBD and Rac1Q61L (Figure 4-6 – C & D). 
This interaction was confirmed by performing the reverse experiment with GST-RBD as a 
ligand on a CM5 chip and His-tagged Rac1Q61L used as the analyte. This sensogram 
showed a very similar affinity (Kd = 27 µM) to the converse set up (Figure 4-6 – E). 
 
Using biochemical and biophysical approaches, we demonstrated that FAM49B is a new 
Rac1 interactor that shows specificity to the active form of the RhoGTPase. Binding seems 
to have some similarity with Rac1 and CYFIP1 binding, which suggested that FAM49B 
might play a role in the regulation of the Scar/WAVE complex by Rac1. 
4.2.3 Modulation of FAM49B expression correlates with 
differential Rac1 activity 
Together, the previous data suggest that FAM49B might be a Rac1 effector, so we 
addressed whether it affects Rac1 activity.. This hypothesis was directly tested using a 
Rac1 FRET biosensor. FRET technology is a useful tool to study protein/protein 
interaction using donor/acceptor proteins. It is based on the passage of energy to a 
fluorescent acceptor from a donor molecule when the two are in close proximity. In our 
case, fluorophores from the well-known Raichu Rac1 probe (Itoh et al., 2002) were 
modified to increase sensitivity and improve the signal-to-noise ratio (Martin et al, in 
revision). Instead of the commonly used CFP/YFP pair, this probe contains mTurquoise2 
as a donor and the sREACh dark acceptor. sREACh was specifically designed by 
mutagenesis to enhance FRET signal while simultaneously reducing the detectable 
emission (Ganesan et al., 2006; Murakoshi et al., 2008). This is very convenient to reduce 
bleed-through between different imaging channels.  
	  
																																										Investigating	the	cross-talk	between	FAM49B	and	Rac1	 	 	
	
108 
 
Figure 4-6: Surface plasmon resonance reveals a low affinity binding between active Rac1 
and RBD 
Sensogram from SPR experiment using purified CRIB-PBD over His-tagged RacWT (A) or Rac1Q61L 
(B) bound to a NTA chip. Purified FAM49B-RBD was processed the same way onto the NTA chip 
(C-D). Reversed experiment (E) with immobilised GST-FAM49B-RBD on a CM5 chip gave a similar 
response to Rac1Q61L.. Affinity (Kd) is mentioned when appropriate. Ligands and analytes are 
represented in green and blue respectively. 
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Similarly to the Raichu probe, the construct contains Rac1 itself, the Pak-CRIB domain 
and a Ras-derived CaaX box that mediates its spatio-temporal regulation at the membrane 
(Appendix 5). 
Upon activation, Rac1 binds to the Pak-CRIB domain, resulting in a modification of the 
probe conformation where the 2 fluorophores end up close enough to allow FRET. FLIM-
based FRET imaging measures the shift in donor fluorescence lifetime that occurs when 
energy is transferred via FRET.  
In the open (inactive) conformation, the donor lifetime is longer as all the energy is emitted 
as donor fluorescence, while in the closed (active) conformation a shorter lifetime is seen. 
This reflects the likelihood of the transfer of the longer components of the lifetime 
distribution to the acceptor (i.e. there are now two routes of decay instead of one). This 
value can then be processed in order to get a FRET efficiency that reflects the activity of 
the protein of interest and is independent from the intensity of the emitted light. 
 
In order to select a cell line to study endogenous protein function, FAM49B expression 
was screened across various cancer cell types (Figure 4-7 – A). HT29 (human colorectal 
carcinoma) and CHL1 cells (human melanoma) highly express FAM49B but CHL1 cells 
were preferred because of the overexpression of FAM49B across various skin cancer types 
(ProteinAtlas). sgRNA oligos targeting 2 distinct regions of fam49b gene (Exon 3 and 
Exon 4) were designed and used in a Cas9-mediated CrispR strategy (hereafter named as 
Ex3 or Ex4.1). Efficiency of knockout was assessed by western blot showed a reduction of 
protein expression of ~90-95% compared with the control cell line (Empty vector or EV) 
(Figure 4-7 – B). To note, knockout cell lines don’t show any growth or proliferation 
defect (Figure 4-7 – C) compared with the control and parental cells. Control and 
knockout cells were transfected with our homemade FRET probe, plated on collagen 24h 
post-transfection and lifetime was measured. 
fam49b-knockout CHL1 cells showed an increase in FRET efficiency (Mean ± S.E.M - 
Ex3=31.40 ± 0.43% and Ex4=31.94 ±0.38%) compared with control (Ctr=29.57±0.35%), 
reflecting a small but significant increase of signals able to activate Rac1 (Figure 4-8). 
This result was confirmed using siRNA-treated COS-7 as an alternative cell line. Protein 
expression was decreased by 70-90% after treatment (siRNA Seq6 and Seq7 respectively) 
(Figure 4-9 - A) and similar FRET data were obtained with an increase in FRET efficiency 
from 30.5 ± 0.65% (Ctr) to 34.07 ± 0.44% and 35.26 ± 0.5% using siRNA Seq6 and Seq7 
respectively (Mean ± S.E.M) (Figure 4-9 - B). 
We next hypothesised that FAM49B overexpression would have an opposite effect on 
Rac1 signalling. Most of the cell lines tested could not cope with high level of exogenous 
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FAM49B, except the COS-7 cells. In order to reduce cell toxicity, we opted for a Tet-ON 
inducible vector expressing in parallel a Venus reporter at the membrane. After 48h in 
presence of doxycycline, untagged FAM49B was greatly enriched compared to the empty 
vector-transfected (EV) or vehicle-treated cells (Figure 4-10 - A). In this case, FRET 
efficiency was reduced upon FAM49B overexpression and not modified in the other 
control conditions, leading to the conclusion that overexpressing cells have a lower ability 
to activate Rac1 (Figure 4-11 - A). 
 
Together, genetic depletion and overexpression data directly correlates the expression level 
of FAM49B to its ability to bind to and modulate Rac1 activity at the membrane. Having 
previously characterised the arginine mutant as being defective for Rac1 binding, we 
aimed to see whether these constructs were still able to regulate Rac1 activity. 
Doxycycline-inducible FAM49B WT, FAM49B R160D, FAM49B R161D and FAM49B 
R160/161D were co-expressed into COS-7 cells along with the Rac1-FRET probe (Figure 4-
11 - B). While overexpression of the WT protein caused a reduction in FRET efficiency as 
previously mentioned, R160D mutant showed a similar FRET efficiency. Similarly, 
R161D mutant was not statistically significantly different from the wild-type condition, 
although a trend toward an increased Rac1 signalling was observed. However, the double 
mutant was not able to modify Rac1 activity and showed no statistical difference compared 
with the control condition. 
4.3 Discussion 
Here we showed that despite the lack of CRIB domain, FAM49B is a novel interactor of 
Rac1, showing specificity to the active form of the GTPase. 
 
We can map the binding domain to an internal portion of ~200 residues, containing a 
conserved sequence previously described in chapter 3. Mutation of either or both 
conserved arginine residues in this region totally abrogates this binding, suggesting that 
FAM49B binds to active Rac1 in a similar way to CYFIP (Chen et al., 2010). This 
observation allowed us to characterise the DUF1394 as a new Rac1-binding domain, 
although the minimum region sufficient for binding is still under investigation.  
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Figure 4-7: Establishment of stable fam49b-knockout cell lines by CrispR-Cas9 strategy 
A – Western blot analysis of FAM49B expression level across different cancer cell lines. 
Membranes are blotted against FAM49B and α-Tubulin. B16F1: mouse melanoma cell lines, 
B16F10: metastatic mouse melanoma cell lines, MDA-MB-231: human breast triple negative 
adenocarcinoma cell line, CHL1: human melanoma cell line, HT29: human colorectal 
adenocarcinoma cell line, Panc1: human pancreatic carcinoma, 266-6: mouse pancreatic acinar 
tumour cell line, NSI, CL4 and CL7: human prostate cancer cells, SC4 and SC8: mouse prostate 
cancer cells, WM852, WM1158: human melanoma cell lines. Molecular weights are displayed on 
the side. 
B – Western blot analysis and quantification by densitometry of fam49b CrispR knockout CHL1 
cells after selection. Molecular weights are displayed on the side. Bar graph represents 
quantification of 3 independent experiments and S.E.M is displayed.  
C – Growth curve of parental, CrispR control or fam49b CrispR knockout CHL1 cells over 5 days 
from 3 independent experiments. 
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Figure 4-8: fam49b-knockout CHL1 cells have higher Rac1 activity 
Representative pictures of FLIM-FRET experiment of CHL1 CrispR cells, transfected with the 
modified Raichu Rac1 probe and plated on Collagen I. Jet2 colour-code shows probe lifetime, 
ranging from 1ns (blue) to 4ns (red). Quantification of FRET efficiency is shown as a scatter plot 
with mean and S.E.M from 3 independent experiments. Scale bar = 10 µm. One-Way ANOVA with 
Dunn’s post-test was applied. ** p<0.01, *** p<0.001 
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Figure 4-9: FLIM/FRET analysis of fam49b-knockdown COS-7 cells 
A – Western blot analysis of siRNA-treated COS-7 cells (10 nM), probed for FAM49B and α-
Tubulin. Molecular weights are displayed on the side. Bar graph represents quantification by 
densitometry of 3 independent experiments and S.E.M is displayed.  
B - Representative pictures of FLIM-FRET experiment of COS-7 cells treated with 10 nM of siRNA, 
transfected with the modified Raichu Rac1 probe and plated on Laminin. Jet2 colour-code shows 
probe lifetime, ranging from 1ns (blue) to 4ns (red). Quantification of FRET efficiency is shown as a 
scatter plot with mean and S.E.M from 3 independent experiments. Scale bar = 10 µm. One-Way 
ANOVA with Dunn’s post-test was applied. *** p<0.001 
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Figure 4-10: Establishment of a FAM49B-overexpressing COS-7 cell line 
A – Western blot analysis of COS-7 cells transiently transfected with an inducible TetON empty 
vector (EV) or containing FAM49B cDNA. Cells were treated with vehicle or doxycycline for 48h 
and expression level was analysed by western blot against FAM49B, α-Tubulin, or mVenus as a 
reporter. GFP antibody cross-reacts with mVenus. Molecular weights are displayed on the side. 
Bar graph represents quantification by densitometry of 3 independent experiments and S.E.M is 
displayed. Red dotted line represents the level of expression standardised to the EV-transfected 
cells. 
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Figure 4-11: FLIM/FRET analysis of FAM49B-overexpressing COS-7 cells 
A – Representative pictures of FLIM-FRET experiment of COS-7 cells co-transfected with the 
inducible TetON vector (EV or containing FAM49B) and the modified Raichu-Rac1 probe. Cells 
were treated with vehicle or doxycycline for 48h and plated on Laminin for imaging. Only mVenus-
positive cells were part of this analysis. Jet2 colour-code shows probe lifetime, ranging from 1ns 
(blue) to 4ns (red). Quantification of FRET efficiency is shown as a scatter plot with mean and 
S.E.M from 4 independent experiment. Scale bar = 10 µm. Mann Whitney t-test was applied. n.s. 
p>0.05, *** p<0.001 
B - Representative pictures of FLIM-FRET experiment of COS-7 cells co-transfected with the 
inducible TetON vector (EV or containing FAM49BWT, FAM49BR160D, FAM49BR161D, 
FAM49BR160/161D) and the modified Raichu-Rac1 probe. Cells were only treated with doxycycline for 
48h and plated on laminin for imaging. Only mVenus-positive cells were part of this analysis. Jet2 
colour-code shows probe lifetime, ranging from 1ns (blue) to 4ns (red). Quantification of FRET 
efficiency is shown as a scatter plot with mean and S.E.M from 3 independent experiments. Scale 
bar = 10 µm. One-Way ANOVA with Dunn’s post-test was applied. n.s. p>0.05, *** p<0.001 
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Indeed, following up our peptide screen assay, the next step is to perform an alanine-
mutant scan where every single amino acid is replaced by an alanine. This would also us to 
investigate what are the important residues sufficient for the interaction and together, to 
work out a minimal binding region. 
Binding to active Rac1 causes a decrease in overall Rac1 activity, so we concluded that 
FAM49B buffers Rac1 activity at the membrane. The fact that mutation of only one 
arginine was able to disrupt the interaction but was not sufficient for modulating Rac1 
activity might reflect a lack of sensitivity of the pull down assay. Indeed, FRET studies 
have been reported to have higher sensitivity and can reflect biologically relevant 
intermediate properties (Hieb et al., 2012). SPR analysis also revealed an affinity of ~25 
µM between RBD and Rac1Q61L. This low affinity is in agreement with the weak binding 
observed in our pull down assays but also with the hypothetical biological function of the 
protein. Indeed, we propose that FAM49B lowers Rac1 activity, which is a highly dynamic 
process. In regard with the dynamism of Rac1 activity and its ability to change within few 
minutes, the interaction between FAM49B and Rac1 requires a high turnover. This is more 
feasible with a low affinity interaction rather than a tight binding as reported for the CRIB 
domain (5 µM in our assay but the commonly accepted affinity ranges from 0.05-2 µM) 
(Thompson et al., 1998). This value of ~25 µM also agreed with the low affinity between 
the WRC and Rac1 (~10 µM) characterised by Chen et al, (Chen et al., 2010) and the need 
for a dynamic interaction at the leading edge. 
 
The fact that GppNHp-loaded Rac1 did not pull-down the RBD still remains unexplained, 
although we can speculate on this observation. It would first be important to check that the 
analogue nucleotide has been properly loaded onto Rac1. Indeed, despite a similar 
interaction observed between loaded-Rac1 and the Q61L mutant, CRIB-PBD has a much 
higher affinity to active Rac1 than FAM49B. In the hypothesis where only 20% of Rac1WT 
is loaded with GppNHp, it will still be able to bind all the CRIB-PBD molecules. However, 
if the GTP analogue is only partially loaded, the effect will be high on FAM49B because 
of its initial low affinity. In order to specifically address this point, nucleotide exchange 
could be checked using high-performance liquid chromatography on GppNHp-loaded 
Rac1. This would allow us to quantify the percentage of loaded/unloaded Rac1 molecules 
and adjust our assay accordingly. Also, GppNHp mimics the conformation of Rac1 in its 
active state but is physically different from the Q61L mutant. Indeed, overall charges over 
the protein surface might be slightly different and might affect low-affinity binding. 
Indeed, despite sharing a similar mechanism, it has been suggested that GppNHp and GTP 
slightly affects H-Ras structure, especially around the β-γ bridging nitrogen group 
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(Scheidig et al., 1999). This could also be true for Rac1. Finally, it would be interesting to 
test other GTP analogues, such as GTPγS and see whether the binding still fails to happen.  
 
The effects on Rac1 could also be explained if FAM49B was a GAP. However, the 
conserved RhoGAP domain, characterised by a 170 amino acids sufficient for GAP 
activity (Zheng et al., 1993), was absent from FAM49B sequence. We could however test 
the ability of FAM49B to hydrolyse GTP by performing a GAP assay using hot-labelled 
GTP or colorimetric readout. GTP can be loaded onto purified Rac1 inorganic phosphate 
release can be measured over time in the presence of absence of purified FAM49B. A GAP 
activity should increase the released of Pi. Although we generated all the controls required 
for this experiment, we have not had time to address this question yet. 
 
Finally, it is interesting to point out that only a central domain of the protein interacts, 
whereas the full-length protein does not show any binding in vitro. However, our FRET 
experiment, with overexpression of the full-length wild type or mutant proteins shows an 
effect in cellulo. Based on the putative structure, we think that the first 30 residues, 
organised in an alpha-helix, have an auto-inhibitory function mediated in part by the post-
translational modifications. In this model, the inactive protein would be folded with the N 
and C-termini covering the RBD and preventing binding to Rac1. Upon Rac1 activation, 
FAM49B would get myristoylated and palmitoylated resulting in a conformational change 
and making the RBD free to bind to and regulate Rac1 signalling. Once Rac1 stimulation is 
over, or once it has reached a balanced level able to mediate a regulated biological effect, 
FAM49B would be turned off by undergoing depalmitoylation and/or being degraded. 
However, it is still not clear whether myristoylation of FAM49B is a post or co-
translational modification. Indeed, myristoylated-protein can shield the myristate group 
within a hydrophobic pocket and only expose it upon protein activation. A structure of the 
protein would be required to test this hypothesis as well as a precise analysis of the surface 
hydrophobicity. Crystal trials have been set up but so far, optimal conditions for 
crystallisation have not been identified. Full-length FAM49B as well as FAM49BΔ1-30 
missing the floppy N-terminus (Figure 1-11 – B) were tested in over 600 conditions with 
no success in either case. 
 
In this model, we hypothesised that deregulation of FAM49B expression would affect cell 
shape and protrusion formation. Indeed, as previously mentioned, Rac1 is a major 
regulator of cytoskeleton and cell shape. In order to test our model, we looked at cell 
morphology and the Scar/WAVE complex as a downstream effector of Rac1 signalling. 
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5 FAM49B, master regulator of cell protrusion 
formation, spreading and migration 
5.1 Introduction 
Our data point toward a role of FAM49B as a new player regulating Rac1 activity via a 
direct interaction. The importance of Rac1 regulation is crucial such that it is a major 
regulator of the cytoskeleton dynamics such as lamellipodia formation, filopodia, 
endocytosis, cytokinesis, migration and invasion. For example, overexpression of the 
active form of Rac1 has been shown to produce pancake-like shaped cells in 2D and 
increase invasion downstream of a Brk/Paxillin loop in different skin and breast cancer cell 
lines model (Chen et al., 2004). Rac1 is also crucial for cell adhesion and focal adhesions 
(Guo et al., 2006), although whether it is a direct consequence from Rac1 activity or driven 
by the increase of the cell area is not clear. 
Given the tight connection between Rac1 and FAM49B, we hypothesised that interfering 
with FAM49B functions would result in defects of cell morphology, adhesion and motility. 
The following results were generated using knockout cells, and confirmed by knockdown 
in different cell types. FAM49B overexpressing COS-7 cells were also used as proof of 
concept. Those cells were used in different assays to look at filopodia, cell shape, matrix 
degradation, 2D migration and invasion. 
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5.2 Results 
5.2.1 FAM49B controls protrusion extension 
In order to see whether FAM49B plays a role in Rac1-driven processes, FAM49B CrispR 
knockout CHL1 cells were plated on collagen and left to spread for 4h before PFA 
fixation. Unlike the parental or control CrispR cells, fam49b-KO cells adopt two distinct 
phenotypes (termed the fried-egg and C-shape phenotype), aside from the normal cell 
morphology (Figure 5-1 - A). Around 35 % of the fam49b-knockout cells assume a fried-
egg phenotype and are characterised by a broad and circular lamellipodia extended all 
around the cell, whereas the C-shape cells (~15 % of the population) have a highly 
polarised lamellipodium dominating one side of the cell. Together, those 2 shapes arose in 
less than 10 % of the control cell lines (Figure 5-1 - B). This difference in cell shape is 
also reflected by an increase of cell area, as the fam49b-knockout cells are on average 25 
% larger than their control counterparts (Figure 5-1 – A & C). In the four independent 
knockout cell lines we have looked at, an accumulation of Cortactin staining at the leading 
edge was observed (Figure 5-1 - A). Cortactin is a NPF that directly stimulates the Arp2/3 
complex and we initially used it as a marker of lamellipodia extension where it colocalised 
with cortical F-actin. According to this definition and reflecting the cell shape phenotype, 
70 % of the fam49b-knockout population have a lamellipodium compared with 15 % of the 
control CrispR cells (Figure 5-1 - D). Indeed, in control condition, Cortactin mainly 
localises at vesicle-like structures and only infrequently at the cell edge. Among the 
Cortactin-positive cells, the lamellipodium is much broader in the absence of FAM49B, 
covering on average 75 % of the total cell perimeter whereas only 20 % on the cell 
perimeter is dedicated to the lamellipodium in the presence of FAM49B (Figure 5-1 - E). 
Because the Cortactin staining is not a specific lamellipodial marker, immunofluorescence 
of WAVE2 was optimised and allowed us to confirm the previous results with similar 
proportion of WAVE2-positive cells and cell edge devoted to lamellipodium (Figure 5-2 – 
A-C). To note, control cells with a fried-egg shape were found in a few cases but 
interestingly these cells show a very weak and patchy WAVE2 staining that contrasts with 
the strong enrichment of the WRC at the cell edge of FAM49B-depleted cells (Figure 5-2 
- A). This enrichment of WRC at the leading edge of knockout cells is followed by an 
accumulation of the WRC-downstream effector p34-ARC2, subunit of the Arp2/3 complex 
and by a recruitment of the WRC regulator Lamellipodin (Figure 5-3). 
In order to back up these data and to show the generality of FAM49B function, various cell 
types (normal, cancer cell lines or mouse primary cells) in combination with different 
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genetic approaches (siRNA or Cre-driven floxed-gene deletion) were used. For example, 
mouse melanoma B16F1 cells treated with siRNA have a reduction of 80% of FAM49B 
level correlating with broader lamellipodia and larger cell area (Figure 5-4). Similarly, 
COS-7 cells depleted in FAM49B (Figure 4-9 – A) exhibit a beautiful fried-egg phenotype 
when plated on laminin (Figure 5-5 - A). WAVE2 is highly enriched at the protrusion 
edge and cells devote most, if not all the cell perimeter to the lamellipodium (Figure 5-5 – 
A & B). This striking phenotype is also reflected by an increase in cell circularity and cell 
area (Figure 5-5 – C & D). 
 
Finally, because of the similarity between FAM49A and FAM49B and due to the absence 
of FAM49A antibody at the time of these experiments, we were worried about a potential 
off-target effect from our siRNA or CrispR strategies. Sperm from a conditional floxed 
FAM49B mouse was obtained and rederived into C57BL/6 mice. Immortalised mouse 
embryonic fibroblasts (MEFs) were isolated from different Cre-ER +/0 : p16-/- fam49bfl/fl 
embryos (C1 and D1) and deletion of fam49b gene was assessed after 5 days of OHT 
treatment by PCR of the genomic DNA and by western blot (Figure 5-6 – A & B). The 
DNA agarose-gel confirmed a switch from a ~1400 bp (corresponding to the expected size 
for a PCR product with no recombination) to a ~650 bp PCR product (representing the 
knockout allele). This disruption of fam49b gene was directly translated at the protein level 
by the absence of signal in the OHT-treated samples. The aim of this targeted strategy was 
to reassure us about the specificity of the observed phenotypes. MEFs were plated on 
laminin and stained for F-actin and the WRC. Representative pictures of either cell lines 
show an increase in cell area and WAVE2 localisation at the lamellipodium upon OHT 
treatment (Figure 5-6 – C). 
 
In order to be sure that WRC enrichment is not due to an overall increase of the 
Scar/WAVE complex members expression, western blot of NAP1, CYFIP1 and WAVE2 
was performed on fam49b-knockout CHL1 cells (Figure 5-7). Analysis showed that 
protein expression is unaffected between control CrispR and fam49b-knockout cells. Also, 
FAM49A antibody was optimised for western blot and confirmed the specificity of the 
sgRNA used for the CrispR knockout as expression level is similar between control and 
fam49b-knockout cells.  
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Figure 5-1: FAM49B regulates cell shape in CHL1 cells 
Immunofluorescence of control (parental and EV) or fam49b-CrispR knockout (Ex3, Ex4.1, Ex4.2, 
Ex4.3) CHL1 cells plated on collagen-I and stained for F-actin (magenta), Cortactin (cyan) and 
nuclei (blue). Scale bar = 15 µm. 
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Figure 5-2: fam49b knockout CHL1 cells show an enlarged lamellipodium 
A – Shape scoring of control or fam49b-knockout cells plated on collagen-I. F-actin staining was 
used to delimit the cell edge. Cells were classified as randomly shaped, C-shaped or round (fried-
egg shaped). Quantification was performed from 4 independent experiments and two-tailed Chi-
square test (95% confidence) was applied for each shape category compared with the EV control 
CrispR cells. n.s. p>0.05, *** p<0.001. Error bars represent S.E.M. 
B – Quantification of cell area of control or fam49b-knockout cells plated on collagen-I. F-actin 
staining was used to delimit the cell edge. Scatter plots represent mean and S.E.M from 3 
independent experiments. One-Way ANOVA with Tukey’s post-test was applied. n.s. p>0.05, *** 
p<0.001. 
C – Quantification of the number of Cortactin-positive cells based on the immunofluorescence 
staining. Bar plots represent quantification from 3 independent experiments and error bars 
represent S.E.M. One-Way ANOVA with Dunn’s post-test was applied. n.s. p>0.05, *** p<0.001. 
D – Quantification of the cell perimeter devoted to lamellipodia was measured based on the 
extension of the cortactin staining at the cell edge over the total cell perimeter. Whisker plots 
represent 10-90 percentile, mean (cross) and S.E.M. One-Way ANOVA with Dunn’s post-test was 
applied. n.s. p>0.05, *** p<0.001. 
_________________________________________________________________________ 
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Figure 5-3: FAM49B-depleted cells have an enrichment of WAVE2 at the cell edge 
A – Immunofluorescence of control (parental and EV) or fam49b-CrispR knockout (Ex3, Ex4.1) 
CHL1 cells plated on collagen-I and stained for F-actin (magenta), WAVE2 (green) and nuclei 
(blue). Magnified view of the white dotted area is shown on the bottom panel. Yellow arrowheads 
represent WAVE2-rich area. Scale bar top panels = 15 µm. Scale bar bottom panels = 10 µm 
B - Quantification of the number of WAVE2-positive cells based on the immunofluorescence 
staining. Bar plots represent quantification from 3 independent experiments and error bars 
represent S.E.M. One-Way ANOVA with Dunn’s post-test was applied. n.s. p>0.05, *** p<0.001. 
C - Quantification of the cell perimeter devoted to lamellipodia was measured based on the 
extension of the WAVE2 staining at the cell edge over the total cell perimeter. Whisker plots 
represent 10-90 percentile, mean (cross) and S.E.M from 3 independent experiments. One-Way 
ANOVA with Dunn’s post-test was applied. n.s. p>0.05, *** p<0.001. 
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Figure 5-4: FAM49B-depleted cells show an enrichment of downstream WRC effectors at the 
cell edge 
A - Immunofluorescence of control (EV) or fam49b-CrispR knockout (Ex3, Ex4.1) CHL1 cells plated 
on collagen-I and stained for F-actin (magenta), p34-ARPC2 (green) and nuclei (blue). Magnified 
view of the white dotted area is shown on the far right panel. Scale bar = 15 µm 
B - Immunofluorescence of control (EV) or fam49b-CrispR knockout (Ex3, Ex4.1) CHL1 cells plated 
on collagen-I and stained for F-actin (magenta), Lamellipodin (green) and nuclei (blue). Magnified 
view of the white dotted area is shown on the far right panel. Scale bar = 15 µm. 
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Figure 5-5: FAM49B function is conserved in B16F1 cells 
A-B – Western blot analysis of parental B16F1 cells or treated with 100 nM of control (Scramble) or 
FAM49B siRNA (Seq1 and Seq4). Membrane was blotted against FAM49B and α-Tubulin. 
Molecular weights are displayed on the side. Bar graph (B) represents quantification of the relative 
protein expression level (normalised to EV) by densitometry of 3 independent experiments. S.E.M 
is displayed. 
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C-E – Immunofluorescence of parental B16F1 cells or treated with 100 nM of control (Scramble) or 
FAM49B siRNA (Seq1 and Seq4) and stained for Cortactin (C). Scale bar = 15 µm. Lamellipodia 
extension was measured using the length of Cortactin staining over the total cell perimeter (D). 
Whisker plots represent 10-90 percentile, mean (cross) and S.E.M from 3 independent 
experiments. One-Way ANOVA with Dunn’s post-test was applied. n.s. p>0.05, *** p<0.001. Cell 
area was obtained from the F-actin staining (not shown) and displayed as a scatter plot in E, with 
mean and S.E.M represented from 3 independent experiments. One-Way ANOVA with Dunn’s 
post-test was applied. n.s. p>0.05, * p<0.05, ** p<0.01. 
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Figure 5-6: FAM49B function is conserved in COS-7 cells 
A – Immunofluorescence of COS-7 cells treated with 25 nM of control (Scramble) or FAM49B 
siRNA (Seq6 and Seq7), plated on laminin and stained for WAVE2 (green), F-actin (magenta) and 
nuclei (blue). Scale bar = 10 µm. 
B – Quantification of the cell perimeter devoted to lamellipodia was measured based on the 
extension of the WAVE2 staining at the cell edge over the total cell perimeter in control or siRNA-
treated cells. Whisker plots represent 10-90 percentile, mean (cross) and S.E.M from 3 
independent experiments. One-Way ANOVA with Dunn’s post-test was applied. *** p<0.001. 
C - Quantification of cell circularity of control or fam49b-knockdown COS-7 cells plated on laminin. 
F-actin staining was used to delimit the cell edge. Scatter plots represent mean and S.E.M from 3 
independent experiments. One-Way ANOVA with Dunn’s post-test was applied. *** p<0.001. 
D- Quantification of cell area of control or fam49b-knockdown COS-7 cells plated on laminin. F-
actin staining was used to delimit the cell edge. Scatter plots represent mean and S.E.M from 3 
independent experiments. One-Way ANOVA with Dunn’s post-test was applied. *** p<0.001. 
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Figure 5-7: Increase of lamellipodia extension is also seen using a different knockout 
strategy 
A – PCR-based analysis of the FAM49B recombination after 5 days of DMSO or OHT treatment. 
Genomic DNA from two distinct Cre-ER+/0:p16-/-, fam49bfl/fl MEF lines (C1 and D1) was isolated and 
floxed-FAM49B locus was amplified and analysed on a 1% agarose gel. Upper arrowhead 
represents the expected band size obtained from the PCR reaction of the un-recombined locus 
(~1400 bp). Lower arrowhead highlights the expected band size obtained after recombination 
(~650 bp). DNA ladder size is highlighted on the left side of the gel (in bp).  
B – Western blot analysis of MEFs lines after 5 days of DMSO or OHT treatment. Membranes were 
blotted against FAM49B and α-Tubulin. Molecular weights are displayed on the side. 
C – Immunofluorescence of DMSO or OHT-treated MEFs, plated on laminin and stained for 
WAVE2 (green), F-actin (magenta) and nuclei (blue). Representative pictures from 2 independent 
experiments. Scale bar = 50 µm. 
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Figure 5-8: FAM49B-depletion does not affect WRC protein level or FAM49A expression 
Western blot analysis of the protein expression of some WRC members (CYFIP1, NCKAP1, 
WAVE2) and FAM49A in control EV or fam49b-CrispR knockout CHL1 cells. Molecular weights are 
displayed on the side. Quantification of 2 independent experiments using densitometry are reported 
as a bar plot with error bar representing S.E.M. Protein expression was normalised to the α-Tubulin 
and standardised to the control cell line. 
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In light of these data, we hypothesised that FAM49B restricts the lamellipodium extension 
and thus, increased FAM49B level should affect cell protrusions. To test this, COS-7 cells 
transfected with the doxycycline-inducible plasmid (Figure 4-10) were plated on laminin 
and analysed by immunofluorescence. Only mVenus-positive cells were taken into account 
for further analysis. Green EV-transfected cells represent the proper control but non-
transfected cells (mVenus negative) could also have been used as an additional internal 
control, although these have not been quantified. Vehicle treated transfected cells or 
doxycycline EV-transfected cells devoted on average 30 % of their perimeter for 
lamellipodia formation whereas this value goes down to 10 % for overexpressing cells 
(Figure 5-8 – A & B). These cells frequently exhibited a hyper-fragmented phenotype, as 
if they were unable to form and extend a lamellipodium (Figure 5-8 – A). This directly 
correlates with a reduction of the circularity index from 0.5 to 0.3 (Figure 5-8 – D). 
Moreover, half of the FAM49B overexpressing population did not spread at all and this 
results in a 50% decrease of the average cell area (Figure 5-8– C). Short time-lapse 
movies confirmed these immunofluorescence observations and also revealed that these fine 
protrusions are quite stable in 2D. However, protrusion rate of those has not been 
investigated further (Figure 5-9). 
 
The observed increase of spreading in fam49b-knockout cells has been investigated 
throughout a timecourse experiment in which cells were plated at the same time on 
fibronectin and collagen-coated coverslips and fixed at different times (Figure 5-10). Cell 
area from over 400 control or fam49b-knockout CHL1 cells was measured for each time 
point and revealed that FAM49B-depleted cells spread faster, independently of the matrix 
used for the coating. This difference in spreading is significant as early as 30 min of 
spreading. This data was confirmed using xCELLigence as an alternative and unbiased 
approach. For this, cells are plated on electrodes that sense the electrical impedance of a 
current created by crawling/spreading cells. In order to limit the effect of cell migration 
and specifically focus on cell adhesion and spreading, the assay was restricted to the first 
few hours (Figure 5-11 - A). Parental and EV CrispR cells plated on collagen-I have a 
spreading halftime of 1h51 and 1h43 respectively that is slightly extended when compared 
to the 2 independent knockout cell lines (1h22 and 1h25 for Ex3 and Ex4.1 respectively) 
(Figure 5-11 - B). Together, these data reflect that cells depleted in FAM49B cannot 
restrict the extension of the lamellipodia so we conclude that FAM49B binds to Rac1 and 
buffers downstream Rac1 signalling allowing a regulation of Scar/WAVE complex. 
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Figure 5-9: FAM49B overexpression leads to a fragmented lamellipodium 
A - Immunofluorescence of COS-7 cells transiently transfected with an inducible TetON empty 
vector (EV) or containing FAM49B cDNA. Cells were treated with vehicle or doxycycline for 48h, 
plated on fibronectin and stained for WAVE2 (magenta) or mVenus (green - GFP antibody cross 
reacts with mVenus). Magnified view of the white dotted area is shown on the far right panel. Scale 
bar = 10 µm. 
B - Quantification of the cell perimeter devoted to lamellipodia was measured based on the 
extension of the WAVE2 staining at the cell edge over the total cell perimeter. Whisker plots 
represent 10-90 percentile, mean (cross) and S.E.M from 4 independent experiments. Two tailed 
unpaired t tests were applied. n.s. p>0.05. *** p<0.001. 
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C - Quantification of the cell area was measured based on the F-actin staining. Scatter plots 
represent mean and S.E.M from 4 independent experiments. Two tailed unpaired t tests were 
applied. n.s. p>0.05. *** p<0.001. 
D - Quantification of the circularity index was measured based on the F-actin staining. Scatter plots 
represent mean and S.E.M from 4 independent experiments. Two tailed unpaired t tests were 
applied. n.s. p>0.05. *** p<0.001. 
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Figure 5-10: FAM49B overexpression leads to a less dynamic lamellipodium  
Stills from time-lapse movies of COS-7 cells transiently transfected with an inducible TetON empty 
vector (EV) or containing Fam49B cDNA and co-expressing Venus as a reporter. Cells were 
treated with vehicle or doxycycline for 48h, plated on fibronectin and imaged every 3 seconds. Cell 
edge is highlighted in different colour at the beginning of each movie and reported at the end in 
order to appreciate how far a cell has moved. Kymographs are presented on the side of each 
condition with space and time shown on y and x-axis respectively. Scale bar = 20 µm 
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Figure 5-11: fam49b-knockout cells show an increase on cell spreading 
A – Timecourse experiment of parental, control EV or fam49b-CrispR knockout cells plated on 
collagen-I and fixed after 30min, 1h, 2h, and 4h. Cells were stained for F-actin (green) and nuclei 
(blue). Scale bar = 40 µm. Quantification of cell area from 3 independent experiments is reported 
on the bar graph, with S.E.M represented. One-Way ANOVA with Tukey’s post test was applied. 
*** p<0.001.  
B – Timecourse experiment of parental, control EV or fam49b-CrispR knockout cells plated on 
fibronectin and fixed after 30min, 1h, 2h, and 4h. Cells were stained for F-actin (green) and nuclei 
(blue). Scale bar = 40 µm. Quantification of cell area from 3 independent experiments is reported 
on the bar graph, with S.E.M represented. One-Way ANOVA with Tukey’s post test was applied. 
*** p<0.001. 
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Figure 5-12: Real-time measurement of cell spreading using xCELLigence 
A – Graphical representation of xCELLigence principle. Chips are covered by 2 electrodes able to 
sense the current. During cell adhesion and spreading, electron flow is affected and impedance 
can be measured. 
B – Real-time measurement of adhesion and cell spreading over 4h of parental, control EV and 
fam49b-knockout CHL1 cells on collagen-I coated chip. Spreading halftime of control and fam49b-
knockout cells is projected on the x-axis using respectively a yellow or red dotted line.  
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To be efficient and transmit forces, a lamellipodium has to be stabilised by focal adhesions. 
Based on the clutch model (Case and Waterman, 2015), focal adhesions follow a quick 
turnover dependent on the lamellipodia extension/retraction. In order to investigate 
whether the broad lamellipodia of fam49b-depeleted cells have any defect in focal 
adhesion organisation or dynamics, we used a combination of immunofluorescence, video-
microscopy and image processing.  
As a marker of active focal adhesion upon integrin engagement, phospho-Paxillin was an 
obvious staining to perform. Immunofluorescence analysis revealed more long and fine 
adhesions in the fam49b-knockout cells, running from the cell periphery toward the nuclei 
and sitting on transverse actin fibres (Figure 5-12 – A). This observation was even more 
obvious when looking at a global marker of focal adhesion, such as Vinculin. In this case, 
control cells showed a small and patchy staining whereas Vinculin staining was extended 
along the focal adhesion in the fam49b-knockout cells (Figure 5-12 – B). 
However, CHL1 cells are not the best cell line to study focal adhesions because of their 
relative small size. So we switched to the B16F1 cells treated with siRNA against 
FAM49B and plated on laminin. The unusual shape of focal adhesions has been confirmed 
in this alternative cell line and gave an even more striking phenotype (Figure 5-13 – A & 
B). Using Fiji, we were able to threshold the vinculin staining and analyse different focal 
adhesion parameters. Quantification reveals that the number of adhesions was higher in 
knockdown cells, peaking at 30-35 focal adhesions (over 0.1 µm2) per cell, compared to 19 
focal adhesion/control cell (Figure 5-13 – C). Focal adhesions were also bigger, although 
the difference was not extremely different compared to the control cell line, which was a 
bit surprising based on the pictures (Figure 5-13 – D). Quite unsurprisingly, knockdown 
cells have more linear focal adhesions but once again, this quantification seems to 
underestimate the severity of the phenotype (Figure 5-13 – E). Indeed, the Fiji plugin 
seems to fragment the long focal adhesion, although they appeared as a homogeneous 
staining on the picture. 
In order to be more confident, timelapse microscopy of GFP-Paxillin-transfected control 
and knockdown B16F1 cells, plated on laminin were obtained every minute. Still images 
from each movie were extracted and were attributed a specific colour corresponding to a 
specific time (Figure 5-14). Channels were merged and colocalisation of the colour means 
that the focal adhesion is stable. In our case, small focal adhesions were created at the 
extended lamellipodia of the control cells suggesting that these cells are able to form 
adhesion when a protrusion is created. However, at the rear, focal adhesions appeared 
relatively stable, as observed from the merge channel. This contrasts with the fam49b-
knockdown cells that still form these elongated adhesions, which look more dynamic. 
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Figure 5-13: FAM49B affects focal adhesion morphology in CHL1 cells 
Immunofluorescence of fam49b-CrispR knockout CHL1 cells plated on collagen-I and stained for 
different focal adhesion markers (pY118-Paxillin (A - green) or Vinculin (B - cyan)), F-actin (A – 
magenta or B - red) and nuclei (blue). Scale bar = 20 µm Magnified view of the white dotted area is 
shown on the far right panel. Scale bar = 10 µm. 
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Figure 5-14: FAM49B regulates adhesions morphology and number in B16F1 cells 
A-B - Immunofluorescence of fam49b knockdown B16F1 cells plated on laminin and stained for 
different focal adhesion markers (pY118-Paxillin (A - green) or Vinculin (B - cyan)), F-actin (red) 
and nuclei (blue). Magnified view of the white dotted area is shown below each panel. Scale bar = 
20 µm. 
C-E – Number of focal adhesion per cell (C), focal adhesion area (D) and focal adhesion circularity 
(E) were quantified based on vinculin staining from 3 independent experiments using Fiji plugin and 
presented as scatter plots with S.E.M displayed. One-Way ANOVA with Dunn’s post-test was 
applied. *** p<0.001. 
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Figure 5-15: Timecourse of focal adhesion turnover in fam49b-knockdown B16F1 cells 
Stills from a time-lapse experiment of control or fam49b-knockdown B16F1 cells transfected with 
GFP-Paxillin and plated on laminin. Pictures were taken every minute for 30 min and frame at 0, 15 
and 30min was assigned a specific colour (red, green and blue respectively). Merge channel is also 
displayed. Scale bar = 2.5 µm 
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Another method to analyse focal adhesion dynamics in a quantitative way is to obtain fast-
time frame movies (1 frame/20sec) and upload them to the Focal Adhesion Analysis 
Server (FAAS - http://faas.bme.unc.edu). Automatic tracking of each paxillin-positive area 
(bigger than 15px2), lasting more than 5 frames, allowed us to analyse the directionality 
and the turnover of these adhesions. After analysis, the read out is a rainbow-colour map of 
each focal adhesion according to their turnover, ranging from cold-colour (fast turnover) to 
hot colour (slow turnover) (Figure 5-15). This server allowed the tracking of thousands of 
focal adhesions over a 30-minute movie and analyses their dynamics. Analysis of these 
preliminary experiments confirmed the previous observation. Indeed the algorithm picked 
longer focal adhesions for knockdown cells. Strikingly, the fam49B-knockdown cells have 
very stable focal adhesions at the cell edge whereas focal adhesion just below the cell body 
turned over more quickly. 
 
Although the global characterisation of focal adhesions is important, their localisation 
within the cell and their organisation compared to the protrusion is even more critical for 
the potency of force transmission. The different staining techniques clearly suggest that 
knockout/down cells have more radially aligned adhesions relative to cell protrusions. We 
used the focal adhesion alignment index (FAAI) obtained from the FAAS. This index 
reflects the standard deviation (SD) from the dominant angle of the entire distribution of 
the population of focal adhesion and is defined by the following: FAAI=90-SD. The more 
alignment and homogeneous the distribution is, the lower the SD should be resulting in a 
high FAAI. The higher the index, the more aligned the adhesions are (Wu et al., 2012). In 
order to have a meaningful value that reflects a proper orientation of the adhesion, this 
index only analyses adhesions with a length/width ratio larger than 3. In our case, adhesion 
alignment of knockdown cells is much higher (in average 58 degrees) compared with 
control condition with an index of 47 degrees. 
 
In summary, we showed using different genetic strategies and cell types that FAM49B-
depleted cells have larger lamellipodia characterised by an increase of WRC at the cell 
edge. This broader protrusion displays numerous, bigger and more elongated focal 
adhesions. Also, these adhesions align in the same direction as the protrusion. Our 
hypothesis that FAM49B restricts lamellipodia extension by inhibition of Rac1 diffusion 
was backed-up by over expression of the protein that leads to pseudopod splitting, WRC 
restriction and lack of pseudopod dynamics. 
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Figure 5-16: Dynamics of focal adhesion in control or fam49b-knockdown B16F1 cells 
A – Stills from a timelapse movie of GFP-Paxillin transfected B16F1 cells, treated with control or 
FAM49B siRNA and plated on laminin. Movies were processed by the FAAS server and 
representative pictures from the focal adhesion turnover analysis are shown in a rainbow colour 
code, with the corresponding FAAI. Scale bar = 20 µm 
B – Preliminary quantification of focal adhesion alignment using the FAAS server algorithm. Scatter 
plot represents quantification of 2 independent experiments and S.E.M is displayed. One-Way 
ANOVA with Dunn’s post test was applied. * p<0.05, ** p<0.01. 
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5.2.2 Loss of FAM49B increases filopodia number using a CDC42-
independent pathway 
During the characterisation of our different knockdown/out cell lines, we came across an 
interesting phenotype linked to filopodia. Filopodia are motile and fine protrusions, arising 
from the lamellipodium and extending out of the cell body. Filopodia are formed by actin 
bundles, tightly linked together by various actin-binding protein (Chapter 1.2.2). The most 
predominant crosslinker is Fascin. Fascin staining has been previously optimised in our 
group and can be considered as a specific filopodium marker. B16F1 are well known for 
their ability to form dynamic and straight filopodia so they represent a good model. Cells 
were treated with siRNA against FAM49B, plated on glass coverslips overnight, ice-cold 
methanol fixed and stained for endogenous Fascin. Unfortunately in these conditions, 
phalloidin staining cannot be performed as methanol fixation affects actin structure 
(Whelan and Bell, 2015). 
Surprisingly, scramble-siRNA treated cells showed an increase of cells exhibiting filopodia 
and also in number of filopodia per cell compared with parental cells (Figure 5-16 – A & 
B). This does not really affect our assay as scramble condition is always used as the control 
cell line but it was worth mentioning this effect in sake of transparency. Despite this effect, 
depletion of FAM49B increased the ability of cells to form filopodia and also increased the 
number of filopodia formed per cell by 75 % (10 filopodia/cell for control versus 17 and 
16 filopodia/cell for Seq1 and Seq4 respectively) (Figure 5-16 – A-C). These filopodia are 
also on average much longer (3.5 µm versus 2 µm for control) and whereas only 15 % of 
the filopodia are longer than 3 µm in control conditions, this percentage increased to 60 % 
in the knockdown cell lines (Figure 5-16 – D & E). 
In order to get more insight into the dynamics of these structures, control or fam49b-
knockdown cells were transfected with GFP-Fascin and imaged by video-microscopy 
(Figure 5-17). Enrichment of GFP-Fascin-positive filopodium was confirmed and 
kymographs showed a very dynamic state of these structures. Indeed, usually 3-4 filopodia 
collide into each other and merge together in knockdown cells whereas this has never been 
seen in control cells. It is also interesting to note that these filopodia are embedded within 
an enlarged lamellipodium. Indeed, this phenotype seems highly dependent on the 
presence and the stability of the lamellipodium. For example, upon lamellipodium 
retraction, filopodia get more disorganised and thinner or disappeared (Figure 5-17 - A - 
see stills from Seq4). 
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To confirm this observation, CHL1 cells were treated with siRNA and protein expression 
was assessed by western blot. FAM49B level was reduced by 80 % using 4 independent 
siRNA oligos (Figure 5-18). Filopodia were manually analysed using fascin-stained 
parental, control or fam49b-knockdown CHL1 cells (Figure 5-19). Similar to B16F1 cells, 
CHL1 depleted of FAM49B formed more filopodia and filopodia-bearing cells compared 
to controls (Figure 5-19 – A-C). The length of the filopodia were also similarly affected in 
the same kind of range as B16F1 cells (Figure 5-19 – D & E). Despite its effects on 
filopodia, Seq5 appeared to be the least tolerated oligo. Treated cells rounded up quickly 
and extensive cell death was observed. This might suggest some off-target effects so 
phenotypes obtained with this oligo were not further investigated. Oligos number 6 and 7 
were picked as they gave the most dramatic phenotype and could be tolerated by the cells. 
Timelapse microscopy of knockdown cells also confirmed the increased of filopodia 
number (Figure 5-20). 
Finally, very similar results were obtained using CrispR knockout cell lines, which 
reassured us about the specificity of our siRNA treatment (Figure 5-21).  
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Figure 5-17: FAM49B-depletion increases filopodia formation and length in fixed B16F1 cells 
A – Immunofluorescence of parental, Scramble-treated or fam49b-knockdown B16F1 cells, plated 
on glass coverslip, methanol-fixed and stained for Fascin (green) and nuclei (blue). Scale bar = 15 
µm. 
B – C – Quantification of the proportion of cells with filopodia (B) and the average number of 
filopodia per cell (C). Scatter and bar plots represent quantification from 3 independent experiment 
and S.E.M is displayed. Exact Cochran-Mantel-Haenszel test (B) and One-Way ANOVA with 
Dunn’s post test (C) were performed. n.s. p>0.05, * p<0.05, ** p<0.01, *** p<0.001. 
D – E – Quantification of filopodia length is shown as the total distribution (D) or ranked according 
to the percentage of filopodia with a designated length (E). Whisker plot and bar plot represent 
quantification of 3 independent experiments. 10-90 percentile, S.E.M and mean (cross) are 
displayed. One-Way ANOVA with Dunn’s post-test (D) and two-Way ANOVA (E) were performed. 
n.s. p>0.05, ** p<0.01, *** p<0.001. 
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Figure 5-18: Live imaging of B16F1 cells upon FAM49B depletion confirmes an increase of 
filopodia number and length 
A – Video-microscopy of parental, control or fam49b-knockdown B16F1 cells transfected with GFP-
Fascin and imaged every minute. Representative still pictures are shown every 10min. Scale bar = 
15 µm 
B – Kymograph from representative movie showing filopodium dynamics in parental, control and 
fam49b-knocdown B16F1 cells. Scale bar = 10 µm 
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Figure 5-19: fam49b-knockdown in CHL1 cells 
A – Western blot analysis of parental, control and fam49b knockdown in CHL1 cells using 4 
independent siRNA. Membrane was blotted against FAM49B and α-Tubulin. Molecular weights are 
displayed on the side. Bar plot represents quantification of 3 independent experiments and S.E.M 
is displayed. (@ = only 2 repeats). 
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Figure 5-20: fam49B-knockdown CHL1 cells display more and longer filopodia 
A - Immunofluorescence of parental, Scramble-treated or fam49b-knockdown CHL1 cells, plated 
on glass coverslip, methanol-fixed and stained for Fascin (green) and nuclei (blue). Scale bar = 15 
µm. 
B-C - Quantification of the proportion of cells with filopodia (B) and the average number of filopodia 
per cell (C). Scatter and bar plots represent quantification from 3 independent experiments and 
S.E.M is displayed. Exact Cochran-Mantel-Haenszel test (B) and One-Way ANOVA with Dunn’s 
post test (C) were performed. n.s. p>0.05, * p<0.05, *** p<0.001. 
D - E - Quantification of filopodia length is shown as the total distribution (D) or ranked according to 
the percentage of filopodia with a designated length (E). Whisker and bar plot represent 
quantification of 3 independent experiments. 10-90 percentile, S.E.M and mean (cross) are 
displayed. One-Way ANOVA with Dunn’s post-test (D) was performed. *** p<0.001 
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Figure 5-21: fam49b-knockdown increases filopodium formation and length in CHL1 cells 
Video-microscopy of control or fam49b-knockdown CHL1 cells transfected with GFP-Fascin and 
imaged every minute. Representative still pictures are shown every 10min. Scale bar = 10 µm 
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Figure 5-22: CrispR knockout of FAM49B increases filopodium formation and length in 
CHL1 cells 
A - Immunofluorescence of parental, control (EV) or 4 independent fam49b-knockout CHL1 cell 
lines, plated on glass coverslip, methanol-fixed and stained for Fascin (green) and nuclei (blue). 
Scale bar = 15 µm 
B-D - Quantification of the proportion of cells with filopodia (B), the average number of filopodia per 
cell (C) and filopodia length (D) in parental, control (EV) and fam49b-knockout CHL1 cells. Scatter 
and Whisker plots represent quantification from 2 independent experiments. 10-90 percentile, 
S.E.M and mean (cross) are displayed. Exact Cochran-Mantel-Haenszel test (B) and One-Way 
ANOVA with Dunn’s post-test (C and D) were performed. n.s. p>0.05, **p<0.01, *** p<0.001 
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CDC42 is commonly seen as the main regulator of filopodium formation (Krugmann et al., 
2001). However, based on our pulldown assay, we have been unable to detect any direct 
interactions between FAM49B and CDC42, suggesting both proteins are unlikely to 
regulate each other’s activity. In order to investigate whether this filopodium phenotype 
was driven by CDC42, B16F1 cells were co-transfected with siFAM49B (Seq1) and 
siCdc42. Western blot analysis confirmed the decrease of expression of both proteins 
(Figure 5-22 – A), so cells were stained for Fascin. Control cells treated with siCdc42 had 
a reduction of filopodia number and length, suggesting that B16F1 cells are dependent of 
CDC42 during filopodium formation. However, preliminary quantification suggests that 
fam49b-knockdown cells and FAM49B and CDC42 double knockdown cells had similar 
numbers of filopodia and similar average lengths, suggesting that filopodium formation 
due to FAM49B depletion is independent of CDC42 activity (Figure 5-22 – B & D). In 
parallel, chemical inhibition of CDC42 was also used in order to corroborate the genetic 
depletion. Control or fam49b-knockdown cells were treated overnight with the non-
competitive allosteric CDC42 inhibitor ML141 at a concentration 5 times higher than the 
reported EC50. Unlike Scramble-treated cells, fam49b-knockdown-induced filopodia were 
not affected by the inhibition of CDC42 (Figure 5-22 – C & E). In either case, inhibition 
of CDC42 did not affect lamellipodium extension and siCdc42 or ML141-treated fam49b-
knockdown cells still maintained large and broad protrusions. 
Taken together, this chapter has shown using a combination of cell lines and strategies that 
FAM49B depletion enhances lamellipodium extension and spreading, correlating with 
bigger focal adhesions. This enlarged lamellipodium is enriched with fast moving 
filopodia, which are regulated in a CDC42-independent pathway. Conversely, FAM49B 
overexpressing cells have a reduction in cell size and exhibit a fractal lamellipodium. 
Together, this increase in actin-based protrusions in FAM49B-depleted cells should be 
directly correlated to a difference in motility.  
5.2.3 Loss of FAM49B enhances 2D migration, matrix degradation 
and 3D invasion 
Since fam49b-knockout/knockdown cells have an increase in focal adhesion, 
lamellipodium formation and filopodia, we asked how does this affect their migration. 
Migration of control or fam49b-knockout CHL1 cells was directly assessed using a random 
migration assay.  
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Figure 5-23: Increase in filopodia formation is independent of CDC42 activity 
A – Western blot analysis of the double siRNA treatment against FAM49B (Seq1) and Cdc42 in 
B16F1 cells. Parental or Scramble-treated cell lysates were also analysed. Membrane was blotted 
against FAM49B, CDC42 and α-Tubulin. Molecular weights are displayed on the side. 
B – Immunofluorescence of control or fam49b knockdown cells or co-transfected with siRNA 
against Cdc42. Cells were plated on glass coverslip, methanol-fixed and stained for endogenous 
Fascin. Scale bar = 20 µm 
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C - Immunofluorescence of control or fam49b knockdown cells treated overnight with DMSO or 10 
µM of ML141. Cells were plated on glass coverslip, methanol-fixed and stained for endogenous 
Fascin. Scale bar = 20 µm 
D-E – Preliminary quantification of number of filopodia/cell (D) and average filopodia length was 
measured (E). Whisker plot and bar plots represent quantification from 2 independent experiments. 
10-90 percentile, S.E.M and mean (cross) are displayed. Mann Whitney tests were performed for 
each data set. n.s. p>0.05, * p<0.05, ** p<0.01, *** p<0.001 
_________________________________________________________________________ 
This assay allows to directly measure the speed of cell translocation in the absence of 
specific directional stimuli. In this setup, cells are sparsely seeded onto fibronectin-coated 
dish and imaged overnight every 10 min under normal culturing conditions.  
Manual tracking of each cell allows the depiction of cell migration over the course of the 
experiment as a spider plot and informs us about average cell speed and travelled distance. 
Cell showing a travelled distance greater than 100 µm are depicted in black on the spider 
plots (Figure 5-23 – A & B). 
Under these conditions, fam49b-knockout CrispR cells migrate slightly faster compared 
with controls. As previously mentioned, the C-shape phenotype is more frequently seen in 
fam49b-CrispR knockout cells (Figure 5-1). This was also observed in this assay and it 
was noticed that the increase in cell motility observed in the random migration assay was 
directly related to this C-shape phenotype (Figure 5-23 – B-F). Indeed, we correlated the 
percentage of time spent by a cell with this phenotype to the average speed over the 17 
hours of movies. fam49b-knockout cells show a much better association between 
phenotype and speed compared with control cells, as expressed by the Pearson coefficient 
(Figure 5-23 – C & D). Interestingly, C-shape cells migrate faster than other randomly 
shaped cells. However, speed of control C-shape cell is much lower compared with 
fam49b-knockout C-shape cells (Control = 0.25 µm/min, Ex3 = 0.5 µm/min, Ex4.1 = 0.4 
µm/min)( Figure 5-23 – G). From this analysis, we conclude that C-shape cells drive the 
increase of cell motility observed upon FAM49B loss. fam49b-knockout cells lacking a 
definite polarisation of their protrusions (random shape or fried-egg shaped cells in either 
control) migrated less than the C-shaped cells but when compared to their control 
counterparts, they still displayed a higher migration (Figure 5-23 - G). 
 
In order to investigate the effect of FAM49B on matrix remodelling and invasion, B16F1 
or CHL1 treated with control or Fam49B siRNA were plated on a fine layer of 
OregonGreen-gelatin. Cells were fixed after 4h, stained for F-actin and gelatin degradation 
was measured by pixel intensity threshold using Fiji. Independently to the cell lines used, 
transient depletion of FAM49B leads to an increase of matrix degradation (Figure 5-24).  
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Figure 5-24: Regulation of membrane protrusion by FAM49B affects 2D-migration of CHL1 
cells 
A – Spider plots from 3 independent random migration assays of Control (EV) or fam49b-CrispR 
knockout cell plated on fibronectin. Displacement of each cell is reported on the x and y-axis and 
reflects the cell path over 17h of tracking (1 frame/10min). Black tracks represent cells with a 
travelled distance greater than 100 µm during 17h and red less than 100µm. Spider plot generated 
using the Chemotaxis tool from Fiji.  
B – Average speed of each cell obtained from the random migration assay experiment. Scatter plot 
represents quantification from 3 independent experiments. Error bars represent S.E.M. One-way 
ANOVA with Dunn’s test was performed. *** p≤0.001 
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C – Representative still phase contrast pictures from a random migration assay of control (EV) and 
fam49b-knockout CHL1 cells plated on fibronectin. C-shaped cells have been highlighted with a 
yellow arrowhead. Scale bar = 100 µm 
D - Correlation between cell shape and average speed in control (Ctr) or fam49b-CrispR knockout 
CHL1 cells. Pearson coefficient and R2 value are shown for each condition. 
E-F - Random migration assay movies were analysed and percentage of cells presenting a C-
shape and time spent with this phenotype were measured and plotted in E and F respectively. 
Scatter and bar plots represent quantification from 3 independent experiments, with S.E.M 
displayed. E - Cochran-Mantel-Haenszel test was applied ** p<0.001, *** p<0.0005. F - One-way 
ANOVA with Dunn’s multiple comparison test was performed. *** p<0.001. 
G) Speed of control (EV) or fam49b-CrispR knockout cells displaying a random or a C-shape. Bar 
plot represents quantification from 3 independent experiments and S.E.M is displayed. One-way 
ANOVA with Dunn’s test was performed. * p<0.05, *** p≤0.001 
_________________________________________________________________________ 
This process is fully mediated by MMP-activity as incubation with a broad spectrum MMP 
inhibitor totally blocked matrix degradation (Figure 5-24). Gelatin-based zymography 
failed to show any increase in the secretion or activity of MMP-2 or MMP-9, the two main 
collagenases (not shown). Surprisingly, fam49b-CrispR knockout CHL1 cells do not show 
any increase of matrix degradation (not shown). This differential effect is not totally 
understood yet but might be due to an adaptation of the cell after knocking-out fam49b 
gene versus a rapid removal of the gene by siRNA.. 
 
Based on the previous data, CrispR knockout cells should not show any phenotype on 
different 3D-invasion assays. To test this hypothesis, cells were plated to confluence 
except in a middle area of the dish, protected by a silicon stopper. The stopper was then 
removed and cells covered with a fine layer of Matrigel and imaged using timelapse video-
microscopy (Figure 5-25 - A). In this assay, cells are forced to invade through a Matrigel 
layer and the closure of the central area can be measured overnight. However, while cells 
are initially on a 2D surface, this experiment allows investigator to observe the transition 
from a 2D to a 3D environment. Surprisingly in these conditions, fam49b-CrispR knockout 
cells showed a slight but consistent increase in invasion, with a 1.5 and 1.3-fold increase of 
invasion (Ex3 and Ex4.1 respectively) compared with control cells (Figure 5-25 - B). 
Despite a statistical difference, these data were not strong enough to convince us about the 
relevance of FAM49B during invasion. 
In order to validate the previous experiment, an alternative experiment classed as the 
inverted invasion assay, was optimised for these cells. Cells were plated at the bottom face 
of a ∅ 8µm filtered insert, filled with Matrigel and a chemotactic gradient was artificially 
created by filling the upper chamber in 10% FBS while the cells in the lower chamber were 
kept in serum-free medium (Figure 5-26 - A). 
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Figure 5-25: FAM49B affects matrix degradation in a MMP-dependent way 
A-B – Immunofluorescence pictures from parental B16F1 (A) and CHL1 (B) cells or treated with 
control or FAM49B siRNA. Cells were plated on OregonGreen Gelatin and treated for 4h with 
DMSO or 5 µM of GM6001. F-actin was also stained using Phalloidin. Matrix degradation was 
quantified from 3 independent experiments and displayed as a bar plot with S.E.M displayed. One-
way ANOVA with Dunn’s test was performed. n.s. p>0.05, *** p≤0.001. Scale bar = 10 µm. 
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Cells were allowed to invade up into the Matrigel plug for 3.5 days before performing a 
Calcein-live staining. Z-stacks of 15 µm were acquired throughout the plug and Fiji 
threshold was applied on the Calcein staining and used as readout for cell invasion. In this 
assay, cells are commonly considered as “invasive” once they migrate at least 45 µm above 
the filter (depicted by a yellow dotted line) (Figure 5-26 - B). In the time of the 
experiment, parental and control CrispR cells invaded up to 165 µm compared to the 
knockout cells that reached 225 µm. Also, more fam49b-knockout cells invaded to a given 
depth compared with controls. Statistical analysis performed by Dr. Matt Neilson show a 
difference between controls and knockout cells for depth equal and above 45 µm (Figure 
5-26 – C-D). 
Together, we can conclude that loss of FAM49B increases 2D cell motility and 3D 
invasion in vitro.  
5.3 Discussion 
In this chapter, I have shown that affecting FAM49B level or disruption of the interaction 
between FAM49B and active Rac1 had important consequences on Rac1’s downstream 
processes, such as lamellipodia formation, focal adhesions and filopodia.  
 
Cells lacking FAM49B exhibit large lamellipodia and frequently assume a fried-egg 
phenotype, which has previously been linked to Rac1 over-activation. Indeed, transfection 
of a dominant active Rac1 into cells leads to the formation of this fried-egg morphology 
(Gautier et al., 2011). This phenotype reflects a tight balance between GEF and GAP and 
their ability to regulate Rac1. Indeed, PDGF-stimulated cells show a similar fried-egg 
phenotype, which has been linked to the Rac1-GEF P-Rex1 (Barber et al., 2012). 
It also appears that FAM49B effects are highly dependent on Rac1. Indeed, Heather 
Spence addressed this question by using immortalised mouse-tail fibroblasts floxed for 
Rac1 gene and treated with siRNA against FAM49B. She found that depletion of FAM49B 
was not able to rescue Rac1 knockout (Fort et al - in revision). Indeed, OHT-treated cells 
do not spread, become linear and bipolar as reflected by a circularity index of 0.3. This 
value was exactly the same when these cells were treated in parallel with 2 independent 
siRNA against FAM49B. In addition, recruitment of WAVE2 to the lamellipodia was not 
rescued upon co-depletion of Rac1 and FAM49B. This observation highlights the 
dependence of FAM49B on Rac1 activity in order to mediate lamellipodium extension.  
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Figure 5-26: Depletion of FAM49B leads to a modest increase of invasion in a circular 
invasion assay 
A – Schematic representation from the circular invasion assay setup.  
B – Representative pictures from a circular invasion assay taken at the beginning and the end of 
the experiment. Invasion of parental, control (EV) and fam49b-CrispR knockout CHL1 cells relative 
to the cell front at t=0h (white dotted line) has been quantified from 4 independent experiments and 
represented as a scatter plot. Each value was standardised to the average invasion from the EV 
control (Red dotted line). Error bars represent S.E.M. One-way ANOVA with Tukey’s test was 
performed. n.s. p>0.05, * p<0.05, *** p≤0.001. Scale bar = 100 µm. 
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Figure 5-27: FAM49B loss increases 3D-invasion in an inverted invasion assay 
A – Schematic representation from the inverted invasion assay setup 
B – Representative z-stack pictures of parental, control (EV) and fam49b-CrispR knockout CHL1 
cells stained with Calcein after 3.5 days. Cells migrating above 45 µm (yellow dotted line) are 
considered as being invasive. Scale bar = 100 µm 
C-D – Quantification of Calcein intensity area using the thresholding tool in Fiji. Intensity for each 
depth of invasion was quantified and reported as a line graph from 0 µm (filter) upwards. Graph 
represented quantification of 3 independent experiments and S.E.M is displayed. Table of 
Bonferroni-adjusted p-values corresponding to the likelihood ratio tests of negative binomial models 
is displayed in D. p-values that are less than 0.05 are highlighted in red. 
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This requirement of Rac1-driven lamellipodium formation has nicely been shown in Rac1-
deficient MEFs rescued by expression of dominant active Rac1 (Steffen et al., 2013). This 
observation seems in slight contradiction with other findings from the same authors. 
Indeed, from 15 min onwards, Rac1-/- MEF spread more than Rac1fl/fl cells on laminin, 
fibronectin or gelatin (Steffen et al., 2013). This paper also contradicts another study that 
reported a strong defect in cell spreading upon genetic depletion of Rac1 using adenoviral-
delivery of Cre-recombination in MEFs (Guo et al., 2006). Interestingly, this study also 
mentioned a spindle-like morphology for Rac1-depleted cells similar to what we observed 
with our Rac1-null fibroblasts (Guo et al., 2006).  
 
Together, data from knockout and overexpression of FAM49B allowed us to investigate 
the function of FAM49B as part of a mathematical model. Cell migration is a complex 
event, involving thousands of different proteins required to fine-tune this process. 
However, the initial event leading to cell movement is based on a differential concentration 
of intracellular activators/inhibitors and this should be easily modelled. Initially, Meinhard 
was one of the first to conceive cell migration as a mathematical model. His work was 
based on a global activator responding to external cues and two types of inhibitors. The 
global inhibitor rapidly responds to the enhancement of activator and equilibrates over the 
cell by competition. The second inhibitor tends to act more locally and restricts peaks of 
activation by destabilisation (Meinhardt, 1999). In this crosstalk, destabilisation of the 
protrusion (peak of activator) leads to the retraction or splitting of the protrusion and the 
emergence of a new one. 
Dr Matthew Neislon from the Beatson’s bio-informatics facility modified Meinhard’s 
model in order to visualise the profile of activation/inhibition over time (Neilson et al., 
2010). A new pseudopod is formed following an increase of activator. This creates a 
feedback loop leading to the increase of the local inhibitor, which limits the diffusion of 
the activator. As a consequence, the local inhibitor directly restricts the spread of the 
pseudopod. Its progressive rise also causes a splitting of the pseudopod. In our model, 
Rac1 or Scar/WAVE is the activator and we here proposed that FAM49B fulfils all 
requirements to be seen as the local inhibitor (Fort et al - in revision). Indeed, its loss 
causes the pseudopod to spread as the activator is not restricted anymore whereas 
overexpressors are characterised by the hyper-splitting of their protrusions. We also 
expected FAM49B to diffuse faster than the Scar/WAVE complex as it is uncoupled to the 
actin network but this will have to await for a fluorescent reporter working in live cells. 
However, the main difference with Meinhard’s model resides in the recruitment of the 
local inhibitor. In Meihard’s model, the inhibitor gets synthesised upon activator 
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recruitment whereas in our case, we propose that FAM49B in its autoinhibitory state gets 
recruited to the plasma membrane following PTMs, where it can restrict Scar/WAVE 
activity by binding to active Rac1.  
 
As mentioned in paragraph 1.5.4, FAM49-knockout D. discoideum or FAM49B-
overexpressing cells show striking shape similarity to mammalian cells. Jose Batista and 
Peter Thomason were able to fully rescue the phenotype of knockout cells using untagged 
FAM49. Cell circularity, directness of migration, and pseudopod splitting returned to their 
wildtype condition. Interestingly, GFP-FAM49 only partially rescued this phenotype, 
suggesting that the protein is not fully active/functional (not shown). The tagging strategy 
seems to greatly affect FAM49 function and this provides a clear reason why we have not 
been able to create a fluorescent reporter so far. Similarly in a mammalian system, 
overexpression of untagged FAM49B commonly resulted in a hyper splitting of the 
lamellipodium.  
Moreover, the relevance of the two conserved arginine residues in this phenotype was 
addressed in D. Discoideum (Arg155 and Arg156, homologues of human Arg160 and 
Arg161 respectively). Indeed, knockout cells stably expressing mutant FAM49R155/156D was 
totally unable to rescue the phenotype and cells show a very round morphology, 
characterised by a lack of pseudopod splitting, at a level similar to the knockout cells (Fort 
et al – in revision). These data strongly support and complement our previous observations 
and allowed us to claim that the function of FAM49 as a regulator of cell shape is totally 
dependent on these two conserved arginine residues in D. discoideum. We assume that this 
is also the case for mammalian cells although we don’t have evidence regarding this part 
yet. Establishment of a rescue cell line, stably expressing FAM49B WT or FAM49B 
R160/161D is currently our priority. To do so, knockout MEFs will be transfected with our 
inducible lentiviral mVenus construct used for the FRET experiment and FACS sorted 
across different cell passages in order to positively select for integrated construct. 
 
Chemotaxis assay performed with wildtype or fam49-knockout D. discoideum cells also 
revealed that a low proportion of cells failed to end cytokinesis properly upon removal of 
fam49 gene and daughter cells stayed connected by a long mid-body (internal 
communication - J. Batista’s thesis). During normal mitosis in HeLa cells, the Matsuda lab 
showed using FRET-biosensor that Rac1 gets inactivated at the cleavage furrow during 
anaphase and telophase (Yoshizaki et al., 2003). This exclusion has also been observed in 
D. discoideum using active Rac-reporter (GTPase-binding domain of PAK1 - GBD) that 
localises at the extremity of each daughter cell at the time of scission, whereas the Rac1-
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sequesterer DGAP1, accumulates at the mid-body (Filic et al., 2012). Moreover, 
overexpression of Rac1 Q61L in HeLa cells increases by 5 fold the number of bi-nucleated 
cells compared with Rac1 WT (Bastos et al., 2012). This effect is dependent on the activity 
of the Rac1-GAP CYK7 and is mediated by ARFGEF7 and PAK protein downstream of 
Rac1. This clearly reflects the need to locally down-regulate Rac1 signalling upon cell 
division. 
As previously shown, FAM49B-depleted cell have higher Rac1 activity so we 
hypothesised that loss of the polarisation of Rac1 activity would interfere with the 
downstream signalling pathways and cells would fail to divide properly. Moreover, we also 
noticed than despite their normal proliferation rate, ~5% of fam49b-knockout CHL1 cells 
are multinucleated, although this phenotype has not been properly quantified. This could 
be directly and precisely assessed using specific DNA markers such as propidium iodide 
followed by FACS analysis and looking at a switch toward higher DNA content. 
Unfortunately, in our hands, cells do not tolerate the GBD-PAK1 reporter very well, 
making the study of active Rac1 localisation more challenging. This could be a 
consequence of the tight interaction between Rac1 and the probe that would therefore 
block Rac1 signalling to other effectors. We also tried to optimise a Rac1-GTP antibody 
for immunofluorescence using various fixation conditions and antibody concentrations but 
the staining was not convincing enough to go further down this road.  
 
The excessive spreading is directly correlated with an increase of adhesion sites underneath 
the growing lamellipodium. Indeed, knockout cells show more total focal adhesions and 
integrin-engaged focal adhesions (Phospho-Paxillin positive focal adhesion) compared 
with control cells. Rac1 has previously been linked to focal adhesion formation under 
different conditions. Guo et al (Guo et al., 2006) showed than Rac1-/- MEFs have a normal 
expression level of adhesion-related proteins (Vinculin, FAK, pFAK, Src and pSrc) but 
failed to interact with each other. Indeed, Vinculin and FAK both pulled-down with Src in 
wild-type cells but failed to do so upon loss of Rac1. This is reflected at the cellular level 
by the absence of p-FAK and Vinculin-positive focal adhesions. 
However, according to Steffen et al (Steffen et al.), Rac1 is not essential for focal adhesion 
formation as Rac1fl/fl and Rac1-/- have a similar number of Vinculin-positive focal adhesion 
per cell area and adhesions showed a similar size. The discrepancy between these two 
datasets is probably due to the difference in the spreading area discussed above. It is 
difficult to distinguish the direct effects of Rac1 on focal adhesion formation or whether 
the increase in number of focal adhesions is just a passive event downstream of Rac1-
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driven lamellipodium formation. Indeed, extension of the lamellipodia should engage more 
integrins in complex with the ECM resulting in more focal adhesions (Chen et al., 2003). 
In our hands, we observed that fam49b-knockout cells show increased spreading, 
correlating with more focal adhesions. However, precise data analysis, notably by 
standardising the focal adhesion number to the cell area reveals the absence of statistical 
difference between conditions. The same result is obtained when looking at the total focal 
adhesion area reported to the global cell area. This would tend to suggest that increase of 
Rac1 activity following FAM49B loss does not really affect focal adhesion in our system 
and the observed difference in numbers is mostly related to the extreme difference in 
morphology. An easy way to test this hypothesis would be to use micropatterns that would 
allow cells to be constrained to a specific morphology and stained for focal adhesion 
markers. In this setup, a difference in focal adhesion number or focal adhesion area would 
be directly linked to Rac1 activity, independently of the cell shape. This would probably be 
the most direct way to investigate Rac1-driven focal adhesion formation upon FAM49B 
loss. Finally, at this point, it is too early to conclude whether FAM49B directly regulates 
focal adhesion, independently of Rac1. 
 
Another striking feature was the shape of the focal adhesions, which were longer and more 
linear. Once again, we cannot exclude that cell shape had any influence on focal adhesion 
morphology. Adhesions seem to stretch radially from the nucleus out to the leading edge 
and form mature focal adhesions (> 5µm). Those can either be mature elongated focal 
adhesions or fibrillar adhesions. The latter are characterised by the presence of specific 
markers such as αSMA and Tensin, the absence of phospho-Paxillin Y118 staining and are 
very often localised in the central region of the cell (Geiger and Yamada, 2011). In 
fam49b-knockout cells, these long focal adhesions are negative for both αSMA and Tensin 
(not shown) and positive for phospho-Paxillin Y118. Also, they mostly accumulate at the 
edge of the cell. Together we conclude that these structures are different from fibrillar 
adhesions. 
Elongated focal adhesions can however be formed if the rate of disassembly is slower than 
the rate of assembly. Data from the FAAS have highlighted the relative stability of those 
long adhesions. A more quantitative way to analyse focal adhesion turnover would be to 
look at the fluorescence recovery of Paxillin-GFP transfected cells by FRAP. 
Finally, James Bear’s lab suggested that one function of the lamellipodium is to spatially 
organise focal adhesions and promote their alignment. This results in a global coherence in 
their organisation relative to the lamellipodium, although mechanisms allowing this have 
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not been addressed (Wu et al., 2012). Our data confirmed that knockdown cells with 
broader lamellipodia realigned their focal adhesions compared with control cells.  
 
Given the close relation between lamellipodia and filopodia formation, we analysed Fascin 
by immunofluorescence staining, in FAM49B-depleted cells. These cells are highly 
enriched in long filopodia that emerged from the lamellipodia. Interestingly, treatment with 
a CDC42-inhibitor or double knockout FAM49B and CDC42 does not rescue this 
phenotype, meaning that filopodia formation is independent of CDC42 activity. This 
observation should really make us challenge the accepted dogma found in most of the 
textbooks, in which Rac1 stimulates lamellipodia and CDC42 strictly promotes filopodia 
(Takenawa and Miki, 2001). 
Three distinct models were proposed to explain the regulation of lamellipoda and 
filopodia. The “parallel pathway model” (the actual dogma) suggests that lamellipodia are 
regulated by Rac1/Scar/WAVE complex whereas CDC42 activates WASP proteins to 
induce filopodia (Takenawa and Miki, 2001). The “cascade pathway model” proposed 
however that Scar/WAVE and WASPs protein, downstream effector of Rac1 and CDC42 
respectively, together stimulate lamellipodia formation and that filopodia result from 
external cues signalling to the lamellipodium (Biyasheva et al., 2004). Using D. 
melanogaster tissue cultured cells, the Borisy lab provided a refinement of the model 
(Biyasheva et al., 2004). The refined cascade model still depicts Scar/WAVE as the main 
driver of lamellipodia extension downstream of Rac1. However, CDC42 appears to have a 
double function, as WASP RNAi does not affect filopodia formation or lamellipodia, 
suggesting that WASP plays other actin-related cellular effects. Meanwhile, CDC42 may 
signal to the lamellipodium in order to induce filopodia formation and this was 
hypothesised to be dependent on specific effector, such as IRSp53 and the Diaphaneous-
related formin Drf3 (Biyasheva et al., 2004). This is also supported by another study in n-
wasp-knockout ES-derived fibroblast-like cells that are still able to form filopodia, 
although the filopodia number is decreased compared to the control (Snapper et al., 2001). 
Microinjection of active CDC42Q61L into n-wasp-knockout cells further increases filopodia 
number. This reveals that CDC42 can induce filopodia formation, independently of N-
WASP and would tend to confirm the Borisy model.  
However, in our case, we showed that CDC42 was not involved in the increase of filopodia 
formation upon FAM49B loss. Since the relationship between Rac1, CDC42 and filopodia 
is not as strict as it was previously described, it would be interesting to see whether an 
increase of Rac1 activity could enhance filopodia numbers. In D. discoideum, active Rac1 
was shown to interact with the D.discoideum Dia2, which in turn localises to filopodia tips 
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and regulates their formation (Schirenbeck et al., 2005). Moreover, MEF cells expressing 
dominant negative Rac1T17N spreading on fibronectin showed a decrease of 50 % in the 
number of filopodia (Johnston et al., 2008). Similarly, neurons transfected with Rac1T17N 
showed a reduction in filopodia numbers in the axon, and this phenotype was not observed 
using Cdc42T17N (Spillane et al., 2012). In this report, authors showed that increase of Rac1 
activity following nerve growth factor stimulation was dependent on PI3K-WAVE1-
Cortactin pathways, inducing filopodia formation. We also noticed that knockout cells are 
not only more prone to form filopodia, but filopodia are also longer. In light of this 
observation, it would be interesting to look at activity of actin-nucleators, such as Arp2/3, 
Ena/VASP and Formin protein and their ability to be responsible for the increased of 
filopodia number and length in knockout cells. Together, we hypothesised that increase 
Rac1 activity in FAM49B-depleted cells is enough to promote filopodia formation. FRET 
imaging of the CDC42 reporter transfected into our knockout cells would allow us to 
confirm our CDC42 inhibition data. 
Finally, in order to distinguish the difference of morphology of the cell, the use of 
micropatterns could be interesting. In this analysis, an increase of filopodia number/length 
could be directly linked to the loss of FAM49B, independent of the increase of the 
lamellipodia extension. 
 
Actin-based protrusions have been correlated with a more invasive phenotype (Jacquemet 
et al., 2015) and allow cells to steer during migration. In parallel, Rac1 and Rac3 (Chan et 
al., 2005) have been linked to tumour invasion in glioblastoma and breast cancer cell lines. 
We then hypothesised that our FAM49B-depleted cell lines with high Rac1 activity would 
show pro-invasive phenotypes. 
We directly tested this hypothesis using a range of 2D, 3D-like and 3D invasion assays 
showing in all cases that loss of FAM49B increased cell migration and invasion. This 
phenotype would correlate with higher Rac1 activity and an increase of actin-based 
protrusions able to drive cell migration. We were surprised by this global increase in 2D 
cell migration. Indeed, cell polarisation and the ability to define a front and a rear, with 
different actin dynamics, is a crucial feature to achieve an effective migration. This is in 
sharp contrast with the fried-egg phenotype obtained with FAM49B-depleted cells, which 
formed this un-polarised rounded shape (fried-egg). Frequently, we could see immobile 
cells switching from a uniform lamellipodium to a more polarised C-shape phenotype that 
represents the main feature responsible for the increase of cell migration. We then 
hypothesised that C-shape and fried-egg shape are actually the same but depict two 
different states of activation of the same cell. Breaking the symmetry has been previously 
																											FAM49B,	master	regulator	of	cell	protrusion,	spreading	and	migration	 	 	
	
165 
reported as important for migration in cell fragments (Verkhovsky et al., 1999) and in 
experiment where inhibitors were locally added using a micropipette (Kaverina et al., 
2000). 
This increase in cell migration and invasion highlights an interesting question regarding the 
role of FAM49B during cancer progression and metastasis. It is worth noticing that unlike 
fam49a, fam49b gene is co-amplified with the oncogene c-myc in ovarian and breast cancer 
(cBioPortal). At this point, it is difficult to conclude anything about the relevance of this 
amplification and to directly translate it at the cellular level. Indeed, fam49b and c-myc 
genes are sitting next to each other on chromosome 8. c-myc is one of the most commonly 
amplified oncogenes upon cancer initiation and cells are highly dependent on it to mediate 
proliferation, survival and transcription (Lin et al., 2012). Given this wide implication, 
FAM49B might just be passively selected and be a passenger from the c-myc 
amplification. Precise analysis is then required to see whether fam49b expression correlates 
with the c-Myc status of different ovarian and breast cancer cell lines. If this were the case, 
it would be interesting to analyses the effect of FAM49B loss on the invasiveness of these 
cells. 
 
However, we would expect from our data that amplification of FAM49B would decrease 
cell migration, which seems in contradiction with the ovarian cancer genome analysis. An 
easy way to potentially explain this discrepancy can be highlighted in few points: 1) 
Different cell types might respond differently to FAM49B. 2) There is no direct relation of 
DNA/protein and a genomic amplification might not be translated at the protein level. 3) 
Signalling pathways might be different between isolated cells and collective cell migration.  
Despite the increase of cell migration seen in our assays, fam49 knockout D. discoideum 
cells show a slower speed in an under agarose assay. Furthermore, migrating fam49b-
knockout melanoblasts also migrated slower compared to wild-type cells (see section 
6.2.2). These two observations would suggest that in a 3D environment, the loss of 
FAM49B might not be pro-invasive. Since cell migration is a complex event reflecting 
directionality, adhesion, protrusion rate and the cell compression, migration speed on its 
own is not very informative and only reflects the sum of how these parameters behaved. In 
our 2D random migration assay, cells were sparsely seeded and individual track reports 
cell migration. This is the only way to say whether intrinsic signalling makes a cell go 
faster/slower, as it is not influenced by the environment. However, it is well established 
that coordination between adhesion and migration is crucial for cell migration. In line with 
this observation, different cell types might emphasise slight modifications in one part of 
the mechanism, resulting in a differential speed. For example, D. discoideum, fish 
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keratocytes and neutrophils are well known for their fast migration, resulting from weak 
adhesions to the substratum. As a consequence, cell speed is limited by how fast the actin 
turns over and the cell polarity. However, mammalian cells from tissues are characterised 
by low speed, typically one to two orders of magnitude slower than the cell types 
mentioned above. This is the consequence of strong dependence to adhesion formation and 
turnover, together representing the main limiting factors. 
 
In order to complete the analysis of FAM49B functions, it would be informative to 
perform some biochemical assay to look at the direct role of FAM49B during actin 
polymerisation. To do so, pyrene fluorescent assay could be performed and analysis of the 
fluorescence emission would give us direct readout of FAM49B effects in an in vitro 
setting. 
It will also be important to work out the most basic function of FAM49B during invasion. 
Despite the contradicting results obtained in 2D and 3D environment, we could try to 
constrain control or knockout cells between two layers of agarose, similarly to the D. 
discoideum experiment and measure cell speed and directionality. Here, we hypothesise 
that knockout cells behave differently if they are in a constraint environment. Other in vivo 
experiments could be done in order to answer this question. Subcutaneous injection of 
control or fam49b-knockout melanoma cells into nude mice and monitoring of tumour 
growth and invasion could be informative. Alternatively, in collaboration with Karthic 
Swaminathan, I developed an ear injection assay to look at invasion of cancer cells stably 
expressing GFP-Lifeact in vivo using 2-photon microscopy. Finally, switching to a cancer 
mouse model, and looking at the effect of genetic loss of fam49b during cancer progression 
would definitively give us more insight about the role of FAM49B in cancer biology. For 
example, based on the Machesky lab’s expertise, we could investigate the role of FAM49B 
in a pancreatic cancer mouse model as all the tool and mouse strains have already been 
developed.. 
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6 Taking step towards FAM49B’s in vivo functions 
using more physiologically relevant models 
6.1 Introduction 
Encouraged by our previous findings, we initiated the investigation of FAM49B using 
more complex models. This allowed us to monitor cell behaviour in a more physiologically 
relevant environment. For example, studying FAM49B using ex vivo protocols or directly 
in an animal with a complete ECM matrix and an immune system, should provide insight 
about FAM49B’s biological relevance. To do so, a wide-range of methods and systems 
was applied. 
 
As we here claim a close relationship between FAM49B and Rac1, we used a 3D-organoid 
model, in which Rac1 has previously been implicated as an important regulator of 
cystogenesis. Early on, it was shown that an autocrine loop involving Rac1 and the ECM, 
was able to signal directly to the cyst in order to regulate its organisation and polarity 
(O'Brien et al., 2001). Specific Rac1-GAPs, such as Chimaerin have also been linked to 
Rac1 polarisation resulting in an apico-basal gradient, which has been imaged using FRET 
reporter probes (Mack et al., 2012; Yagi et al., 2012a; Yagi et al., 2012b) (Figure 6-1 - A). 
In all these studies, increase of Rac1 activity and loss of Rac1 polarisation lead to a multi-
lumen phenotype and an accumulation of cells inside the lumen. This model is a great tool 
for us to monitor the potential effect of FAM49B on 3D epithelial organisation. 
 
One example of a system for study of individual cell migration in a physiological setting is 
the migration of melanoblasts through mouse embryo skin. We have optimised a method to 
image migrating melanoblasts from the developing skin of mouse embryo. Skin explants 
have been successfully used in the past by our lab to look at Rac1 and Cdc42 requirement 
during melanoblast development (Li et al., 2011; Mort et al., 2010; Woodham et al., 2017). 
 
Finally, D. melanogaster is a quick and straightforward genetic model to study actin 
dynamics and we used it to confirm some of our in cellulo data. 
 
In this chapter, I describe experiments that go beyond the role of FAM49B in cellulo and 
extrapolate to a more universal role in cells but also at the level of the whole organism. 
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6.2 Results 
6.2.1  FAM49B is crucial during epithelial cell cyst polarisation 
using a Rac1-dependent mechanism 
Cell polarisation is a fundamental event that results in plasma membrane segregation into 
an apical and a basolateral domain, which are functionally and morphologically different. 
It happens in all epithelial cells and maintains specific signalling molecules at one side of 
the cell. For example, intestinal epithelial cells are characterised by an apical brush-like 
zone, facing the intestine lumen and specialised in the absorption of nutrients. Similar 
structures cover most body surfaces in direct contact with the extracellular environment. 
On the other side, the basolateral domain allows cell-cell and cell-matrix interaction. 
Physical separation between these domains is mediated by the apical junctional complex 
composed by the zonula occludens, zonula adherens and macula adherens. Specific protein 
delivery to one end or the other is a complex event mediated by the Rab family proteins 
and is beyond the scope of this thesis. 
 
For this work, we used Madin–Darby canine kidney (MDCK) cells that have the property 
to form spheroid-like structures when grown in 3D and mimic a simplified epithelium. 
This multi step process starts with one non-polarised cell that undergoes several mitotic 
events (Figure 6-1 - A). From the 2-cell stage onwards, intense and highly regulated 
trafficking events lead to the relocalisation of the apical markers to the apical membrane 
initiation site (AMIS). At this stage, the lumen is not fully formed and only becomes 
visible upon active pumping of ions and water into the lumen, while the cyst continues to 
expand.  
 
Given the great model provided by MDCK cells, stable fam49b-knockdown cells were 
created by shRNA-lentiviral infection. To do so, human shRNA were aligned against the 
dog genome and matching oligos were selected. Puromycin selection followed by western 
blot analysis confirmed fam49b knockdown and shRNA cell lines number 2 and 4 
(FAM49B level reduced by ~90% compared to control) were selected for further analysis 
(Figure 6-1 - B). Control or knockdown MDCK cells were plated on a Matrigel-coated 
chamber as a single cell suspension and grown 5 days in low Matrigel concentration. At 
this stage, cysts were fixed and stained for the apical marker Podocalyxin1/gp135 
(Pdx1/gp135), F-actin and nuclei, before imaging using a confocal microscope (Figure 6-2 
- A).  
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Figure 6-1: MDCK cyst development and knockdown cell lines generation 
A – Schematic representation of early steps during lumen organisation in MDCK cyst development. 
Non-polarised single cell undergoes multiple mitotic events during which apical markers (green) get 
endocytosed and trafficked to the AMIS where they form the expanding apical domain. Magenta 
lines denote apico-basal membranes. Red lines represent microtubule spindle and nuclei are blue. 
Inset is a graphical representation of Rac1 gradient running from the apical to the baso-lateral 
membranes. Inspired from Overeem et al (Overeem et al., 2015). 
B – Western blot analysis of parental (Par.), shControl (shCtr) or shFam49B MDCK cells. 
Membranes were blotted against FAM49B and α-Tubulin. Molecular weights are displayed on the 
side. Bar graph represents quantification of FAM49B expression of 3 independent experiments and 
S.E.M is displayed. 
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Figure 6-2: Loss of FAM49B causes a multilumen phenotype in MDCK cysts 
A – Immunofluorescence of Control or fam49b-knockdown MDCK cysts grown in 3D. Cyst were 
fixed after 5 days and stained for Pdx1/gp135 (green), F-actin (red) and nuclei (blue). Top row is a 
confocal section across different cysts and bottom row represents Z-maximal projection intensity of 
the Pdx1/gp135 staining. Scale bare = 50 µm 
B – Whisker-plot representing the number of lumen per cyst. Whiskers show 10th and 90th 
percentile. Cross shows the mean from 4 independent experiments. Error bar represent S.E.M. 
One-way ANOVA with Dunn’s multiple comparison test was performed. *** p<0.001 
C - Bar plot representing the distribution of cysts with a specific number of lumen from 4 
independent experiments. Error bar represent S.E.M. 
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Unlike control cysts, fam49b-knockdown cysts are characterised by an enrichment of 
multiple small lumens, filling the middle of the cyst. This multilumen phenotype is even 
clearer if we take a z-stack running throughout the entire cyst and process the pictures 
using the maximum-z projection tool for the Pdx1/gp135 channel. Precise quantification 
reveals that control cysts have on average 2 lumina/cyst, compared to 6 and 9 lumina for 
FAM49B-depleted cysts (shRNA #2 and #4 respectively) (Figure 6-2 - B). Moreover, only 
20% of the control cysts have more than 5 lumina whereas this phenotype was observed in 
55 and 90% of the knockdown cyst with shRNA #2 and #4 respectively. Frequently, cysts 
containing more than 20 lumina were found, especially for shRNA #4 (Figure 6-2 – B & 
C). 
 
It is well established that orientation of the mitotic spindle during cell division is 
fundamental to maintain the polarity of the cyst. Indeed a very regulated crosstalk between 
polarity markers and the cell division machinery assures a symmetrical division. However, 
defect in maintaining this polarity results in spindle misorientation and multi-lumen 
phenotype (Figure 6-3 – A & B). For example, LGN protein, a regulator of G-protein 
signalling, accumulates at the basolateral side of dividing cells and the current model 
suggests they are required for the capture and the stabilisation of astral microtubules (Peyre 
et al., 2011). In order to visualise the microtubule spindle, cysts were stained for tubulin 
and the angle formed by the mitotic spindle and the apico-basal axis was measured across 
multiple dividing cells (Figure 6-3 - C). On average, control cysts form a 70 degrees angle 
and this value goes down to ~40 degrees upon FAM49B loss. Similarly, only 25-30% of 
the knockdown cysts have an angle above 45 degrees, which is the accepted threshold 
value to consider a mitotic event as normal (Rodriguez-Fraticelli et al., 2010) (Figure 6-3 
– D & E). Interestingly, staining for Ki-67 revealed that knockdown cysts are more 
proliferative, a feature that was not observed for cells plated on a 2D surface (Figure 6-4). 
This suggests that FAM49B might have differential functions between 2D and 3D 
environment. 
 
As previously mentioned, Rac1 has been involved as a key player during cyst polarisation, 
by creating a signalling gradient, increasing from the apical to the basolateral membrane 
(Figure 6-1 – A). My hypothesis is that FAM49B-deficient MDCK cells have higher Rac1 
activity and are not able to form this gradient anymore, resulting in abnormal signalling 
pathways downstream of Rac1, which are important for normal cystogenesis. If Rac1 was 
involved in the FAM49B-dependent multilumen phenotype, down-regulation of Rac1 
should be able to rescue this phenotype. We tested this hypothesis by treating growing 
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cysts with different Rac1 inhibitors. EHT1864 is a pan-Rac inhibitor that binds to Rac1 
(Rac1a and Rac1b) at low concentration and Rac2 and Rac3 at higher molarity. (Desire et 
al., 2005; Shutes et al., 2007). Binding to Rac destabilises the nucleotide interaction and 
interferes with the nucleotide-exchange process, inducing the blockage of further 
interaction with GEF and Rac effectors. (Shutes et al., 2007). Cysts were treated with 50 
nM of EHT1864, a concentration that targets Rac1a and Rac1b over other Rac isoforms. 
Rac1 inhibition partially reverted the multi-lumen phenotype caused by FAM49B loss 
(Figure 6-5 – A). This rescue was confirmed using a second Rac1 inhibitor, NSC23766 
that prevents GEF-mediated Rac1 activation (Gao et al., 2004). In either case, lumen 
number was decreased by a 2-fold factor and reached similar values (Figure 6-5 – B & C). 
We concluded that FAM49B is important for regulating Rac1 activity during epithelial cyst 
formation, which has direct consequences for the polarisation of the epithelium. 
Altered Rac1 signalling should also directly affect downstream Rac1 effectors. Based on 
the 2D staining of our CrispR cells, the WRC seems to be a good initial candidate to look 
at. Cysts were stained for WAVE2 and Pdx1/gp135 and z-stacks were obtained by 
confocal microscopy (Figure 6-6 - A). Maximal intensity projection reveals that WAVE2 
localised at the cell-cell junction (basolateral domain) in control cysts, similar to what is 
already published for the WRC localisation in monolayer of epithelial cells (Yamazaki et 
al., 2007). However, we found that upon FAM49B-depletion, WAVE2 relocalised to the 
apical membrane and colocalised with Pdx1. Indeed, pixel intensity measurements show 
that Pdx1/gp135 and WAVE2 staining co-varied in knockdown cysts to a much greater 
extent than in control cysts (Figure 6-6 - A & B). Thus the regulation of Rac1 activity is 
important for WAVE2 localisation. In turn, WAVE2 regulates localised branched actin 
polymerisation at cell-cell junctions and helps to define the polarity of epithelial cells. 
 
Together, these results on 3D cyst polarisation suggest that FAM49B-mediated Rac1 
regulation is important for normal organoid formation, especially establishment of the 
apico-basolateral axis. 
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Figure 6-3:  Microtubule spindle orientation is affected in fam49b-knockdown MDCK cells, 
probably responsible for the multilumen phenotype 
A – Schematic representation of how microtubule spindle misorientation can lead to multilumen 
phenotype. Green = apical membrane, Orange = basolateral membrane, Blue = nuclei and Red = 
microtubule spindle 
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B – Schematic representation of normal and abnormal mitotic events. Angle formed between the 
apico-basal axis (full black line) and the mitotic axis (dotted black line) was measured in each 
condition. Green = apical membrane, Orange = basolateral membrane and Red = microtubule 
spindle. For simplification, nuclei were omitted. 
C - Immunofluorescence of Control or fam49b-knockdown MDCK cysts grown in 3D. Cyst were 
fixed after 5 days and stained for Pdx1/gp135 (green), Tubulin (red) and nuclei (blue). Scale bar = 
25 µm 
D – E – Mitotic angle was quantified from 3 independent experiments and plotted as a scatter plot 
(D). One-way ANOVA with Dunn’s multiple comparison test was performed. *** p<0.001. Angles 
were divided as greater or lower than 45 degrees and plotted as a bar graph in E. Two-tailed Chi-
square test (95% confidence) was applied for each condition compared with the control cells. *** 
p<0.001. Error bars represent S.E.M. 
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Figure 6-4: Loss of FAM49B increases proliferaton of 3D-cultured cysts 
A - Immunofluorescence of Control or fam49b-knockdown MDCK cysts grown in 3D. Cyst were 
fixed after 5 days and stained for Ki-67 (magental) and nuclei (blue). Scale bar = 100 µm 
B – C – Quantification of number of proliferating cysts (B) and number of proliferating cells per cyst 
(C) obtained from 3 independent experiments. S.E.M is displayed on each graph. 
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Figure 6-5: Inhibition of Rac1 signalling partially rescues the loss of FAM49B during 
cystogenesis 
A – Immunofluorescence of control or fam49b-knockdown MDCK cysts grown during 5 days, 
treated or not with 50 nM EHT1864 and stained for Pdx1/gp135. Pictures represent maximum 
intensity projection of z-stack running across the entire cyst volume. Scale bar = 25 µm 
B – C – Number of lumina from control or fam49b-knockdown cysts treated or not with 50nM 
EHT1864 (B) or 100 µM NSC23766 (C). Whisker plots represent 10-90 percentile, mean (cross) 
and S.E.M from 3 independent experiments. One-Way ANOVA with Dunn’s post-test was applied 
between vehicle-treated knockdown cysts and vehicle-treated control cysts. Two-tailed t-test was 
applied to untreated versus treated cysts. n.s. p>0.05, ** p≤0.01, *** p≤0.001 
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Figure 6-6: WRC localisation in MDCK cysts is affected following FAM49B loss 
A – Immunofluorescence of fam49b-knockdown MDCK cysts grown during 5 days and stained for 
WAVE2 (green) and Pdx1/gp135 (red). Inverted LUT images for each individual channel and the 
merge picture are displayed. Scale bar = 9 µm. Insets provide a magnified view of the dotted 
square area. Scale bar = 5 µm. 
B – Surface profile plot of both Pdx1/gp135 (red) and WAVE2 (green) staining intensity across the 
blue line represented on the merge picture in A. Note the different units scale for Control compared 
to knockdown conditions. 
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6.2.2 FAM49B regulates melanoblast migration using an ex vivo 
skin explant model 
Very dynamic migration processes occur during embryo development, which are crucial 
for the position and the architecture of the future organs. In the lab, former colleagues 
refined a method published by Mort et al (Mort et al., 2010) in order to get high-resolution 
movies from migrating melanoblasts. Melanoblasts are the precursors of melanocytes that 
represent the specialised melanin-secreting cells in adult skin. They originate from a 
transient pluripotent population arising at embryonic day 10 (E10) around the dorsal neural 
tube, where they start their journey. Briefly, melanoblast differentiation is regulated by 
simultaneous signalling involving the Wnt pathway, the transient activation of Sox10 and 
Pax3, and the down regulation of FoxD3 (Silver et al., 2006) Together, these signals drive 
the expression of melanocyte-specific genes such as tyrosinase, downstream of the 
activation of MITF, a key transcription factor for the melanocytic lineage. At this point, 
they received sufficient information to migrate to their final destination. 
The melanoblast journey has been studied for years and still, precise signalling pathways 
are missing. Our current understanding suggests that melanoblasts follow a dorsolateral 
path, making their way between the dorsal surface of the somite and the ectoderm. 
Following a proliferation step in the staging area, melanoblasts migrate into the dermis, 
just underneath the basement membrane from E11.5-E13.5. At this stage, few cells have 
already crossed the epidermal basement membrane but most, if not all melanoblasts reside 
in the epidermis by E15.5. Specifically, cells gather in structures called hair follicles where 
they will play their function from birth onward. Another population of pluripotent neural 
crest cells migrate ventrally, between the lateral sides of the neural tube and the somites, 
and develop into nervous structures, medulla of the adrenal glands. Specific population of 
cells derived from the Schwann cells may also differentiate into melanocytes of the skin 
(Adameyko et al., 2009). 
This brief description is enough to understand why embryo skin is a perfect model for a lab 
working on cell migration. The superficiality of migrating cells makes the imaging easier 
and allows testing the effect of the genetic depletion of a gene in an ex vivo setup. 
During this journey, melanoblasts use highly dynamic pseudopods to migrate through the 
tight layer of keratinocytes and pull their cell body forward. This crawling between 
keratinocytes and the basement membrane crossing seems to be independent from the 
activity of metalloproteinases and does not rely on invadopodia. Indeed, depletion of N-
WASP, a key protein for invadopodia function does not alter fur colour (Li et al., 2011). 
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Figure 6-7: Tool and setup for studying ex vivo melanoblast migration 
A – Development of a transgenic approach to achieve genetic depletion of fam49b gene at the 
same time as expression of the tdTomato reporter in the melanoblast lineage. Melanoblast-specific 
Tyrosine expression leads to the recombination of the LoxP sites at each end of the fam49b gene 
and the STOP codon. This results in expression of the reporter alongside to the loss of fam49b 
transgene. 
B – Skin explant setup to achieve high-resolution imaging. Embryo skin was overlaid with a 
nucleopore membrane. Matrigel was added on the top of the skin and allowed to polymerise 30 min 
before adding Phenol red-free media. 
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We took the advantage of our floxed-fam49b mouse to investigate FAM49B functions 
during melanoblast migration. To do so, the fam49bfl/fl mouse was crossed with other 
transgenic strains in order to get a Tyr::CRE fam49bfl/fl LSL-tdTomato mouse. Basically, 
only cells expressing Tyrosinase will be able to produce the Cre enzyme, recombine the 
fam49b transgene and allow the removal of the Lox-STOP-Lox sequence (Figure 6-7 – A). 
As a consequence, tdTomato is only driven in the melanoblast lineage. 
Timed matings were set up and embryos were harvested at E14.5. Embryos were dissected 
and the skin was isolated, flipped, flattened, placed with the epidermis side down and 
sandwiched between the gas permeable plate and the nucleopore membrane. Pure Matrigel 
was overlaid onto the skin in order to immobilise the skin and this setup was kept moist by 
filling the well with phenol red-free medium (Figure 6-7 – B). Skin explants from 
fam49bfl/fl, fam49bfl/- and fam49b-/- were imaged every 5min using confocal microscopy 
during 4h. 
Migrating melanoblasts exhibit a common morphology with a round cell body, extending 
at least one dynamic pseudopod. Preliminary quantification by manual tracking of 
tdTomato-positive cells from two different litters revealed a strong defect in migration for 
FAM49B-recombined melanoblasts (Figure 6-8 – A-B). Homozygote fam49b knockout 
cells migrate half as fast compared with control whereas heterozygotes have an 
intermediate phenotype (Figure 6-8 – C). Similarly to our in cellulo and D. discoideum 
work, FAM49B-depleted melanoblasts looked less polarised and much rounder, although 
cell size does not seem affected (Figure 6-9 – A). Knockout melanoblasts more frequently 
lack a pseudopod (16% for fam49bfl/fl versus 33% for fam49b-/- cells). In the same line, 
50% of the wild type cells extend two or more pseudopods and this value is as low as 24% 
for knockout cells (Figure 6-9 – B). This reduction in pseudopod numbers was 
accompanied by a slight decrease in the pseudopod length (Figure 6-9 – C). Preliminary 
quantification suggests that fam49b-knockout pseudopods are more unstable, with an 
average lifetime of 50 min compared to 100 min for wild type cells (Figure 6-9 – D). From 
the movie analysis, it was also quite clear that knockout cells with an extending protrusion 
frequently displayed patchy and enlarged portions of pseudopod (Figure 6-9 – A) that 
contrast with the homogeneous and slender pseudopods formed by control cells. This 
phenotype might reflect membrane bursts throughout the pseudopod related to increasing 
Rac1 activity. Moreover, once a pseudopod is formed, knockout cells seem to fail to pull 
their cell body forward. This can result from the lack of coordination between membrane 
extension and physical traction and the ability of the cell to form potent and efficient 
protrusions. Therefore, FAM49B is important for controling pseudopod number, dynamics 
and morphology, probably resulting in the defect in migration observed in the spider plot.  
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Figure 6-8: Loss of FAM49B impairs melanoblast migration (preliminary experiment) 
A – Representative confocal pictures from a 4h timelapse movie. Still pictures have been extracted 
from the begging/end of each movie from wild-type (fam49bfl/fl), heterozygote (fam49bfl/-) and 
homozygote (fam49b-/-) melanoblasts. Tracking from tdTomato-positive melanoblasts has been 
overlaid on the last image. 
B – Spider plots combining tracks from technical replicates of 3 fam49bfl/fl, 5 fam49bfl/- and 4 
fam49b-/- embryo skins (respectively 419 cells, 540 cells, 569 cells), over 4h of movie. Embryos 
came from 2 independent litters. 
C - Quantification of cell speed from technical replicates of 3 fam49bfl/fl, 5 fam49bfl/- and 4   
fam49B-/- embryo skins (respectively 419 cells, 540 cells, 569 cells), over 4h of movies. Embryos 
came from 2 independent litters. One-Way ANOVA with Dunn’s post-test was applied. *** p<0.001 
																																						FAM49B	functions	using	more	physiologically	relevant	models	 	 	
	
182 
	
Figure 6-9: FAM49B-deficient melanoblasts have altered shape and pseudopod dynamics 
A – Representative stills from a skin explant movie. tdTomato-positive melanoblasts from 
fam49bfl/fl, fam49bfl/- and fam49b-/- skins were imaged every 5 min. Yellow arrowhead represents 
burst of the plasma membrane. Scale bar = 25 µm. 
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B – Manual quantification of pseudopod number across 2 independent litters (3-4 mice/genotype 
with 2 technical replicates), representing >700 cells per genotype. Error bars represent S.E.M. 
C – Manual quantification of pseudopod length for each genotype. Scatter plot summarises data 
from 2 independent litters (3-4 mice/genotype with 2 technical replicate), representing >250 
pseudopods per condition. S.E.M is displayed and One-Way ANOVA with Dunn’s post-test was 
applied. n.s. p>0.05, *** p<0.001 (1 pixel = 0.6274978 µm). 
D – Preliminary quantification of pseudopod lifetime. Pseudopods were tracked from their initiation 
until their retraction or split. Whisker plot summarises quantification from 1 mouse per genotype (2 
technical replicate), representing 45 pseudopods. 10-90 percentile, mean (cross) and S.E.M are 
shown. One-Way ANOVA with Dunn’s post-test was applied. n.s. p>0.05, *** p<0.001 
_________________________________________________________________________ 
 
6.2.3 fam49b-knockdown affects embryonic haemocyte 
membrane protrusion and dynamics in D. melanogaster 
D. melanogaster (Dm) was used as an alternative model to study FAM49 in vitro and in 
vivo. Development of D. melanogaster follows three distinct stages referred to as larval, 
pupal and adult. Once hatched, the egg undergoes 3 larval instar stages, known as L1, L2, 
L3 before transiting to the pupal stage. This step allows the outgrowth and the 
development of the adult organs during a process called metamorphosis, resulting in an 
adult fly. In total, the life cycle lasts between 10-12 days and is dependent on the ambient 
temperature. During development, specific cell lineages will differentiate and colonise 
adult tissues. For example, embryonic haemocytes are the embryonic blood cells and 
originate from the procephalic and thoracic mesoderm (early and late development) before 
spreading across the embryo by using some pre-defined paths (Wood and Jacinto, 2007). 
In a healthy fly, blood cells are composed at 95% by plasmocytes (hereafter referred to as 
haemocytes). The remaining 5% is divided between crystal cells and lamellocytes. The 
latter is absent from a healthy fly and has only been found upon parasite infection of the 
larva. Haemocytes are the professional phagocytes and their function can be related to the 
mammalian macrophages. Indeed, they patrol across the developing embryos and later on 
in the adult fly in order to clear pathogens or apoptotic debris. As a consequence, they are 
crucial elements for the fly immune system (Wood and Jacinto, 2007). 
Because of their function of scanning the environment, embryonic plasmocytes have to be 
extremely motile and they have been used as a tool to study cell migration and 
actin/microtubule dynamics. Also they are easily accessible as they circulate within the 
hemolymph and can be isolated by simple dissection.  
Because of their motility capacity dependent on Rac1 activation (Paladi and Tepass, 2004; 
Stramer et al., 2005), we used D. melanogaster haemocytes as a tool to study the effect of 
FAM49 loss. Specific conditional knockdown of D. melanogaster fam49 gene was based 
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on the GAL4/UAS system and obtained from the Vienna Drosophila RNAi Centre. GAL4 
is a transcription factor and will be expressed accordingly to the promoter it has been 
placed under. Since the main effector sequence of GAL4 is the UAS, reporter gene or 
RNAi can be placed downstream of a UAS sequence and will be expressed in the GAL4-
positive population. Fly lines containing a UAS-Scramble (Ctr) or UAS-FAM49 RNAi 
oligos ( and #2) were crossed with Tub>GAL4 flies and recombinants were selected. 
Tubulin promoter drives a constitutive depletion of FAM49. Knockdown of fam49 gene 
from L3 stage larvae was evaluated by qRT-PCR and reported to the ribosomal-related 
protein Rpl32 as housekeeping transcript. Mutants #1 and #2 showed a 6-fold reduction in 
fam49 gene expression following RNAi targeting. (Figure 6-10 – A). Interestingly, mutant 
#2 stopped developing at the pupal stage and the mechanisms leading to this early lethality 
have not been further investigated. However, mutant #1 flies looked viable and fertile. 
Hemolymph from L3 larvae of control or mutants flies was isolated and plated on a glass 
coverslip for 20 min. Cells were fixed, stained for F-actin and analysed by confocal 
microscopy (Figure 6-10 – B). 
The first striking feature was the number of isolated cells from the fam49-knockdown 
larvae compared with control. On average, dissection of the same number of larvae 
resulted to 2.5 times more cells in the knockdown condition (Figure 6-10 – B). On glass, 
control cells appeared quite round with a strong cortical actin staining from which emerged 
few short filopodia. In contrast, FAM49-depleted cells widely spread a large 
lamellipodium, full of filopodia, although this phenotype tends to be subtler in mutant #2. 
Similarly to our previous work using other models, mutant cells are bigger (Figure 6-10 – 
C) and this difference was maintained during a time-course experiment (Figure 6-10 - D). 
The exact same phenotypes were also observed using a Tub-Gal4>UAS-LifeAct-GFP line 
(Figure 6-11). This increase of spreading was finally confirmed by live imaging of isolated 
haemocytes, plated on glass-bottom dish. DIC imaging allowed us some insight about 
protrusion dynamics. Movies and kymograph showed that control cells eventually do 
spread but with a much slower dynamism compared to the fam49-knockdown (Figure 6-12 
– A - B). At some point, both cell type reached a state where lamellipodium is at its 
maximal extension. However, FAM49-depleted cells have a more steady lamellipodium 
compared with the instability of the control cells.  
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Figure 6-10: fam49-knockdown haemocytes recapitulate mammalian phenotype 
A – Expression level of D. melanogaster fam49b gene in control or knockdown L3 larvae, using 
Tubulin promoter as driver (TubG4). Quantification represents qRT-PCR data from 3 independent 
experiments. Mean ± S.E.M is displayed. 
B-C – Immunofluorescence of isolated haemocytes extracted from three L3 larvae of each 
condition. Cells were plated on glass coverslip, fixed after 20 min and stained for F-actin (magenta) 
and nuclei (blue). Bottom row is a magnified view from the dotted square area. Scale bar = 15 µm. 
Manual quantification of the cell area for each condition is shown as a scatter plot with mean ± 
S.E.M. One-way ANOVA with Dunn’s post-test was performed. *** p<0.001. 
D – Immunofluorescences from a timecourse experiment. Cells were plated on glass coverslip, 
fixed at each timepoint and stained for F-actin (magenta) and nuclei (blue). Scale bar = 15 µm 
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Figure 6-11: fam49-knockdown haemocytes extend larger actin-based protrusions 
Still pictures of haemocytes expressing UAS-LifeAct-GFP and UAS-RNAi, under the control of 
TubGal4 (TubG4) promoter were plated on glass, left spreading for 20 min and live-imaged by 
confocal microscopy. Scale bar = 15 µm 
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Figure 6-12: Effect of fam49b-knockdown on haemocyte spreading 
A - Stills extracted from a DIC movie. Control or knockdown haemocytes were plated on a glass-
bottom dish and imaged while they were adhering/spreading. Cell edges were highlighted by a 
black dotted line. Scale bar = 10 µm. 
B – Kymograph analysis of spreading haemocytes. Cell edges were highlighted by a white dotted 
line. Time is shown on the x-axis and space on the y-axis Scale bar = 5 µm 
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As mentioned in the introductory paragraph, haemocytes are the major immune cells in D. 
melanogaster and can be activated upon a wide range of stimuli (infection, inflammation). 
In such a situation, naïve haemocytes get activated and undergo a profound re-arrangement 
of their morphology that could also explain the phenotype we observed. This is even more 
relevant because FAM49 is depleted across the whole body and might lead to 
inflammation of some tissues followed by the recruitment and activation of the 
haemocytes. 
To rule out this possibility and ascertain whether loss of FAM49 was directly responsible 
for this phenotype, we performed haemocyte-specific fam49-knockdown by using the 
hemolectin-driven GAL4 line (hml-G4). Hemolectin is only expressed in plasmatocytes 
and crystal cells and is totally absent from lamellocytes after wasp infection or L. boulardi 
parasitation. It is expressed throughout the larval stages until the end of the puparisation, 
before strongly decreasing in the adult fly (Goto et al., 2003). In parallel of the RNAi, GFP 
was also expressed as a reporter. Isolated cells displayed a similar phenotype as previously 
described, so we conclude that cell enlargement and filopodia formation was specific to the 
loss of FAM49 and independent from external factors (Figure 6-13).  
 
Given the striking phenotype in 2D, we hypothesised that cell shape will also be affected in 
vivo. Short movies from the hml-G4>UAS-RNAi/GFP L3 larvae were acquired using ligh 
sheet imaging (LSFM) (Figure 6-14). This technique allows a less phototoxic way of 
imaging living organisms by illumination of a thin slice of the sample. Unfortunately, only 
one larva of each condition was imaged during the trial-time of this microscope at the 
Beatson but it gave us some exciting preliminary videos that have to be further confirmed 
by more analysis and bigger sampling. Control haemocytes displayed a very smooth-edged 
phenotype with only few rare and not very active protrusions (yellow arrowheads). 
However, cells lacking FAM49 protrude actively and have a total different morphology. 
Cell body is enriched in vesicle-like structures and generally speaking, cells looked in an 
active state. Further work and collaboration will aim to confirm this phenotype and more 
careful analysis of cell behaviour and protrusion features is required. 
.  
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Figure 6-13: Specific depletion of fam49b in the haemocyte lineage leads to increase 
lamellipodia extension and filopodia 
Immunofluorescence of isolated haemocytes extracted from three L3 larvae of each condition. 
Cells were plated on glass coverslip, fixed after 20 min and stained for F-actin (magenta) and 
nuclei (blue). Hml promoter drives the expression of GFP (green) in haemocytes containing the 
control or FAM49 RNAi. Bottom row shows magnified views from the dotted square area. Scale bar 
= 15 µm. 
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Figure 6-14: In vivo LSFM imaging reveals abnormality in pseudopods morphology of L3 
larva haemocytes specifically knockdown for fam49  
hmlGal4>UAS-GFP/RNAi L3 larvae were immobilised in an agarose plug and imaged every 20 
seconds using light sheet microscopy. GFP-expressing haemocytes were imaged from one of the 
epidermal-muscular pocket located on the lateral side of the larva. Yellow arrowheads highlight 
active protrusions. Scale bar = 20 µm 
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6.3 Discussion 
In this chapter, we tried to address the role of FAM49B using more complex physiological 
models, which have been previously used to study Rac1.  
The MDCK organoid model turned out to be a great tool and gave us new insights about 
the potential role of FAM49B during cyst formation. Together, we hypothesised that 
FAM49B might play a role in the establishment of Rac1 gradient across the cyst. Rac1 has 
been previously shown to be required for proper organisation of the cyst architecture 
(Mack et al., 2012; O'Brien et al., 2001; Yagi et al., 2012a; Yagi et al., 2012b). 
Establishment of Rac1 gradient seems to be a fundamental step during cystogenesis and 
Mack et al (Mack et al., 2012) proposed an elegant model of differential recruitment of the 
Rac-GEF Tiam1 by distinct proteins along the cyst. According to their model, low Rac1 
activity at the lumen is dependent on a Par3-mediated inhibition of Tiam1 whereas this 
GEF gets recruited and activated by β2-syntrophin at the basolateral side. Here, we 
propose that FAM49B might also be involved in the differential Rac1 activity and as a 
consequence, allows to restrict the spatial activation of the WRC at the apical membrane. 
Indeed, WAVE2 switches from a basolateral to an apical localisation upon FAM49B loss 
and correlates with a multilumen phenotype. This was rescued by chemical inhibition of 
Rac1 
In this model, it would be interesting to measure Rac1 activity using FLIM/FRET imaging 
and we hypothesise that Rac1 activity would be much higher at the apical domain in 
fam49b-knockdown cysts. This model also implies FAM49B to be more enriched at the 
apical domain, or at least to have a differential activity between apical and basolateral 
membrane. This can be linked to the myristoylation/palmitoylation state of the protein. 
Genetic tools, such as membrane targeting using a dimeriser or optogenetic systems based 
on light-induced clusterisation (Nguyen et al., 2016) could allow us to affect localisation of 
one protein to one side of the cyst or the other. For example, techniques using FKBP-FRB 
and rapamycin (Banaszynski et al., 2005; Inobe and Nukina, 2016) would be useful to ask 
whether the mislocalisation of FAM49/WRC/Rac1 is sufficient to disrupt cell polarity. We 
could also directly address whether Rac1 accumulation at the basolateral domain would 
restore Rac1 gradient across the cyst following FAM49B loss. 
The fundamental question here would be to understand the initial defect leading to this 
multilumen phenotype. De novo apical lumen formation has been investigated in different 
systems and basically two models have been proposed. The cavitation model results from 
apoptotic event occurring in the centre of a mass of cell and was shown to take place in 
mammary and salivary tissues (Aranda et al., 2006). However, in most of the tissues and 
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particularly in the MDCK-derived cysts grown in Matrigel, apoptosis does not seem to be 
required for apical lumen formation (Martin-Belmonte et al., 2008). Instead, the hollowing 
model establishes a coordination between cell division and trafficking events that lead to 
the formation of the apical membrane initiation site (AMIS) (Bryant et al., 2010). This is a 
key step that will drive and organise the primary polarity of the growing cyst. 
Relocalisation of apical protein is dependent on Rab11-mediated endocytosis and specific 
microtubule-dependent delivery (Casanova et al., 1999). This process has also been shown 
to be coupled to the WRC and Rac1 at the early stages of the cyst formation (Mangan et 
al., 2016). WRC-dependent actin polymerisation is crucial for proper localisation of 
Cingulin, a tight-junction protein, to the primary apical lumen during mid-body formation. 
This requirement towards the WRC for the mid-body formation is interesting as multi-
lumen phenotype can also arise from defect in mid-body position (Lujan et al., 2016). 
 
In this model, we can hypothesise that loss of WRC restriction during cytokinesis upon 
FAMB-knockout might abnormally orientate the midbody. This mispositioning might 
enhance the defect in the microtubule-spindle orientation even further. This could be easily 
addressed by staining 48h-cultured cysts and record the localisation of early midbody 
markers such as Cep55 and MKLP1/KIF23. 
Mangan et al (Mangan et al., 2016) also showed that Rac1 inhibition during the 1st cell 
division results in a multilumen phenotype. This observation combined with our and others 
data would suggest that the actual level of Rac1 activity is not important for lumen 
formation. However, the differential activity in Rac1 signalling between apical and 
basolateral domain is. Indeed, having too much Rac1 at the apical side or not enough at the 
basolateral side would compromise the formation of the gradient and leads to defect in 
endocytosis-delivery to the AMIS. Based on Mangan’s work, it would be interesting to 
perform a timecourse experiment at earlier timepoint in order to see whether loss of 
FAM49B affects trafficking and AMIS formation. Preliminary results showed that after 
48h, cysts already presented apical accumulation of WAVE2. This points toward an early 
effect of FAM49B on WAVE2 localisation. Interestingly, we noticed that control cysts 
with a multi lumen phenotype at 48h (not shown) or 5 days (Figure 6-6), don’t show a 
defect in WAVE2 localisation. This observation suggests that apical targeting of WAVE2 
is not enough to drive the multilumen phenotype. Finally, Rab11 staining at early 
timepoint (12h, 24h, 48h) should also give us more details about the potential endosomal 
defects in knockdown cysts. 
As a follow up for this part, in vivo FAM49B study in epithelial tissues has already started. 
Floxed FAM49B mouse was crossed with the Pdx1-CRE mouse. Pdx1 gene is expressed 
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by early pancreatic progenitors and is then considered as a multipotent pancreatic stem 
cells marker (Offield et al., 1996). Some leakiness of Pdx1 promoter has also been reported 
in the gastro-intestinal tract and some parts of the central nervous system (Schonhoff et al., 
2004; Song et al., 2010). Laura’s lab has a strong background in the pancreatic model, 
which is the reason we chose this system. The exocrine part of the pancreas is formed by 
pancreatic ducts ending as a secretory gland formed by acinar cell (see chapter 8). These 
structures are covered by a columnar epithelium allowing the secretion of digestive 
enzymes. As any epithelium, establishment of cell polarity is essential for pancreatic 
functions and would allow us to confirm the data obtained with the MDCK cysts, using an 
in vivo model. Pancreata from FAM49Bfl/fl or FAM49B-/- mice were analysed by western 
blot and showed a strong reduction in FAM49B signal (not shown). Preliminary data 
showed that Pdx1-CRE fam49b-null mice are viable and don’t have any growth defect 
compared to their wild-type littermates. Haematoxylin/Eosin staining of pancreas from 15-
weeks old mice does not present any obvious morphology and organisational defect upon 
FAM49B loss. There are two possible explanations for this result. First, FAM49B is 
dispensable for pancreatic development from E8.5 onwards. Then, it has been reported that 
the Cre recombinase can show mosaic expression across the targeted organs (Gannon et 
al., 2000; Gu et al., 2002a). It could be possible that only a small proportion of ductal 
epithelial cells get recombined, not leading to enough depletion to see a phenotype. 
Unfortunately, FAM49B antibody has not been optimised for IHC on tissue yet. However, 
it showed a weak staining in CrispR control CHL1 embedded in an agarose-plug, which 
was lost in fam49b-CrispR knockout cells.  
Finally, studying FAM49B during PDAC progression would also be a project to consider. 
Specific pancreatic depletion of Rac1 has been shown to reduce/stop pre-malignant lesion 
(acino-ductal metaplasia, PanIN) and cancer progression in both a KRasG12D slow 
pancreatic model or a KRasG12D and p53R172H aggressive model. (Heid et al., 2011). This, 
combined to the fact that only one mouse showed advanced PanIN lesions, suggest an 
early and fundamental function of Rac1 in PDAC development. In either model, we would 
hypothesise that loss of FAM49B would lead to higher Rac1 activity, leading to increase 
tumour burden and invasion. Recently, major findings obtained from genomic analysis of 
human pancreatic tumours characterised four main subclasses of cancer correlating with 
histopathological features (Squamous, ADEX, Immunogenic, Pancreatic progenitor). 
(Bailey et al., 2016). Data from over 450 human samples reveal than the 4 subtypes 
express relatively high amount of FAM49B. Moreover, FAM49B expression correlates 
with survival: Indeed, high FAM49B expression leads to a poor outcome (p-value=0.016) 
in this cohort of patients (internal communication). However, it isn’t yet possible to 
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interpret this in the context of Rac1 in PDAC. Further in vivo studies would be required to 
find out the specific roles of FAM49B and the potential crosstalk FAM49B/Rac1 in this 
context. 
 
Ex vivo skin explant provided a contrasting model to epithelial organisation as 
melanoblasts migrate individually in the skin. This model allowed us to directly address 
FAM49B functions in individually migrating cells during development. Specific knockout 
in the melanoblast lineage and imaging at E14.5 suggests a function of FAM49B in 
migration, although depletion of the protein led to less migration, which was quite 
unexpected based on our in vitro data. A quick and easy way to detect melanoblast 
migration defect is to look at the colour coat of the mouse after weaning. Indeed, if a 
white-belly phenotype appears, it would suggest a migration defect at the embryonic stage. 
This has already been shown after Rac1 or Cdc42 depletion in Black6 background mice (Li 
et al., 2011; Woodham et al., 2017). Despite the reduced migration observed in this assay, 
we have not noticed any white-belly phenotype, suggesting that FAM49B-null 
melanoblasts are still able to complete their journey to the ventral part of the embryo. This 
means these cells might overcome the loss of FAM49B by alternative pathways. It would 
be informative to picture the melanoblast journey at different stages of the embryo 
development. An easy way to do so would be to use the DCT::LacZ reporter combined 
with our Tyr-Cre::FAM49Bfl/fl. Briefly, this gene allows the expression of the β-
galactosidase, an enzyme that will only be expressed in DCT-positive cells (another 
marker of the melanoblast lineage). Incubation with X-Gal, the substrate of the β-
galactosidase, will result in its conversion into a blue metabolite that can be visualised. 
This technique should allow us to spot any abnormality during melanoblast migration from 
the back up to the belly, and might explain why no white belly phenotype is observed 
despite a slower migration. Meanwhile, proliferation of these cells will be assessed in vivo 
by BrdU injection and staining. Indeed, migration defect could be compensated by an 
increase of proliferation.  
Analysis of our skin explant movies revealed that pseudopod dynamics was also affected 
in FAM49B-null melanoblasts. Pseudopods were shorter and short-lived compared to 
control. As a comparison, migrating melanoblasts navigate using short and long 
protrusions and Rac1 was shown to control the formation and the frequency of the long 
protrusions that are the main drivers for the cell persistence and speed. (Li et al., 2011). 
Further analysis should allow us to determine whether FAM49B and Rac1 are playing a 
dual function during this process.  
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Moreover, we frequently observed bursts of td-Tomato signal along the pseudopod. This 
may reflect uncontrolled Rac1 activity resulting in membrane extension. In order to test 
this hypothesis, our Tyr-Cre::FAM49Bfl/fl, LSL-tdTomato mouse will be crossed with the 
Raichu Rac FRET reporter knock-in mouse (Johnsson et al., 2014). Tyrosinase-positive 
cells will express recombined FAM49B gene along with the Rac-FRET reporter and skin 
explant would be performed the same way as previously described but using a FLIM-
FRET microscope. With this setup, we should find out more about the potential crosstalk 
between FAM49B and Rac1 during melanoblast migration. FRET efficiency from 
migrating melanoblasts could be measured as well as Rac1 activity during membrane 
bursts.  
 
Similarly to our mammalian work, primary haemocytes isolated from fam49-knockdown 
Drosophilia (whole body or haemocyte-specific) extend a broader lamellipodium 
compared with control cells. It also contained lot of filopodia-like structure. This would 
tend to point toward a link between FAM49 and Rac1. Overexpression of Rac1 has also 
been shown to release the sessile population of haemocytes from the epidermis resulting in 
a 3-3.5-fold increase of circulating cells (Williams et al., 2006; Zettervall et al., 2004). We 
observed a similar hyper-recruitment to the hemolymph in our fam49-knockdown larvae. 
This effect had previously been shown to require the Drosophila Jun-kinase-homologue, 
called Bsk. Together they regulate lamellipodium extension and focal adhesion turnover, 
leading to increase mobility (Williams et al., 2006). However, signals leading to their 
release into the circulation have not been investigated. Drosophila would be a useful 
system to study genetic interaction between FAM49 and Rac1. Dominant negative Rac1 
mutant showed important developmental defects leading to lethality (Harden et al., 1995). 
We could overcome this by driving dominant Rac1 expression into the haemocytes and 
look at potential rescue of the phenotype. This observation would suggest that Rac1 is 
important for FAM49 functions. 
Imaging haemocyte morphology and migration in vivo would also be a project to follow 
up. Our results are too preliminary to conclude anything but more sophisticated models 
could be used. Haemocytes are becoming a powerful system for migration study, 
especially in vivo. Because of their immune functions, different groups have induced 
haemocyte recruitment after epithelium wounding using UV laser ablation. Haemocytes 
switch from a random to a directed migration after wounding (Moreira et al., 2011) and 
this chemotaxis seem to be dependent on PI3K (Wood et al., 2006). PI3K is potent 
activator of Rho family GTPase and a positive feedback loop exists downstream of the 
GTPase (Yang et al., 2012). Our hypothesis is that haemocyte-specific fam49-knockdown 
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would reinforce and unbalance this feedback loop resulting in Rac1 activity mis-regulation 
and defect in directed migration. 
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7 Conclusions, working model and future 
directions 
The aim of my thesis was to work out the cellular role of a previously un-studied protein 
(FAM49B), which we now believe, is the first discovered negative regulator of cell 
protrusion. We carried out this analysis using a range of biological systems combining 
biochemistry, in vitro, in cellulo and in vivo data. Our current hypothesis suggests that 
FAM49B directly competes with active Rac1 for binding to the Scar/WAVE complex. 
This competition results in spatial regulation of Scar/WAVE activity in restricted and 
highly polarised patches, which are required for F-actin polymerisation and membrane 
protrusion. The direct interaction between active Rac1 and FAM49B makes this protein 
totally distinct from other negative regulators of actin branching such as Arpin, which acts 
downstream of the Scar/WAVE complex and does not interact with Rac1, although its 
functions are Rac1-dependent (Dang et al., 2013). In the absence of FAM49B, the 
Scar/WAVE complex cannot be constrained anymore and is free to diffuse around the cell 
membrane, which causes loss of pseudopod formation. We also show that FAM49B was 
required for different biological processes linked to actin dynamics and cell motility. 
Importantly, FAM49B is dispensable, although cells tend to dislike excessive amount of 
the protein, suggesting that regulation of FAM49B expression is tightly regulated to avoid 
any excess of the protein that could be toxic for the cell. Based on our mathematical model, 
the amount of FAM49B required for restricting the activator has to be just above the 
activator level at its edge. If we lose this higher level of inhibitor, the activator will enter 
into a positive feedback loop and expand across the entire cell. Biological data and 
modelling of FAM49B function led to the working model described in Figure 7-1. 
 
We are currently prioritising 3 major projects that should give us a better understanding of 
FAM49 proteins: 1) FAM49B activation and regulation 
   2) Elucidating FAM49B structure 
   3) What are the other biological processes regulated by FAM49B? 
 
As previously mentioned, the N-terminus part of FAM49B seems to be involved the 
protein regulation. This flexible part of the protein starts with a short alpha helix and then 
is followed by a predicted unfolded region. Pull-downs with Rac1 have only been 
successful using a construct truncated for the first ~35 amino acids. Anh Le, a PhD student 
in the lab has also confirmed the importance of these residues by using the FAM49B’s 
DUF1394 domain with or without the N-terminus part. He has nicely shown that the alpha 
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helix and the unfolded region have an inhibitory effect on active Rac1 binding. This region 
contains the myristoylated residue and one putative S-acylated cysteine. Together, our 
hypothesis is that the protein is auto-inhibited by the N-terminus part, which folds over the 
RBD of the protein. Posttranslational modifications or myristoyl-switch would cause the 
following: Protein targeting to the membrane with concomitant unfolding of the N-
terminal region, opening of the protein structure in order to expose the internal RBD, and 
finally, binding of the protein to Rac1. The signalling pathways that lead to FAM49B 
activation still remain elusive, although we may hypothesise that it is dependent on the 
regulation of the N-myristoyl-transferases and protein acyltransfereases. In order to get 
more information relative to the activation state and whether the protein switch from a 
cytosolic to a membrane localisation, we are developing our recombinant FAM49B protein 
that is being used for antibody production and purification. We hope to get a specific 
antibody against the endogenous protein that we could use for immunofluorescence. To do 
so, soluble protein and inclusion body were obtained and injected into rabbits. We are now 
about to start the purification of the total IgG and anti-FAM49B antibody using affinity 
purification and glycine elution. 
 
The FAM49B structure presented throughout this thesis has been generated using i-
TASSER. This tool generates tertiary structure prediction based on the primary structure of 
the protein. It uses sequence homology between the query protein and the sequences of 
structural templates from the protein database, and then reassembles each fragment to 
obtain a 3D structure prediction. Despite different conditions and screening tray set up, 
attempts to crystallise the protein have failed. We have now started a collaboration with 
Prof. Matthias Geyer in order to test more buffer conditions and also increase our yield of 
protein. The medium-term plan for this part would be to obtain a crystal good enough for 
X-ray diffraction and solve the structure of FAM49B. Solving the structure of the co-
crystal FAM49B-Rac1 would be very informative and would allow us to design 
compounds, which could stabilise/destabilise this complex. A Kd of 20 µM is at the edge 
of co-purification so we would rather try to purify Rac1Q61L alone and set up crystal trays 
with stoichiometric amounts of either FAM49B or RBD. 
 
This work on FAM49B is not restricted to its role on cell migration. Proteomics analysis of 
FAM49B gave a broader picture of potential new interacting proteins. Briefly, triplicate 
samples of COS-7 cells expressing GFP, GFP-FAM49B, FAM49B-GFP and GFP-RBD 
were used for a GFP-Trap pulldown and sent for LC-MS/MS analysis. Selected hits are 
displayed in appendix 6 based on the Label-free quantification (LFQ intensity). Data were 
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processed and the relative abundance of each protein compared with the GFP sample were 
analysed in order to get statistical value. Unlike the full-length protein that only shows a 
robust and consistent interaction with few proteins (10 proteins for FAM49B-GFP and 20 
proteins for GFP-FAM49B), RBD-GFP interacts with over than 200 candidates. This 
massive difference in number of interacting proteins between the full length and the 
truncated construct is interesting and currently, 2 options are foreseen. Although unlikely, 
the first hypothesis would be that the RBD is not properly folded and forms aggregates, 
which interact with diverse proteins. However, cells respond to protein misfolding by 
recruitment of chaperones and none have been found in this screen. This implied that we 
can be fairly confident about the specificity of interaction. The second option would be that 
this construct represents an active form of FAM49B that binds to more effectors than the 
auto inhibited full-length protein. Once again, it seems that cells cannot handle very well 
this construct as we found a lot of subunits of the 26S proteasome, suggesting that cell 
tried to get rid of the excess protein. Among other interesting hits, FAM49A interacted 
with the 3 constructs, suggesting that its minimum-binding domain lies within the Rac-
binding region and can form a heterodimer. Endogenous Rac protein (the MS was unable 
to differentiate between Rac isoforms) was statistically enriched in GFP-RBD and GFP-
FAM49B, although, Cdc42 and RhoA have also been found as a significant interactor of 
GFP-RBD and would tend to contradict our GST-pulldown data. However, internal 
communication from Prof. Ivan Dikic shed a light on this potential interaction between 
FAM49 and RhoGTPases. Indeed his group found that FAM49A directly interacts with 
FAM49B and Cdc42. So Cdc42 might just be an indirect interactor of FAM49B, mediated 
by FAM49A. At the moment, the relation to RhoA is still being investigated. Other Ras-
related GTPases such as Rab, Ral were also found and could might interesting candidates 
to look at. Of particular interest was Rab5C that has been linked to Rac1-dependent cell 
motility and was specifically found in GFP-RBD (Chen et al., 2014b). Interesting 
candidates will be individually confirmed by pulldown and immunofluorescence and 
should allow us to find out more about the biological functions of FAM49B. 
 
To conclude, based on the mechanism of activation and the description of the functions of 
FAM49B during cell migration, we proposed to name this new protein CYRI-B. This 
stands for Cyfip-related Rac1-interacting protein B. 
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Figure 7-1: Working model of FAM49B functions during cell protrusion 
1 – Following cell stimulation (growth factor, integrin signalling,..), GDP-Rac1 gets released from 
the GDI and activated by GEF resulting to the nucleotide exchange. 
2 – GTP-Rac1 interacts with diverse effectors, for example, Scar/WAVE complex. Activation of the 
Scar/WAVE complex leads to the expulsion of the VCA tail from the core of the complex and 
stimulation of Arp2/3-dependent actin polymerisation, resulting in fine to actin-based protrusions. 
Arpin, Gadkin and Pick1 have previously been described as negative regulators of protrusion 
formation and actin branching, directly acting at the level of the Arp2/3 complex. 
3 – Cytosolic autonihibitted FAM49B gets recruited to the plasma membrane following direct 
myristoylation or myristoyl switch. This weak membrane binding is strengthened by additional 
palmitoylation mediated by zDHHCs (active at the membrane or endomembrane followed by 
protein trafficking to the membrane). Protein modifications result to release the auto-inhibition from 
the N/C terminus of FAM49B and expose the RBD. Binding to active Rac1 blocks the Scar/WAVE 
complex activation. Reversibility of the palmitoylation (by APT or ABHD depalmitoylases) might 
regulate stable association to the plasma membrane and Rac1 interaction. 
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8 The bundling protein Fascin 1 increases pre-
malignant lesions during pancreatic cancer 
progression 
8.1 Introduction 
Located in the upper left side of the abdomen, the pancreas is a glandular organ that has a 
dual function during digestion. The exocrine part is formed by acinar cells, which are 
specialised in the secretion of important digestive enzymes required for proper nutrient 
absorption by the small intestine. Pancreatic tubules directly connecting each acinus merge 
into a main pancreatic duct that connects the pancreas to the duodenum. The endocrine part 
is formed by the Islets of Langerhans and that are sparsely distributed across the exocrine 
pancreas. Islets are composed of α, β, δ, and γ cells, which are specialised in hormone 
secretion and work together using endocrine, paracrine and autocrine loops to tightly 
control the glucose level in the blood stream. Briefly, α cells secrete glucagon, responsible 
for conversion of glycogen into glucose and its discharge by the liver into the blood 
stream. On the other side, β cells are insulin-producing cells that act to decrease glucose by 
stimulating glycogenesis and lipogenesis. These two cell types are both negatively 
regulated by somastotastin, a peptide secreted by δ cells. Finally, γ cells are predominantly 
restricted to the head of the pancreas and release pancreatic polypeptides, stimulating 
gastric secretion and also regulating α and β cells. Together endocrine and exocrine 
pancreas functions assure coordination between food intake and energy storage/release 
during fasting periods. 
 
Pancreatic cancer is the 11th most frequent cancer in the UK, although it represents the 5th 
most common cause of cancer-related death. Familial predisposition to develop pancreatic 
cancer only accounts for 2-10% (Hruban et al., 2010) whereas external factors and 
lifestyle, such as smoking and obesity, have been correlated with 37% of the cases (Cancer 
Research UK, http://www.cancerresearchuk.org/health-professional/cancer-
statistics/statistics-by-cancer-type/pancreatic-cancer, August 2017). However, only 1% of 
patients diagnosed with a pancreatic cancer will survive beyond 10 years, making 
pancreatic cancer the cancer with the poorest survival rate. Even more alarming is that 
survival has remained stable over the last 40 years and reveals a lack of understanding 
about the molecular mechanisms. These poor statistics can be explained by the late 
diagnosis of pancreatic cancer. Indeed, 8 out of 10 patients in the UK were diagnosed with 
a late stage in 2014, resulting in more challenging surgery and a more aggressive line of 
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treatment. (Cancer Research UK, http://www.cancerresearchuk.org/health-
professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer, August 2017). 
Frequently, cancer has already spread across the body before the onset of clinical 
symptoms. These observations raise the question about early detection during pancreatic 
cancer and push researchers and clinicians to identify key proteins initiating the first stage 
of this cancer. 
Histopathological features reveal a progressive evolution of pancreatic cancer, starting 
from pancreatic lesions (pancreatic intraepithelial neoplasia - PanIN1-3) to a fully 
developed cancer (hereafter referred to as pancreatic ductal adenocarcinoma – PDAC) 
(Yachida and Iacobuzio-Donahue, 2013). PDAC represents the most frequent type of 
pancreatic cancer, although other sub-types exist but are not of our interest. As mentioned 
by its name, it develops from ductal cells. Briefly, PanIN1 are subdivided into 1A (flat 
epithelial lesion characterised by mucin accumulation above the nucleus) and 1B (same as 
1A but with papillary or pseudostratified structures). PanIN2 can be flat or papillary and 
show a loss of nuclear polarity correlating with morphological defects of the nucleus. 
Finally, PanIN3 show several cytological defects, with abnormal mitoses, nuclear 
irregularity, budding of cell clusters into the lumen and necrosis and is the last 
characterised lesion before the PDAC (John Hopkins university 
http://pathology.jhu.edu/pancreas/professionals/DuctLesions.php, August 2017). Other 
lesions, not directly related to ductal cells have been frequently noticed in patients and 
mouse models. To cite few, pancreatic cysts are commonly observed in patients with no 
pancreatic history (13.5%) and are thought to be precursor lesions. Classification of cyst 
types is out of the focus and we will just refer cystic structures as cysts, regardless to their 
origin or localisation. Finally, acinar to ductal metaplasia (ADM) corresponds to a 
metaplastic switch leading to the formation of ductal structures within acini. These lesions 
have been linked to an increased risk of developing PDAC in both mouse models and 
human (Lowenfels et al., 1993; Wagner et al., 1998). Origins of ADM are not well 
understood but matrix metalloproteinase-7 has been shown to regulate ADM formation, 
although other factors might be involved (Crawford et al., 2002). 
PanIN formation correlates with an accumulation of various genetic alterations such as 
increase in gene copy number or gene expression, point mutation, epigenetic abnormality, 
etc. (Hansel et al., 2003). Sequencing effort has allowed identification of key driver genes 
and revealed mutation of K-Ras in 95% of cases (Almoguera et al., 1988). In particular, 
one hot spot mutation leads to the substitution of Gly12 to an Asp although other missense 
mutations have also been reported (Kalthoff et al., 1993). K-Ras belongs to the Ras-
GTPase family and is involved in intracellular signalling. This mutation affects the 
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intrinsic GTPase activity, resulting in a higher proportion of molecules in the GTP-bound 
form. This dominant active form directly signals to downstream effectors such as the 
MAPK pathway, PI3K, mTOR and AKT which together, promote cell survival, 
proliferation and invasion (di Magliano and Logsdon, 2013). K-Ras has also been found 
highly mutated in early lesions, so it is thought to be the activator event (Yanagisawa et al., 
1993). Based on the two-hits hypothesis proposed by Knudson, cancer initiation requires 
multiple hits (Knudson, 1971). In agreement with this model, K-Ras mutation is followed 
in 50-75% of cases by the alteration of the TP53 gene (encoding p53), mainly through a 
missense mutation at the hot spot Arg172 (Olivier et al., 2002; Redston et al., 1994). The 
fact that cancer cells preferentially mutate TP53 reflects a potential growth advantage 
compared to the deletion of the gene. p53 is the master regulator of cell cycle by 
controlling the G1-S or-G2-M transition. Upon DNA damage, TP53 lifetime increases and 
it accumulates in the nucleus where it stimulates transcription of key genes involved in cell 
arrest and apoptosis (Lakin and Jackson, 1999).  
This brief introduction about the main genetic features occurring during pancreatic cancer 
is crucial to understand the mouse models that have been created to study PDAC. The 
different models have in common to mimic the evolution of the human disease, in terms of 
timing and histopathology. PDAC models differ about targeted genes and promoter used 
upstream of the CRE-recombinase (Guerra and Barbacid, 2013). The most widely used 
model (KPC model) is based on the concomitant expression of the two main driver 
mutations, K-RasG12D and p53R172H under the control of a Pdx1-CRE driver (Hingorani et 
al., 2005; Morton et al., 2010). This model reflects the human disease as mutation of TP53 
highly correlates with distant lymph node metastasis in human samples based, whereas 
metastasis-free lymph nodes had weaker p53 staining (Morton et al., 2010). TP53 status 
also correlates with ability to metastasise and mutated TP53 drives more aggressive cancer 
compared to mice harbouring the null allele (Lang et al., 2004; Olive et al., 2004). The 
KPC mouse model develops PanIN and PDAC and is highly metastatic with a median 
survival of 5 months (Hingorani et al., 2005). 
 
For this project, we aimed to look at early pancreatic lesions so we used a slower version 
of this model by using Pdx1-CRE::K-RasG12D mice (KC model). These mice form fully 
penetrant PanIN lesions, developing into a long latency PDAC that will lead to the 
sacrifice of the mouse within 12-16 months (Hingorani et al., 2003). This mouse model 
was used to look at the effect of Fascin overexpression during pancreatic cancer 
progression. Fascin is one of the most well known actin binding proteins, involved in actin 
filament bundling and predominantly localised in filopodia, In mammals, three isoforms 
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have been described with different expression profiles. Unlike Fascin 2 and 3 that localise 
in the retina and testis respectively, Fascin 1 is ubiquitously expressed in a wide variety of 
tissues and will be referred to as Fascin throughout this chapter. Fascin is a globular 
protein formed by four β-trefoil subdomains (F1-4), organised in 2 main lobes (Lobe 1 = 
F1-F2 and Lobe 2 = F3-F4) (Sedeh et al., 2010). Its actin binding function comes from 2 
actin-binding sites (Kabsch et al., 1990) that have been biochemically characterised using 
alanine-scanning mutagenesis. ABS1 extend between the N and C-terminus of the protein 
(F1 and F4) whereas ABS2 has been localised opposite to ABS1 (F1 and F2) (Jansen et al., 
2011; Ono et al., 1997; Yang et al., 2013). Fascin regulation is based on the activity of 
Protein Kinase C (PKC) that specifically phosphorylates Ser39. This residue belongs to the 
ABS1 and the current dogma suggests that Ser39 phosphorylation impedes filament 
binding and therefore inhibits Fascin activity (Ono et al., 1997). Independently of its 
function as an actin-binding protein, Fascin also binds to microtubules (MT) and regulates 
MT dynamics under specific conditions (nocodazole washout) (Villari et al., 2015). In 
vitro and in cellulo experiments suggest a MT-binding site within the ABS2 and regulated 
by phosphorylation of a Ser274 on F2.  
Disruption of the Fascin gene is viable and mice only show a slight abnormality in brain 
development and angiogenesis, which is not fatal. Moreover, the mendelian ratio at birth is 
respected, although early lethality was frequently observed in homozygote mice within the 
48h post birth (Ma et al., 2013b; Yamakita et al., 2009). Moreover, Fascin-knockout MEFs 
have reduced filopodia number and are shorter-lived compared to wild-type cells 
(Yamakita et al., 2009). Previously, we discussed about the role of filopodia during 
invasion and migration (Jacquemet et al., 2015), so Fascin is a good candidate to look at 
during cell migration and invasion. During melanoblast migration, Tyr-CRE::fscn-/- mice 
showed a defect in coat pigmentation, characterised by a white belly phenotype and pale 
paws and tails (Ma et al., 2013a). This was a direct consequence of slower melanoblast 
migration and a defect in pseudopod formation during embryogenesis. Also, Fascin-null 
melanoma cells are delayed in their cell cycle (G1 blockage) (Ma et al., 2013a). Finally, a 
large amount of literature suggests Fascin as a pro-tumorigenic factor in breast cancer  
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Figure 8-1: Introduction to Fascin, an actin-bundling protein 
A – PyMol representation of human Fascin structure (PDB 3P53) (Jansen et al., 2011). Actin-
Binding site 1 and 2 (ABS1 and ABS2) are highlighted. 
B – Schematic representation of Fascin regulation. Fascin is composed of 4 domains (F1-4) 
organised in a globular shape. F-actin binding is mediated via at least 2 actin-binding sites (green 
stars) located between F1-F2 and F1-F4. Fascin forms 7nm-spaced actin bundles and organises 
filopodia formation. Under specific integrin activation/environmental cues, Protein Kinase C (PKC) 
phosphorylates Ser39 within the ABS1 and abrogates actin binding. Phosphatase(s) involved in the 
activation of the protein are unknown. 
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 (Barnawi et al., 2016; Xing et al., 2011) and pancreatic cancer (Li et al., 2014). Using a 
KPC mouse model, Li and co-workers made a major step forward to understand the 
involvement of Fascin during PDAC evolution. Specific depletion of Fascin in acinar cells 
significantly improves survival, reduces tumour burden and strongly inhibits both local and 
distant metastasis. Finally, ChIP experiments, Western blot and RNA expression data 
showed a Slug-dependent regulation of Fascin. 
However, loss of Fascin does not affect PanIN formation in a KC model. Both wild-type 
and Fascin-KO mice developed PanIN1 at 4 months (Li et al., 2014). We decided to 
specifically address the effect of Fascin overexpression on early lesion formation using a 
KC model and forcing its expression. Indeed, Fascin expression has been shown to 
correlate with survival and can be considered as a prognostic marker (Li et al., 2014).  
Based on these data, our main hypothesis here is that forcing Fascin expression should 
increase tumour burden at early timepoints. 
8.2 Results 
8.2.1 Fascin overexpression does not affect pancreatic functions 
ROSA26-LSL-Fascin1 mouse was obtained from Douglas Strathdee’s group and bred with 
our KC model (Pdx1-CRE::K-RasG12D). Pdx1 expression arises from E8.5 in pancreatic 
pluripotent cells and results in the specific expression of the CRE-recombinase in these 
cells, allowing genetic recombination of the different transgenes. Other cell types or tissues 
don’t undergo any recombination event, maintaining the Lox-STOP-Lox sequence in front 
of the Fascin transgene. For clarity, genotypes will be referred as K-Ras WT or Het and 
Fascin Pos or Neg, always mentioning the K-Ras status first. Mice included in each cohort 
were Pdx1-Cre positive. Our initial experimental design was based on a small cohort (3-9 
mice) of each genotype that were aged and sacrificed at 6 weeks, 15 weeks or 6 months. 
Physiological parameters such as body and pancreas weight, pancreatic profile and number 
of metastases was recorded. In addition, histological analyses were performed for different 
proliferation markers, tissue architecture based on Haematoxylin/Eosin staining, and 
immune cell infiltration.  
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Figure 8-2: KC model used for this study and experimental design 
A – Schematic of the gene targeting strategy to study Fascin overexpression in a pancreatic KC 
model. Cre-recombinase is placed under the pancreatic-specific Pdx1 promoter, leading to the 
specific excision of the Lox-STOP-Lox sequence from the Rosa-Fascin-Tg and K-RasG12D knock-in 
mouse. 
B – Representation of the experimental design, with mice cohorts and analyses performed. All mice 
used were Cre-positive. Genotypes are represented with the K-Ras status first, followed by the 
Fascin status. 
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Figure 8-3: Validation of the Fascin KC model 
A - Immunohistochemistry analysis of Fascin expression in a WT/Neg (left) and WT/Pos (right) 
pancreas at 6 weeks of age. Fascin is brown and nuclei are blue. 
B – Western Blot analysis from a tissue lysate of a WT/Neg and WT/Pos pancreas at 6 weeks of 
age. Membrane was blotted against Fascin (green) and α-Tubulin (red). Molecular weights are 
displayed on the side. 
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Figure 8-4: Physiological parameters from the 4 cohorts at different time points 
A-F – Results from the pancreatic profile obtained after terminal bleeding. Serum was collected and 
sent to the veterinary school for analysis. 
G – Pancreas versus body mass ratio obtained by reporting the weight of the pancreas at the time 
of sacrifice to the total animal weight. 
6 weeks: 9 mice/cohort – 15 weeks: WT/Neg = 3 mice, WT/Pos = 9 mice, Het/Neg = 3 mice, 
Het/Pos = 6 mice – 6 months: 6 mice/cohort 
Error bars represent S.E.M. 
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Fascin expression of WT/Neg and WT/Pos pancreata of 6 weeks old mice were analysed 
by immunohistochemistry (IHC) and Western blot. In both cases, we were able to confirm 
a strong increase of Fascin expression in the pancreas. IHC revealed that expression of the 
CRE was mosaic, as already described for the same model. WT/Neg mice did not show 
any staining and this observation is in line with the reported transient expression of Fascin 
during development in epithelial tissues (Zhang et al., 2008b).  
The pancreatic profile of each mouse was obtained from a blood sample at the time of 
sacrifice and pancreatic enzymes concentration was analysed. Differences observed 
between cohorts were statistically non-significant, probably reflecting the variability of the 
population. Therefore, Fascin overexpression in a wild-type background or a KC model did 
not affect pancreatic functions. Moreover, all sacrificed mice were healthy at each 
timepoint.  
The pancreas/body weight ratio is a reporter of PDAC formation. Tumours are 
characterised by a dense necrotic core characterised by a lot of fibrosis, which together are 
heavier than the normal tissue. Mice bearing mutated K-Ras showed a 3-fold increase in 
this ratio, but no differences were observed when Fascin was overexpressed. This suggests 
that K-Ras drives initial lesion formation but Fascin does not affect it. 
8.2.2 Fascin overexpression increases pre-malignant lesions at 
an early time point 
Initial observations were made using H&E staining, in order to analyse the tissue 
architecture on a small cohort of mice. This included any types of lesion and reflects the 
tumour burden between conditions, without classification of the PanIN sub-classes. This 
value corresponds to the percentage of lesion area over the total tissue surface. Histology 
analysis of 6-week old pancreata did not show any lesions in WT/Neg or WT/Pos mice. 
However, Het/Pos mice show extensive lesions compared to the Het/Neg counterparts and 
this is reflected by a 10-fold increase of the tumour burden ratio. The lesions are still small 
and minor compared to the total pancreas but may be the initial seeds driving PDAC 
formation. In this situation, Fascin and mutated K-Ras have a synergic effect as Fascin 
alone (i.e. in a K-Ras WT background) does not affect lesion initiation. When we extended 
our analysis to the 15-week and 6-month cohorts, the difference between these two 
genotypes was lost and suggests that the effect of K-Ras might over take the effect 
mediated by Fascin. However, the difference between K-Ras WT and K-Ras Het mice was 
more and more pronounced at later time points. Few lesions or only few of them were 
observed in K-Ras WT whether Fascin was overexpressed or not. This reinforced all the 
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published data focusing on the central role of mutated K-Ras during PDAC development. 
We also hypothesise that Fascin is not important for lesion initiation at later timepoint as 
mutated K-Ras alone is enough to increase the area affected by pancreatic lesions. 
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Figure 8-5: Fascin expression increases pancreatic tumour burden at an early time point 
Scatter plot representing the area of abnormal pancreatic structures (ADM, PanIN, PDAC) relative 
to the area of the section at each time point. Medium and S.E.M are represented. Mann Whitney 
test was applied. * p<0.05. 
6 weeks: WT/Neg = 5 mice, WT/Pos = 9 mice, Het/Neg = 8 mice, Het/Pos = 8 mice 
15 weeks: WT/Neg = 3 mice, WT/Pos = 7 mice, Het/Neg = 3 mice, Het/Pos = 4 mice 
6 months: 6 mice/cohort 
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Figure 8-6: Classification of the different lesions observed in the 6-week cohort 
A – Manual counting of the number of ducts observed for each pancreas section. Bar plot 
represent quantification of WT/Neg = 4 mice, WT/Pos = 9 mice, Het/Neg = 5 mice, Het/Pos = 8 
mice. Error bars represent S.E.M. 
B – Ranking of the pancreatic lesion according to their microscopic features 
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In order to characterise this phenotype, pancreata were precisely analysed and each 
lesion/duct ranked according to their type, starting from ADM to PDAC. This refinement 
of the previous quantification was restricted to the 6-weeks cohort as no differences were 
observed at later time points. Although the duct numbers were similar between each 
comparative cohort (WT/Neg vs WT/Pos = 20 ducts/section and Het/Neg vs Het/Pos = 45 
ducts/section), lesion types were different. Unlike Het/Neg mice that only show some 
ADM and PanIN1, Het/Pos cohort develops a wide range of lesions and notably, 2 
pancreata out of 8 had a small PDAC. Also, the proportion of ADM and PanIN1 was 5-
fold higher. 
For further characterisation, 2h before sacrifice, mice were injected with BrdU, a specific 
marker of cells during S-phase. In combination IHC against Ki-67, another proliferative 
marker that accumulates in all actively cycling cells was performed, excluding resting cells 
(G0). In addition, tissues were also stained by IHC against a key regulator of apoptosis, 
cleaved Caspase-3. This staining is specific to the fragmented protein and not the full 
length. This truncation occurs at Asp175 by activation of upstream Caspases (Caspase 8 
and 9) and activates downstream apoptotic pathways. In order to standardise our 
quantification method, seven random fields were taken across each pancreas and positive 
cells were manually counted according to their localisation (duct or acini). We did not 
observe any significant difference in proliferation of ductal cells, although there may be a 
trend towards more proliferation. No differences in proliferation of acinar cells or in 
apoptosis (acini and duct) were significant at 6 weeks. We did not observe any difference 
in proliferation and apoptosis at 15 weeks and 6 months by BrdU/Ki-67 and cleaved 
Caspase-3 staining. A larger sample size would be required to confirm an effect of Fascin 
overexpression on ductal cell proliferation.  
 
Overall we can conclude that Fascin overexpression accelerates development of early 
pancreatic ductal lesions. Higher grade lesions (PanIN2 and PanIN3) arise more frequently 
and may also end in PDAC formation. However, at 6 weeks of age, PDAC is too small to 
be diagnostic using apparent symptoms. Also, it is worth highlighting that Fascin 
overexpression alone, with no initial “hit” (K-Ras mutation) is not enough to initiate the 
aforementioned effects. 
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Figure 8-7: Histology analysis of 6-week old pancreata 
BrdU, Ki-67 and Cleaved Caspase-3 stained were performed by IHC. Positive cells were counted 
and attributed to an acinar or ductal localisation. Bar plots represent an average number of positive 
cells across seven random fields. Error bars represent S.E.M. Mann Whitney test was applied. n.s. 
p>0.05.  
3 pancreas/genotype were quantified. 
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Figure 8-8: Histology analysis of 15-week old pancreata 
BrdU, Ki-67 and Cleaved Caspase-3 stained were performed by IHC. Positive cells were counted 
and attributed to an acinar or ductal localisation. Bar plots represent an average number of positive 
cells across seven random fields Error bars represent S.E.M. Mann Whitney test was applied. n.s. 
p>0.05 
3 pancreas/genotype were quantified. 
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gure 8-9: Histology analysis of 6-month old pancreata 
BrdU, Ki-67 and Cleaved Caspase-3 stained were performed by IHC. Positive cells were counted 
and attributed to an acinar or ductal localisation. Bar plots represent an average number of positive 
cells across seven random fields.  Error bars represent S.E.M. Mann Whitney test was applied. 
6 pancreas/genotype were quantified. 
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8.3 Discussion, Future directions and Conclusion 
The data presented here suggest that Fascin is not crucial for early lesion formation but 
might synergise the effects mediated by K-Ras in a slow pancreatic cancer mouse model. 
Following the observation that Het/Pos mice were developing earlier lesions, we started a 
small cohort to look at 4 weeks old pups. This cohort is still on-going but the smaller size 
of the mice makes the terminal bleeding for pancreatic profile more difficult. Also, because 
blood sample analyses were normal at 6 weeks, we decided to not perform pancreatic 
profile analysis at 4 weeks. From the macroscopic analysis of the 4-week old cohort, 
Het/Pos mice have an enlarged pancreas compared to Het/Neg mice (Pancreas/body mass 
ratio = 0.9 ± 0.05 versus 0.55 ± 0.06 – S.E.M). Interestingly, out of 8 mice, one developed 
a small PDAC and one had a hyperplasic pancreas. However, none of these features were 
observed in the 4 control mice that we analysed. 
On its own, Fascin cannot drive lesion formation and only amplifies the effect of an initial 
hit. In our case, we looked at K-Ras but the phenotype related to K-Ras is too strong and 
may quickly overtake the effect of Fascin. To overcome this, we could switch to a 
pancreatitis model. Indeed, chronic inflammation also increases the risk of developing 
PDAC (Lowenfels et al., 1993). In an in vivo model, this protocol includes daily injection 
of Caerulein from 4 weeks old for 2 weeks. Dosage varies according to the different study 
but ranges from 50-400ng/g. Caerulein is a cholecystokinin (CCK) analogue that 
stimulates secretion of pancreatic enzymes. However, to understand the Caerulein-induced 
inflammation, it is important to look at the mechanism of action of CCK. CCK binds to a 
high and low affinity population of receptor. When CCK concentration is within the 
physiological range, it binds to high affinity receptors and stimulates exocytosis of 
granules containing pancreatic enzymes. Whenever the concentration rises, high-affinity 
receptors get saturated and CCK binds to low-affinity receptors, which inhibits enzyme 
secretion as they get trapped within the acinar cells (Saluja et al., 1985). Despite this 
storage as precursor enzymes, it is unknown how pro-peptides get activated and what is the 
mechanisms linking accumulation of inactive zymogens and pancreatitis. However, this 
acute response seeds the soil for an initial tumour burden, making it possible to study the 
role of Fascin during PanIN initiation. Alternative PDAC models could also been 
investigated. A model not requiring K-Ras has been developed by Wagner et al (Wagner et 
al., 2001) and is based on the overexpression of TGF-α under the elastase promoter and the 
deletion of TP53. Other models using a different promoter for the Cre recombinase 
expression have also different latency and could be useful for our purposes (Guerra and 
Barbacid, 2013). 
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We saw a trend towards more proliferation at 6 weeks in the Het/Pos cohort but this 
quantification was only done on a pilot cohort. Since this time, more pancreata have been 
sampled and we will complete our Ki-67 and BrdU counting. This effect on proliferation is 
however interesting as Li et al showed a direct relationship between the transcription factor 
Slug and Fascin (Li et al., 2014). Slug is a major regulator EMT regulator and has been 
linked to loss of cell-cell contacts and proliferation, although the exact effects seem to be 
cancer-type dependent (Emadi Baygi et al., 2010; Liu et al., 2010). The hypothesis here 
would be that Fascin might act on Slug expression using a feedback loop and affect 
downstream proliferation of ductal and acinar cells. IHC staining and western blot against 
Slug will be performed in our different cohorts at 6 weeks could suggest a potential loop of 
regulation.  
Finally, 6-week old pancreata were stained for immune cell infiltration. The GPI-anchored 
protein Ly-6G and the glycoprotein F4/80 were used as specific markers for neutrophils 
and macrophages respectively. Het/Pos pancreata showed increased infiltration of 
neutrophils and macrophages (data not shown) but this has not been properly quantified 
yet. Because of the irregular and diffuse staining and in order to be more transparent and 
precise, we are planning to use the HALO software that includes analysis of pixel intensity 
and shape in a semi-automatic manner. This should help us to determine whether mice 
develop an inflammation response during PanIN progression and address whether Fascin 
overexpressing induces any recruitment of immune cells following PanIN development. 
 
In conclusion, following the work of a previous PhD student looking at the role of Fascin 
during PDAC develop at late stage, we developed a project to investigate the effects of 
Fascin during early pancreatic development. We found that Fascin overexpressing mice 
had a higher tumour background, as early as 6 weeks of age and this correlates with a 
slight but non-significant increase in proliferation, although this might be linked to the size 
of the population in this cohort. Preliminary data even suggest an effect of Fascin 
overexpression at 4 weeks. We are hoping in the future to look deeper into the mechanisms 
driving this phenotype. This project is part of a bigger project co-lead by Nikki Paul, a 
post-doc in the lab. Together, we are planning to investigate the global modification of the 
proteome by laser dissection and mass spectrometry between our different cohorts. These 
data should be useful to understand the biology early development of lesions and 
potentially use Fascin as an early prognostic marker in patient biopsies. 
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10 Appendices 
 
Appendix 1: Multi-alignment of FAM49 
Sequences were obtained from Uniprot and correspond to the following UniProt ID: A2E1F1 
(Trichomonas vaginalis), C3Y224 (Branchiostoma floridae), H2ZNC1 (Ciona savignyi), Q09387 
(Caenorhabditis elegans), Q9H0Q0 (Homo sapiens FAM49A), Q7K1H0 (Drosophila melanogaster), 
Q9NUQ9 (Homo sapiens FAM49B), Q8T2H0 (Dictyostelium discoideum), A7SA43 (Nematostella 
vectensis), A0A075APQ0 (Rozella allomycis), I1F5T7 (Amphimedon queenslandica). Sequences 
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were aligned using macVector software. Red numbers above the first sequence highlight the 
residue position. A dash (-) represents a gap in the alignment, which might reflects deletion events 
during evolution. The bottom row highlights the 75% consensus sequence. Colour code represents 
the number of entries with similar amino acid at this position. 
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Appendix 2:  Co-evolution of FAM49 with the actin-machinery 
Phylogenetic tree representing the co-evolution of Arp2/3 (green), Scar/WAVE (brown) and FAM49 
(orange) across the main phyla of the eukaryotic tree. Each superfamily is represented with a 
specific background colour: Excavates (blue), Unikonts (yellow), chromalveolates (pink) and plants 
(green). Branch length is not proportional to the evolution distance between organisms. Incomplete 
circles represent the lack of some subunits in the protein complex. Asterisk * correspond to the lack 
of putative N-myristoylation site on FAM49. In the Unikonts phylum, branch colours correspond to 
amoebazoa (yellow), metazoan (purple), fungi (brown) and Rozella allomycis (blue). This figure 
was inspired from (Veltman and Insall, 2010). 
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Appendix 3: Hidden Markov Model (HMM) representing the conservation of the DUF1394 
domain from the "full Pfam database" 
HMM profile of 915 sequences corresponding to the evolution of the DUF1394 domain and 
generated by Skylign. The height of the stack corresponds to the residue conservation at this 
position while the height of each letter reflects the frequency of the residue at this position. Each 
residue got assigned a colour according to the default parameters of the Skylign tool. Numbers 
above each sequence represent the cumulative number of residues used in the analysis. Numbers 
from the bottom row correspond to an occupancy score (Ranging from 0-1) and is defined as the 
probability of observing a letter at this position. The darker the colour, the lower the probability is, 
meaning that only a small proportion of sequences has a residue at this position in the alignment. 
The red line running across the sequence highlights the Rac1 Binding Domain (RBD). 
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Appendix 3: Hidden Markov Model (HMM) representing the conservation of the DUF1394 
domain from the "full Pfam database" (continued) 
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Appendix 3: Hidden Markov Model (HMM) representing the conservation of the DUF1394 
domain from the "full Pfam database" (continued) 
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Appendix 3: Hidden Markov Model (HMM) representing the conservation of the DUF1394 
domain from the "full Pfam database" (continued) 
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Appendix 3: Hidden Markov Model (HMM) representing the conservation of the DUF1394 
domain from the "full Pfam database" (continued) 
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Appendix 3: Hidden Markov Model (HMM) representing the conservation of the DUF1394 
domain from the "full Pfam database" (continued) 
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Appendix 4: Thermal shift assay  
Protein folding was tested by thermal shift assay before being used for further analysis. Protein 
was mixed with a dye that specifically binds to hydrophobic (unfolded) regions before being diluted 
either in gel filtration buffer (GF buffer) or the buffer provided in the kit (dilution buffer). Four 
technical replicates were obtained and displayed with a specific colour to assess the variability of 
the assay. Temperature was then gradually increased, resulting in the denaturation of the protein, 
which exposes a larger hydrophobic surface. This is reflected by a rapid increase of the dye 
fluorescence and corresponds to the “protein melt”. In this assay, GST-Rac1 binding domain, 
untagged Rac1 binding domain, Histidine-tagged wild-type or constitutively active Q61L Rac1 were 
tested. 
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Appendix 5: Rac1 FRET probe  
Vector map and graphical representation of the folding of the Rac1 FRET probe designed by Kirsty 
Martin (Martin et al, 2017). In an inactive state, GDP-loaded Rac1 cannot interact with the Rac1 
binding domain of PAK1, resulting to an open conformation of the reporter. Upon GEF activity, GTP 
gets loaded onto Rac1, which in turn can bind to the PAK1 protein. This folding allows 
mTurquoise2 and sREACh to be in close proximity, allowing FRET. 
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Appendix 6: Heat-map of selected putative FAM49B interactors identified by mass 
spectrometry 
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COS-7 cells were transfected with GFP, GFP-FAM49B, FAM49B-GFP or GFP-30-236 
(corresponding to FAM49B-RBD and referred to as GFP-30) and GFP-trap was performed before 
tryptic digestion “on-beads” and LS-MS/MS analysis. Enriched candidates are presented according 
to the label-free quantitation intensities calculated by MaxQuant. 
Rac1 is highlighted in red. 
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